10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

___________________________________________________ 

FORM 10-Q

___________________________________________________ 

☒ QUARTERLY REPORT PURSUANT TO SECTIONS 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended: January 31, 2020

or

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                      to                     

Commission file number: 1-5111

 ___________________________________________________

The J. M. Smucker Company

(Exact name of registrant as specified in its charter)

___________________________________________________ 

Ohio			34-0538550
(State or other jurisdiction of incorporation or organization)			(I.R.S. Employer Identification No.)
One Strawberry Lane
Orrville,	Ohio		44667-0280
(Address of principal executive offices)			(Zip code)
Registrant’s telephone number, including area code:			(330)	682-3000
N/A
(Former name, former address and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class		Trading symbol	Name of each exchange on which registered
Common shares, no par value		SJM	New York Stock Exchange

 ___________________________________________________

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  ý    No  o

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes  ý    No  o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	ý	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes  ☐    No  ý

The Company had 114,037,925 common shares outstanding on February 19, 2020.

TABLE OF CONTENTS

		Page No.
PART I. FINANCIAL INFORMATION
Item 1.	Financial Statements
	Condensed Statements of Consolidated Income	2
	Condensed Statements of Consolidated Comprehensive Income	2
	Condensed Consolidated Balance Sheets	3
	Condensed Statements of Consolidated Cash Flows	4
	Condensed Statements of Consolidated Shareholders’ Equity	5
	Notes to Unaudited Condensed Consolidated Financial Statements	6
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	22
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	30
Item 4.	Controls and Procedures	33
PART II. OTHER INFORMATION
Item 1.	Legal Proceedings	34
Item 1A.	Risk Factors	34
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	35
Item 6.	Exhibits	35
SIGNATURES		36
INDEX OF EXHIBITS		37

1

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements.

THE J. M. SMUCKER COMPANY

CONDENSED STATEMENTS OF CONSOLIDATED INCOME

(Unaudited)

	Three Months Ended January 31,				Nine Months Ended January 31,
Dollars in millions, except per share data	2020		2019		2020		2019
Net sales	$	1,972.3	$	2,011.9	$	5,709.0	$	5,935.9
Cost of products sold	1,212.3		1,238.1		3,495.4		3,712.6
Gross Profit	760.0		773.8		2,213.6		2,223.3
Selling, distribution, and administrative expenses	358.9		373.1		1,100.9		1,138.8
Amortization	58.8		59.7		176.4		179.9
Other intangible assets impairment charges	52.4		107.2		52.4		107.2
Other special project costs (A)	3.3		18.8		9.9		51.9
Other operating expense (income) – net	(2.4)		(2.6)		(2.4)		(29.5)
Operating Income	289.0		217.6		876.4		775.0
Interest expense – net	(45.1)		(51.6)		(143.6)		(158.8)
Other income (expense) – net	(1.4)		(8.8)		(4.5)		(16.5)
Income Before Income Taxes	242.5		157.2		728.3		599.7
Income tax expense	55.1		35.8		175.1		156.8
Net Income	$	187.4	$	121.4	$	553.2	$	442.9
Earnings per common share:
Net Income	$	1.64	$	1.07	$	4.85	$	3.89
Net Income – Assuming Dilution	$	1.64	$	1.07	$	4.85	$	3.89

(A)Other special project costs includes integration and restructuring costs. For more information, see Note 4: Integration and Restructuring Costs.

See notes to unaudited condensed consolidated financial statements.

THE J. M. SMUCKER COMPANY

CONDENSED STATEMENTS OF CONSOLIDATED COMPREHENSIVE INCOME

(Unaudited)

	Three Months Ended January 31,				Nine Months Ended January 31,
Dollars in millions	2020		2019		2020		2019
Net income	$	187.4	$	121.4	$	553.2	$	442.9
Other comprehensive income (loss):
Foreign currency translation adjustments	(2.5)		1.6		2.6		(10.1)
Cash flow hedging derivative activity, net of tax	(17.4)		(37.0)		(92.0)		(28.8)
Pension and other postretirement benefit plans activity, net of tax	1.5		(0.5)		4.0		2.7
Available-for-sale securities activity, net of tax	0.5		(1.0)		0.9		(0.4)
Total Other Comprehensive Income (Loss)	(17.9)		(36.9)		(84.5)		(36.6)
Comprehensive Income	$	169.5	$	84.5	$	468.7	$	406.3

See notes to unaudited condensed consolidated financial statements.

2

THE J. M. SMUCKER COMPANY

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

Dollars in millions	January 31, 2020		April 30, 2019
ASSETS
Current Assets
Cash and cash equivalents	$	74.4	$	101.3
Trade receivables, less allowance for doubtful accounts	477.3		503.8
Inventories:
Finished products	615.1		590.8
Raw materials	343.7		319.5
Total Inventory	958.8		910.3
Other current assets	92.2		109.8
Total Current Assets	1,602.7		1,625.2
Property, Plant, and Equipment
Land and land improvements	123.7		122.1
Buildings and fixtures	958.2		903.2
Machinery and equipment	2,369.0		2,185.0
Construction in progress	194.9		321.8
Gross Property, Plant, and Equipment	3,645.8		3,532.1
Accumulated depreciation	(1,734.1)		(1,619.7)
Total Property, Plant, and Equipment	1,911.7		1,912.4
Other Noncurrent Assets
Operating lease right-of-use assets	168.0		—
Goodwill	6,312.8		6,310.9
Other intangible assets – net	6,491.4		6,718.8
Other noncurrent assets	149.6		144.0
Total Other Noncurrent Assets	13,121.8		13,173.7
Total Assets	$	16,636.2	$	16,711.3
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current Liabilities
Accounts payable	$	575.0	$	591.0
Accrued trade marketing and merchandising	198.7		142.7
Current portion of long-term debt	499.8		798.5
Short-term borrowings	310.0		426.0
Current operating lease liabilities	41.7		—
Other current liabilities	452.2		383.3
Total Current Liabilities	2,077.4		2,341.5
Noncurrent Liabilities
Long-term debt, less current portion	4,583.3		4,686.3
Deferred income taxes	1,364.2		1,398.6
Noncurrent operating lease liabilities	133.5		—
Other noncurrent liabilities	307.4		314.4
Total Noncurrent Liabilities	6,388.4		6,399.3
Total Liabilities	8,465.8		8,740.8
Shareholders’ Equity
Common shares	29.0		28.9
Additional capital	5,787.2		5,755.8
Retained income	2,620.5		2,367.6
Accumulated other comprehensive income (loss)	(266.3)		(181.8)
Total Shareholders’ Equity	8,170.4		7,970.5
Total Liabilities and Shareholders’ Equity	$	16,636.2	$	16,711.3

See notes to unaudited condensed consolidated financial statements.

3

THE J. M. SMUCKER COMPANY

CONDENSED STATEMENTS OF CONSOLIDATED CASH FLOWS

(Unaudited)

	Nine Months Ended January 31,
Dollars in millions	2020		2019
Operating Activities
Net income	$	553.2	$	442.9
Adjustments to reconcile net income to net cash provided by (used for) operations:
Depreciation	156.7		154.1
Amortization	176.4		179.9
Other intangible assets impairment charges	52.4		107.2
Share-based compensation expense	19.8		16.5
Gain on divestiture	—		(27.6)
Other noncash adjustments – net	15.9		4.6
Defined benefit pension contributions	(1.1)		(20.1)
Changes in assets and liabilities, net of effect from acquisition and divestiture:
Trade receivables	26.7		(51.4)
Inventories	(48.0)		(18.8)
Other current assets	7.0		19.5
Accounts payable	12.3		(11.2)
Accrued liabilities	44.6		73.1
Income and other taxes	(40.9)		10.1
Other – net	(7.9)		(11.8)
Net Cash Provided by (Used for) Operating Activities	967.1		867.0
Investing Activities
Business acquired, net of cash acquired	—		(1,903.0)
Additions to property, plant, and equipment	(192.9)		(267.2)
Proceeds from divestiture	—		371.4
Other – net	15.3		(24.0)
Net Cash Provided by (Used for) Investing Activities	(177.6)		(1,822.8)
Financing Activities
Short-term borrowings (repayments) – net	(122.6)		360.0
Proceeds from long-term debt	—		1,500.0
Repayments of long-term debt	(400.0)		(600.0)
Quarterly dividends paid	(296.7)		(281.4)
Purchase of treasury shares	(4.3)		(5.2)
Proceeds from stock option exercises	7.0		—
Other – net	0.5		0.2
Net Cash Provided by (Used for) Financing Activities	(816.1)		973.6
Effect of exchange rate changes on cash	(0.3)		(3.9)
Net increase (decrease) in cash and cash equivalents	(26.9)		13.9
Cash and cash equivalents at beginning of period	101.3		192.6
Cash and Cash Equivalents at End of Period	$	74.4	$	206.5

( ) Denotes use of cash

See notes to unaudited condensed consolidated financial statements.

4

THE J. M. SMUCKER COMPANY

CONDENSED STATEMENTS OF CONSOLIDATED SHAREHOLDERS’ EQUITY

(Unaudited)

Dollars in millions	Common Shares Outstanding	Common Shares		Additional Capital		Retained Income		Accumulated Other Comprehensive Income (Loss)		Total Shareholders’ Equity
Balance at May 1, 2019	113,742,296	$	28.9	$	5,755.8	$	2,367.6	$	(181.8)	$	7,970.5
Net income						154.6				154.6
Other comprehensive income (loss)								(34.9)		(34.9)
Comprehensive income										119.7
Purchase of treasury shares	(22,793)	—		(2.7)		(0.2)				(2.9)
Stock plans	330,289	0.1		20.4						20.5
Cash dividends declared, $0.88 per common share						(100.1)				(100.1)
Other						—				—
Balance at July 31, 2019	114,049,792	$	29.0	$	5,773.5	$	2,421.9	$	(216.7)	$	8,007.7
Net income						211.2				211.2
Other comprehensive income (loss)								(31.7)		(31.7)
Comprehensive income										179.5
Purchase of treasury shares	(4,930)	—		(0.6)		—				(0.6)
Stock plans	14,882	—		8.8						8.8
Cash dividends declared, $0.88 per common share						(100.1)				(100.1)
Other						—				—
Balance at October 31, 2019	114,059,744	$	29.0	$	5,781.7	$	2,533.0	$	(248.4)	$	8,095.3
Net income						187.4				187.4
Other comprehensive income (loss)								(17.9)		(17.9)
Comprehensive income										169.5
Purchase of treasury shares	(7,180)	—		(1.0)		0.2				(0.8)
Stock plans	(11,251)	—		6.5						6.5
Cash dividends declared, $0.88 per common share						(100.1)				(100.1)
Other						—				—
Balance at January 31, 2020	114,041,313	$	29.0	$	5,787.2	$	2,620.5	$	(266.3)	$	8,170.4

Dollars in millions	Common Shares Outstanding	Common Shares		Additional Capital		Retained Income		Accumulated Other Comprehensive Income (Loss)		Total Shareholders’ Equity
Balance at May 1, 2018	113,572,840	$	28.9	$	5,739.7	$	2,239.2	$	(116.7)	$	7,891.1
Net income						133.0				133.0
Other comprehensive income (loss)								(2.1)		(2.1)
Comprehensive income										130.9
Purchase of treasury shares	(43,913)	—		(4.6)		(0.1)				(4.7)
Stock plans	243,521	—		10.0						10.0
Cash dividends declared, $0.85 per common share						(96.5)				(96.5)
Other						—				—
Balance at July 31, 2018	113,772,448	$	28.9	$	5,745.1	$	2,275.6	$	(118.8)	$	7,930.8
Net income						188.5				188.5
Other comprehensive income (loss)								2.4		2.4
Comprehensive income										190.9
Purchase of treasury shares	(2,485)	—		(0.3)		—				(0.3)
Stock plans	(9,883)	—		5.1						5.1
Cash dividends declared, $0.85 per common share						(96.5)				(96.5)
Other		—				—				—
Balance at October 31, 2018	113,760,080	$	28.9	$	5,749.9	$	2,367.6	$	(116.4)	$	8,030.0
Net income						121.4				121.4
Other comprehensive income (loss)								(36.9)		(36.9)
Comprehensive income										84.5
Purchase of treasury shares	(1,746)	—		(0.2)		—				(0.2)
Stock plans	122	—		3.7						3.7
Cash dividends declared, $0.85 per common share						(96.4)				(96.4)
Balance at January 31, 2019	113,758,456	$	28.9	$	5,753.4	$	2,392.6	$	(153.3)	$	8,021.6

See notes to unaudited condensed consolidated financial statements.

5

THE J. M. SMUCKER COMPANY

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars and shares in millions, unless otherwise noted, except per share data)

Note 1: Basis of Presentation

The unaudited interim condensed consolidated financial statements of The J. M. Smucker Company (“Company,” “we,” “us,” or “our”) have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments of a normal recurring nature considered necessary for a fair presentation have been included.

Operating results for the nine months ended January 31, 2020, are not necessarily indicative of the results that may be expected for the year ending April 30, 2020. For further information, reference is made to the consolidated financial statements and notes included in our Annual Report on Form 10-K for the year ended April 30, 2019.

Note 2: Recently Issued Accounting Standards

In December 2019, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2019-12, Income Taxes (Topic 740) Simplifying the Accounting for Income Taxes, which removes certain exceptions for investments, intraperiod allocations and interim calculations, and adds guidance to reduce complexity in accounting for income taxes. ASU 2019-12 will be effective for us on May 1, 2021, with the option to early adopt at any time prior to the effective date. Accounting for franchise taxes will require adoption on a retrospective or modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the fiscal year of adoption. All other applicable provisions will require adoption on a retrospective, modified retrospective, or prospective basis, as required by ASU 2019-12. We do not anticipate that the adoption of this ASU will have a material impact on our financial statements and disclosures.

In August 2018, the FASB issued ASU 2018-15, Intangibles – Goodwill and Other – Internal-Use Software (Subtopic 350-40) Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract. ASU 2018-15 aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. ASU 2018-15 is effective for us on May 1, 2020, but we elected to early adopt on May 1, 2019, as permitted, on a prospective basis. During the nine months ended January 31, 2020, we capitalized implementation costs related to third-party cloud computing services of $3.4, which is reflected in other noncurrent assets in the Condensed Consolidated Balance Sheet.

In August 2018, the FASB also issued ASU 2018-14, Compensation – Retirement Benefits – Defined Benefit Plans – General (Subtopic 715-20) Disclosure Framework – Changes to the Disclosure Requirements for Defined Benefit Plans, which modifies the disclosure requirements for employers that sponsor defined benefit pension or other postretirement benefit plans. The guidance removes disclosures that are no longer considered cost beneficial and adds new, as well as clarifies certain other, disclosure requirements. ASU 2018-14 will be effective for us on May 1, 2020, with the option to early adopt at any time prior to the effective date, and it will require adoption on a retrospective basis. We do not anticipate that the adoption of this ASU will have a material impact on our disclosures.

In August 2018, the U.S. Securities and Exchange Commission (“SEC”) adopted the final rule under SEC Release No. 33-10532, Disclosure Update and Simplification, to eliminate or modify certain disclosure rules that are redundant, outdated, or duplicative of U.S. GAAP or other regulatory requirements. This rule was effective on November 5, 2018, and as a result, we adopted a portion of the amendments during 2019. This rule also amended the disclosure requirements related to the analysis of shareholders’ equity, which was expanded to the interim financial statements and was effective for us on May 1, 2019. While the new shareholders’ equity disclosure requirements impacted our interim financial statements beginning May 1, 2019, the amendments in this rule did not have a material impact on our other financial statements and disclosures.

In February 2016, in an effort to increase transparency and comparability among organizations, the FASB issued ASU 2016-02, Leases (Topic 842), which requires lessees to recognize a right-of-use asset and lease liability for all leases with a term of more than 12 months. We adopted the requirements of ASU 2016-02 and all related amendments on May 1, 2019, utilizing an optional transition method that allows for a cumulative-effect adjustment in the period of adoption with no restatement of prior periods. This transition method also does not require new lease disclosures for periods prior to the effective date. We elected certain practical expedients available under the guidance, including a package of practical expedients which allowed us to not reassess prior conclusions related to existing contracts containing leases, lease classification, and initial direct costs.

6

Adoption of ASU 2016-02 on May 1, 2019, resulted in the recognition of operating lease right-of-use assets and lease liabilities of $159.2 and $166.6, respectively, in the Condensed Consolidated Balance Sheet. The difference between the additional lease assets and lease liabilities was primarily due to an existing deferred rent balance that was reclassified to the operating lease liability. The new standard did not materially impact our Condensed Statement of Consolidated Income or Condensed Statement of Consolidated Cash Flows. The additional disclosures required are presented within Note 13: Leases.

Note 3: Acquisition

On May 14, 2018, we acquired the equity of Ainsworth Pet Nutrition, LLC (“Ainsworth”), a leading producer, distributor, and marketer of premium pet food and pet snacks, predominantly within the U.S., in an all-cash transaction valued at $1.9 billion. The transaction was funded with a bank term loan and borrowings under our commercial paper program of approximately $1.5 billion and $400.0, respectively. For additional information on the financing associated with this transaction, refer to Note 9: Debt and Financing Arrangements.

During 2019, the final purchase price was allocated to the underlying assets acquired and liabilities assumed based upon their estimated fair values at the date of acquisition. We determined the estimated fair values based on independent appraisals, discounted cash flow analyses, quoted market prices, and other estimates made by management. The purchase price allocation included total intangible assets of $1.3 billion. The purchase price exceeded the estimated fair value of the net identifiable tangible and intangible assets acquired and, as a result, the excess was allocated to goodwill. As a result of the acquisition, we recognized total goodwill of $617.8 within the U.S. Retail Pet Foods segment, which represented the value we expected to achieve through the implementation of operational synergies and growth opportunities as a result of integrating Ainsworth into our U.S. Retail Pet Foods segment. Of the total goodwill, $446.0 was deductible for income tax purposes at the acquisition date, of which $392.9 remains deductible at January 31, 2020. The goodwill and indefinite-lived trademarks within the U.S. Retail Pet Foods segment, inclusive of the recently acquired Ainsworth business, remain susceptible to future impairment charges due to the narrow differences between fair value and carrying value. Any significant adverse change in our near or long-term projections or macroeconomic conditions could result in future impairment charges. For more information, see Note 8: Goodwill and Other Intangible Assets.

Note 4: Integration and Restructuring Costs

Integration and restructuring costs primarily consist of employee-related costs and other transition and termination costs related to certain acquisition or restructuring activities. Employee-related costs include severance, retention bonuses, and relocation costs. Severance costs and retention bonuses are recognized over the estimated future service period of the affected employees, and relocation costs are expensed as incurred. Other transition and termination costs include fixed asset-related charges, contract and lease termination costs, professional fees, and other miscellaneous expenditures associated with the integration or restructuring activities, which are expensed as incurred. These integration and restructuring costs are not allocated to segment profit and are reported in other special project costs in the Condensed Statements of Consolidated Income. The obligation related to employee separation costs is included in other current liabilities in the Condensed Consolidated Balance Sheets.

Integration Costs: Total integration costs related to the acquisition of Ainsworth are anticipated to be approximately $50.0, the majority of which are expected to be cash charges. Of the total anticipated integration costs, we expect approximately one-third to be employee-related costs. All remaining integration costs are expected to be incurred by the end of 2020.

The following table summarizes our integration costs incurred related to the Ainsworth acquisition.

	Three Months Ended January 31,				Nine Months Ended January 31,				Total Costs Incurred to Date at January 31, 2020
	2020		2019		2020		2019
Employee-related costs	$	0.3	$	5.4	$	1.7	$	13.2	$	17.2
Other transition and termination costs	3.0		2.3		8.2		10.7		24.8
Total integration costs	$	3.3	$	7.7	$	9.9	$	23.9	$	42.0

Noncash charges of $0.1 and $1.0 were included in the integration costs incurred during the three months ended January 31, 2020 and 2019, respectively, and $0.5 and $2.8 during the nine months ended January 31, 2020 and 2019, respectively. Cumulative noncash charges incurred to date were $4.6 and primarily consisted of accelerated depreciation. The obligation related to severance costs and retention bonuses was $0.3 and $1.6 at January 31, 2020, and April 30, 2019, respectively.

7

Restructuring Costs: We completed the restructuring activities associated with our organization optimization program as of April 30, 2019, and as a result, we did not incur any related costs during the three and nine months ended January 31, 2020. We incurred restructuring costs of $11.1 and $28.0 during the three and nine months ended January 31, 2019, respectively, primarily consisting of employee-related costs. Total restructuring costs of $74.6 were incurred related to the program, which included $48.7 and $25.9 of employee-related costs and other transition and termination costs, respectively. Noncash charges included in the total restructuring costs were $15.2, of which $1.2 and $2.2 were incurred during the three and nine months ended January 31, 2019, respectively. Noncash charges primarily consisted of accelerated depreciation. The obligation related to severance costs and retention bonuses was fully satisfied as of January 31, 2020, and was $0.8 at April 30, 2019.

Note 5: Divestiture

On August 31, 2018, we sold our U.S. baking business to Brynwood Partners VII L.P. and Brynwood Partners VIII L.P., subsidiaries of Brynwood Partners, an unrelated party. The transaction included products that were primarily sold in U.S. retail channels under the Pillsbury^®, Martha White^®, Hungry Jack^®, White Lily^®, and Jim Dandy^® brands, along with all relevant trademarks and licensing agreements, and our manufacturing facility in Toledo, Ohio. This business generated net sales of approximately $370.0 in 2018. The transaction did not include our baking business in Canada.

The operating results for this business were primarily included in the U.S. Retail Consumer Foods segment prior to the sale. We received proceeds from the divestiture of $369.5, which were net of cash transaction costs and included a working capital adjustment. During 2019, we recognized a pre-tax gain of $27.7 related to this transaction, of which $1.0 was recognized during the third quarter associated with the working capital adjustment that was finalized during the fourth quarter. The gain was included in other operating expense (income) – net within the Condensed Statement of Consolidated Income.

Note 6: Reportable Segments

We operate in one industry: the manufacturing and marketing of food and beverage products. We have four reportable segments: U.S. Retail Pet Foods, U.S. Retail Coffee, U.S. Retail Consumer Foods, and International and Away From Home.

The U.S. Retail Pet Foods segment primarily includes the domestic sales of Rachael Ray^TM Nutrish^®, Meow Mix^®, Milk-Bone^®, Natural Balance^®, Kibbles ’n Bits^®, 9Lives^®, Nature’s Recipe^®, and Pup-Peroni^® branded products; the U.S. Retail Coffee segment primarily includes the domestic sales of Folgers^®, Dunkin’ Donuts^®, and Café Bustelo^® branded coffee; and the U.S. Retail Consumer Foods segment primarily includes the domestic sales of Smucker’s^®, Jif^®, and Crisco^® branded products. The International and Away From Home segment comprises products distributed domestically and in foreign countries through retail channels and foodservice distributors and operators (e.g., restaurants, lodging, schools and universities, health care operators).

Segment profit represents net sales, less direct and allocable operating expenses, and is consistent with the way in which we manage our segments. However, we do not represent that the segments, if operated independently, would report operating profit equal to the segment profit set forth below, as segment profit excludes certain expenses such as corporate administrative expenses, unallocated gains and losses on commodity and foreign currency exchange derivative activities, as well as amortization expense and impairment charges related to intangible assets.

Commodity and foreign currency exchange derivative gains and losses are reported in unallocated derivative gains and losses outside of segment operating results until the related inventory is sold. At that time, we reclassify the hedge gains and losses from unallocated derivative gains and losses to segment profit, allowing our segments to realize the economic effect of the hedge without experiencing any mark-to-market volatility. We would expect that any gain or loss in the estimated fair value of the derivatives would generally be offset by a change in the estimated fair value of the underlying exposures.

8

	Three Months Ended January 31,				Nine Months Ended January 31,
	2020		2019		2020		2019
Net sales:
U.S. Retail Pet Foods	$	721.9	$	759.0	$	2,101.7	$	2,158.3
U.S. Retail Coffee	558.8		561.6		1,567.9		1,596.0
U.S. Retail Consumer Foods	422.9		422.7		1,251.2		1,367.9
International and Away From Home	268.7		268.6		788.2		813.7
Total net sales	$	1,972.3	$	2,011.9	$	5,709.0	$	5,935.9
Segment profit:
U.S. Retail Pet Foods	$	146.0	$	147.9	$	403.1	$	372.2
U.S. Retail Coffee	189.5		183.7		500.9		505.8
U.S. Retail Consumer Foods	84.2		95.9		256.6		327.5
International and Away From Home	49.0		52.5		131.7		152.6
Total segment profit	$	468.7	$	480.0	$	1,292.3	$	1,358.1
Amortization	(58.8)		(59.7)		(176.4)		(179.9)
Other intangible assets impairment charges	(52.4)		(107.2)		(52.4)		(107.2)
Interest expense – net	(45.1)		(51.6)		(143.6)		(158.8)
Unallocated derivative gains (losses)	7.7		(2.9)		37.6		(25.0)
Other special project costs (A)	(3.3)		(18.8)		(9.9)		(51.9)
Corporate administrative expenses	(72.9)		(73.8)		(214.8)		(219.1)
Other income (expense) – net	(1.4)		(8.8)		(4.5)		(16.5)
Income before income taxes	$	242.5	$	157.2	$	728.3	$	599.7

(A)Other special project costs includes integration and restructuring costs. For more information, see Note 4: Integration and Restructuring Costs.

The following table presents certain geographical information.

	Three Months Ended January 31,				Nine Months Ended January 31,
	2020		2019		2020		2019
Net sales:
United States	$	1,837.6	$	1,880.6	$	5,311.1	$	5,526.1
International:
Canada	$	108.7	$	106.7	$	318.9	$	319.2
All other international	26.0		24.6		79.0		90.6
Total international	$	134.7	$	131.3	$	397.9	$	409.8
Total net sales	$	1,972.3	$	2,011.9	$	5,709.0	$	5,935.9

9

The following table presents product category information.

	Three Months Ended January 31,				Nine Months Ended January 31,
	2020		2019		2020		2019		Primary Reportable Segment (A)
Coffee	$	650.7	$	653.5	$	1,824.5	$	1,867.3	U.S. Retail Coffee
Dog food	300.8		337.5		899.0		980.9		U.S. Retail Pet Foods
Cat food	223.9		218.9		633.6		615.2		U.S. Retail Pet Foods
Pet snacks	214.6		217.9		617.8		607.6		U.S. Retail Pet Foods
Peanut butter	180.0		188.5		533.3		574.6		U.S. Retail Consumer Foods
Fruit spreads	88.3		86.0		264.0		254.6		U.S. Retail Consumer Foods
Frozen handheld	82.6		67.3		247.5		210.5		U.S. Retail Consumer Foods
Shortening and oils	68.9		74.8		192.2		207.0		U.S. Retail Consumer Foods
Portion control	42.0		40.1		123.9		122.6		International and Away From Home
Juices and beverages	30.4		30.6		94.0		96.7		U.S. Retail Consumer Foods
Baking mixes and ingredients	19.6		21.9		59.3		164.6		International and Away From Home (B)
Other	70.5		74.9		219.9		234.3		International and Away From Home
Total net sales	$	1,972.3	$	2,011.9	$	5,709.0	$	5,935.9

(A)The primary reportable segment generally represents at least 75 percent of total net sales for each respective product category.

(B)During the three and nine months ended January 31, 2019, the primary reportable segment was U.S. Retail Consumer Foods, as the majority of the net sales within this category were related to the divested U.S. baking business. For more information, see Note 5: Divestiture.

Note 7: Earnings per Share

The following table sets forth the computation of net income per common share and net income per common share – assuming dilution under the two-class method.

	Three Months Ended January 31,				Nine Months Ended January 31,
	2020		2019		2020		2019
Net income	$	187.4	$	121.4	$	553.2	$	442.9
Less: Net income allocated to participating securities	1.1		0.6		3.2		2.3
Net income allocated to common stockholders	$	186.3	$	120.8	$	550.0	$	440.6
Weighted-average common shares outstanding	113.4		113.2		113.3		113.1
Add: Dilutive effect of stock options	—		—		—		—
Weighted-average common shares outstanding – assuming dilution	113.4		113.2		113.3		113.1
Net income per common share	$	1.64	$	1.07	$	4.85	$	3.89
Net income per common share – assuming dilution	$	1.64	$	1.07	$	4.85	$	3.89

10

Note 8: Goodwill and Other Intangible Assets

The following table summarizes our other intangible assets and related accumulated amortization and impairment charges including foreign currency exchange adjustments.

	January 31, 2020						April 30, 2019
	Acquisition Cost		Accumulated Amortization/Impairment Charges/Foreign Currency Exchange		Net		Acquisition Cost		Accumulated Amortization/Impairment Charges/Foreign Currency Exchange		Net
Finite-lived intangible assets subject to amortization:
Customer and contractual relationships	$	4,471.1	$	1,302.8	$	3,168.3	$	4,471.1	$	1,156.8	$	3,314.3
Patents and technology	168.5		135.6		32.9		168.5		127.4		41.1
Trademarks	502.0		188.0		314.0		499.9		166.9		333.0
Total intangible assets subject to amortization	$	5,141.6	$	1,626.4	$	3,515.2	$	5,139.5	$	1,451.1	$	3,688.4
Indefinite-lived intangible assets not subject to amortization:
Trademarks	$	3,319.0	$	342.8	$	2,976.2	$	3,321.1	$	290.7	$	3,030.4
Total other intangible assets	$	8,460.6	$	1,969.2	$	6,491.4	$	8,460.6	$	1,741.8	$	6,718.8

We review goodwill and other indefinite-lived intangible assets at least annually on February 1 for impairment, and more often if indicators of impairment exist.

During the third quarter of 2020, we began our annual planning cycle, which was not complete as of January 31, 2020; however, certain brand-level decisions were made during the quarter that we evaluated to determine whether the carrying value of certain indefinite-lived intangible assets more likely than not exceeded fair value. As a result, we recognized an impairment charge of $52.4 related to the Natural Balance brand within the U.S. Retail Pet Foods segment due to a decline in current year and long-term net sales expectations and the royalty rate used in the interim analysis, primarily driven by the market environment and re-positioning of this brand within the Pet Foods brand portfolio. This charge was included as a noncash charge in our Condensed Statement of Consolidated Income. Additionally, we reassessed the long-term strategic expectations for the Natural Balance brand and will reclassify this brand as a finite-lived intangible asset as of February 1, 2020, resulting in annual amortization expense of $4.5.

As of January 31, 2020, there were no other indicators of impairment, and as a result, we do not believe that our reporting units or any of our remaining indefinite-lived intangible assets are more likely than not impaired. However, the goodwill and indefinite-lived trademarks within the U.S. Retail Pet Foods segment, inclusive of the recently acquired Ainsworth business, remain susceptible to future impairment charges due to the narrow differences between fair value and carrying value. Any significant adverse change in our near or long-term projections or macroeconomic conditions could result in future impairment charges. The carrying values of the goodwill and indefinite-lived intangible assets within the U.S. Retail Pet Foods segment were $2.4 billion and $1.4 billion, respectively, as of January 31, 2020.

During the third quarter of 2019, we recognized a noncash impairment charge of $107.2 related to certain indefinite-lived intangible assets within the U.S. Retail Pet Foods segment.

11

Note 9: Debt and Financing Arrangements

Long-term debt consists of the following:

	January 31, 2020				April 30, 2019
	Principal Outstanding		Carrying Amount (A)		Principal Outstanding		Carrying Amount (A)
2.20% Senior Notes due December 6, 2019	$	—	$	—	$	300.0	$	299.5
2.50% Senior Notes due March 15, 2020	500.0		499.8		500.0		499.0
3.50% Senior Notes due October 15, 2021	750.0		762.9		750.0		768.4
3.00% Senior Notes due March 15, 2022	400.0		398.5		400.0		398.0
3.50% Senior Notes due March 15, 2025	1,000.0		995.8		1,000.0		995.2
3.38% Senior Notes due December 15, 2027	500.0		496.6		500.0		496.2
4.25% Senior Notes due March 15, 2035	650.0		643.8		650.0		643.5
4.38% Senior Notes due March 15, 2045	600.0		586.4		600.0		586.0
Term Loan Credit Agreement due May 14, 2021	700.0		699.3		800.0		799.0
Total long-term debt	$	5,100.0	$	5,083.1	$	5,500.0	$	5,484.8
Current portion of long-term debt	500.0		499.8		800.0		798.5
Total long-term debt, less current portion	$	4,600.0	$	4,583.3	$	4,700.0	$	4,686.3

(A) Represents the carrying amount included in the Condensed Consolidated Balance Sheets, which includes the impact of capitalized debt issuance costs, terminated interest rate contracts, and offering discounts.

We entered into interest rate contracts in November 2018 and June 2018, with notional values of $300.0 and $500.0, respectively, to manage our exposure to interest rate volatility associated with anticipated debt financing in 2020. These interest rate contracts are designated as cash flow hedges, and as a result, the mark-to-market gains or losses on these contracts are deferred and included as a component of accumulated other comprehensive income (loss) and reclassified to interest expense in the period during which the hedged transactions affect earnings. At January 31, 2020, unrealized losses of $168.9 were deferred in accumulated other comprehensive income (loss) for these derivative instruments. For additional information, see Note 11: Derivative Financial Instruments.

In April 2018, we entered into a senior unsecured delayed-draw Term Loan Credit Agreement (“Term Loan”) with a syndicate of banks and an available commitment amount of $1.5 billion. The full amount of the Term Loan was drawn on May 14, 2018, to partially finance the Ainsworth acquisition, as discussed in Note 3: Acquisition. Borrowings under the Term Loan bear interest on the prevailing U.S. Prime Rate or London Interbank Offered Rate (“LIBOR”), based on our election, and are payable either on a quarterly basis or at the end of the borrowing term. The Term Loan does not require scheduled amortization payments. Voluntary prepayments are permitted without premium or penalty. As of January 31, 2020, we have prepaid $800.0 on the Term Loan to date, including $100.0 in 2020. The interest rate on the Term Loan at January 31, 2020, was 2.45 percent. In November 2019, we entered into an amendment to the Term Loan that decreased the applicable margins on LIBOR, based on our long-term unsecured debt rating. This amendment did not have a material impact on our condensed consolidated financial statements.

All of our Senior Notes outstanding at January 31, 2020, are unsecured and interest is paid semiannually, with no required scheduled principal payments until maturity. We may prepay all or part of the Senior Notes at 100 percent of the principal amount thereof, together with the accrued and unpaid interest, and any applicable make-whole amount.

We have available a $1.8 billion unsecured revolving credit facility with a group of 11 banks that matures in September 2022. Borrowings under the revolving credit facility bear interest on the prevailing U.S. Prime Rate, LIBOR, or Canadian Dealer Offered Rate, based on our election. Interest is payable either on a quarterly basis or at the end of the borrowing term. We did not have a balance outstanding under the revolving credit facility at January 31, 2020, or April 30, 2019.

We participate in a commercial paper program under which we can issue short-term, unsecured commercial paper not to exceed $1.8 billion at any time. The commercial paper program is backed by our revolving credit facility and reduces what we can borrow under the revolving credit facility by the amount of commercial paper outstanding. Commercial paper will be used as a continuing source of short-term financing for general corporate purposes. As of January 31, 2020, and April 30, 2019, we had $310.0 and $426.0 of short-term borrowings outstanding, respectively, which were issued under our commercial paper program at weighted-average interest rates of 1.79 percent and 2.75 percent, respectively.

12

Interest paid totaled $18.3 and $24.4 for the three months ended January 31, 2020 and 2019, respectively, and $118.3 and $131.8, for the nine months ended January 31, 2020 and 2019, respectively. This differs from interest expense due to the timing of interest payments, effect of interest rate contracts, amortization of debt issuance costs and discounts, capitalized interest, and payment of other debt fees.

Our debt instruments contain certain financial covenant restrictions, including a leverage ratio and an interest coverage ratio. We are in compliance with all covenants.

Note 10: Pensions and Other Postretirement Benefits

The components of our net periodic benefit cost for defined benefit pension and other postretirement benefit plans are shown below.

	Three Months Ended January 31,
	Defined Benefit Pension Plans				Other Postretirement Benefits
	2020		2019		2020		2019
Service cost	$	0.4	$	0.6	$	0.4	$	0.5
Interest cost	5.2		5.9		0.5		0.6
Expected return on plan assets	(6.0)		(6.8)		—		—
Amortization of net actuarial loss (gain)	2.0		2.0		(0.1)		(0.1)
Amortization of prior service cost (credit)	0.2		0.2		(0.2)		(0.4)
Curtailment loss (gain)	—		0.3		—		—
Settlement loss (gain)	—		4.2		—		—
Net periodic benefit cost	$	1.8	$	6.4	$	0.6	$	0.6

	Nine Months Ended January 31,
	Defined Benefit Pension Plans				Other Postretirement Benefits
	2020		2019		2020		2019
Service cost	$	1.2	$	1.7	$	1.3	$	1.4
Interest cost	15.7		17.6		1.7		1.8
Expected return on plan assets	(18.1)		(20.3)		—		—
Amortization of net actuarial loss (gain)	6.0		6.1		(0.2)		(0.4)
Amortization of prior service cost (credit)	0.6		0.7		(0.8)		(1.0)
Curtailment loss (gain)	—		0.3		—		—
Settlement loss (gain)	—		4.2		—		—
Net periodic benefit cost	$	5.4	$	10.3	$	2.0	$	1.8

Note 11: Derivative Financial Instruments

We are exposed to market risks, such as changes in commodity prices, foreign currency exchange rates, and interest rates. To manage the volatility related to these exposures, we enter into various derivative transactions. We have policies in place that define acceptable instrument types we may enter into and establish controls to limit our market risk exposure.

Commodity Price Management: We enter into commodity derivatives to manage price volatility and reduce the variability of future cash flows related to anticipated inventory purchases of key raw materials, notably green coffee, corn, edible oils, soybean meal, and wheat. We also enter into commodity derivatives to manage price risk for energy input costs, including diesel fuel and natural gas. Our derivative instruments generally have maturities of less than one year.

We do not qualify commodity derivatives for hedge accounting treatment, and as a result, the derivative gains and losses are immediately recognized in earnings. Although we do not perform the assessments required to achieve hedge accounting for derivative positions, we believe all of our commodity derivatives are economic hedges of our risk exposure.

13

The commodities hedged have a high inverse correlation to price changes of the derivative instrument. Thus, we would expect that over time any gain or loss in the estimated fair value of the derivatives would generally be offset by an increase or decrease in the estimated fair value of the underlying exposures.

Foreign Currency Exchange Rate Hedging: We utilize foreign currency derivatives to manage the effect of foreign currency exchange fluctuations on future cash payments primarily related to purchases of certain raw materials and finished goods. The contracts generally have maturities of less than one year. We do not qualify instruments used to manage foreign currency exchange exposures for hedge accounting treatment.

Interest Rate Hedging: We utilize derivative instruments to manage interest rate risk associated with anticipated debt transactions, as well as to manage changes in the fair value of our long-term debt. At the inception of an interest rate contract, the instrument is evaluated and documented for qualifying hedge accounting treatment. If the contract is designated as a cash flow hedge, the mark-to-market gains or losses on the contract are deferred and included as a component of accumulated other comprehensive income (loss) and reclassified to interest expense in the period during which the hedged transaction affects earnings. If the contract is designated as a fair value hedge, the contract is recognized at fair value on the balance sheet, and changes in the fair value are recognized in interest expense. Generally, changes in the fair value of the contract are equal to changes in the fair value of the underlying debt and have no net impact on earnings.

We entered into interest rate contracts in November 2018 and June 2018, with notional values of $300.0 and $500.0, respectively, to manage our exposure to interest rate volatility associated with anticipated debt financing in 2020. These interest rate contracts are designated as cash flow hedges, and as a result, unrealized losses of $168.9 were deferred in accumulated other comprehensive income (loss) at January 31, 2020.

In 2015, we terminated the interest rate swap on the Senior Notes due October 15, 2021, which was designated as a fair value hedge and used to hedge against the changes in the fair value of the debt. As a result of the early termination, we received $58.1 in cash, which included $4.6 of accrued and prepaid interest. The gain on termination was recorded as an increase in the long-term debt balance and is being recognized over the remaining life of the underlying debt as a reduction to interest expense. To date, we have recognized $39.2 of the gain, of which $2.1 and $6.2 was recognized during the three and nine months ended January 31, 2020, respectively. The remaining gain will be recognized as follows: $1.9 through the remainder of 2020, $8.4 in 2021, and $4.0 in 2022.

The following tables set forth the gross fair value amounts of derivative instruments recognized in the Condensed Consolidated Balance Sheets.

	January 31, 2020
	Other Current Assets		Other Current Liabilities		Other Noncurrent Assets		Other Noncurrent Liabilities
Derivatives designated as hedging instruments:
Interest rate contracts	$	—	$	168.9	$	—	$	—
Total derivatives designated as hedging instruments	$	—	$	168.9	$	—	$	—
Derivatives not designated as hedging instruments:
Commodity contracts	$	8.6	$	16.4	$	—	$	—
Foreign currency exchange contracts	0.4		0.1		—		—
Total derivatives not designated as hedging instruments	$	9.0	$	16.5	$	—	$	—
Total derivative instruments	$	9.0	$	185.4	$	—	$	—

14

	April 30, 2019
	Other Current Assets		Other Current Liabilities		Other Noncurrent Assets		Other Noncurrent Liabilities
Derivatives designated as hedging instruments:
Interest rate contracts	$	—	$	49.1	$	—	$	—
Total derivatives designated as hedging instruments	$	—	$	49.1	$	—	$	—
Derivatives not designated as hedging instruments:
Commodity contracts	$	4.8	$	25.8	$	—	$	—
Foreign currency exchange contracts	1.4		0.2		—		—
Total derivatives not designated as hedging instruments	$	6.2	$	26.0	$	—	$	—
Total derivative instruments	$	6.2	$	75.1	$	—	$	—

We have elected to not offset fair value amounts recognized for our exchange-traded derivative instruments and our cash margin accounts executed with the same counterparty that are generally subject to enforceable netting agreements. We are required to maintain cash margin accounts in connection with funding the settlement of our open positions. At January 31, 2020, and April 30, 2019, we maintained cash margin account balances of $25.7 and $40.7, respectively, included in other current assets in the Condensed Consolidated Balance Sheets. The change in the cash margin account balances is included in other – net, investing activities in the Condensed Statements of Consolidated Cash Flows. In the event of default and immediate net settlement of all of our open positions with individual counterparties, all of our exchange-traded derivative liabilities would be fully offset by either our derivative asset positions or margin accounts based on the net asset or liability position with our individual counterparties.

Interest expense – net, as presented in the Condensed Statements of Consolidated Income, was $45.1 and $51.6 for the three months ended January 31, 2020 and 2019, respectively, and was $143.6 and $158.8 for the nine months ended January 31, 2020 and 2019, respectively. The following table presents information on the pre-tax gains and losses recognized on interest rate contracts designated as cash flow hedges.

	Three Months Ended January 31,				Nine Months Ended January 31,
	2020		2019		2020		2019
Gains (losses) recognized in other comprehensive income (loss)	$	(22.7)	$	(48.1)	$	(119.8)	$	(37.6)
Less: Gains (losses) reclassified from accumulated other comprehensive income (loss) to interest expense	(0.1)		(0.1)		(0.3)		(0.3)
Change in accumulated other comprehensive income (loss)	$	(22.6)	$	(48.0)	$	(119.5)	$	(37.3)

Included as a component of accumulated other comprehensive income (loss) at January 31, 2020, and April 30, 2019, were deferred net pre-tax losses of $172.0 and $52.5, respectively, related to the active and terminated interest rate contracts. The related net tax benefit recognized in accumulated other comprehensive income (loss) at January 31, 2020, and April 30, 2019, was $39.6 and $12.1, respectively. Approximately $8.9 of the net pre-tax loss will be recognized over the next 12 months related to the active and terminated interest rate contracts.

The following table presents the net gains and losses recognized in cost of products sold on derivatives not designated as hedging instruments.

	Three Months Ended January 31,				Nine Months Ended January 31,
	2020		2019		2020		2019
Gains (losses) on commodity contracts	$	(7.3)	$	(25.8)	$	(4.8)	$	(55.9)
Gains (losses) on foreign currency exchange contracts	0.3		0.2		(0.8)		1.7
Total gains (losses) recognized in cost of products sold	$	(7.0)	$	(25.6)	$	(5.6)	$	(54.2)

15

Commodity and foreign currency exchange derivative gains and losses are reported in unallocated derivative gains and losses outside of segment operating results until the related inventory is sold. At that time, we reclassify the hedge gains and losses from unallocated derivative gains and losses to segment profit, allowing our segments to realize the economic effect of the hedge without experiencing any mark-to-market volatility. The following table presents the activity in unallocated derivative gains and losses.

	Three Months Ended January 31,				Nine Months Ended January 31,
	2020		2019		2020		2019
Net gains (losses) on mark-to-market valuation of unallocated derivative positions	$	(7.0)	$	(25.6)	$	(5.6)	$	(54.2)
Less: Net gains (losses) on derivative positions reclassified to segment operating profit	(14.7)		(22.7)		(43.2)		(29.2)
Unallocated derivative gains (losses)	$	7.7	$	(2.9)	$	37.6	$	(25.0)

The net cumulative unallocated derivative losses were $14.9 and $52.5 at January 31, 2020, and April 30, 2019, respectively.

The following table presents the gross notional value of outstanding derivative contracts.

	January 31, 2020		April 30, 2019
Commodity contracts	$	808.9	$	544.8
Foreign currency exchange contracts	88.1		144.9
Interest rate contracts	800.0		800.0

Note 12: Other Financial Instruments and Fair Value Measurements

Financial instruments, other than derivatives, that potentially subject us to significant concentrations of credit risk consist principally of cash investments, short-term borrowings, and trade receivables. The carrying value of these financial instruments approximates fair value. Our remaining financial instruments, with the exception of long-term debt, are recognized at estimated fair value in the Condensed Consolidated Balance Sheets.

The following table provides information on the carrying amounts and fair values of our financial instruments.

	January 31, 2020				April 30, 2019
	Carrying Amount		Fair Value		Carrying Amount		Fair Value
Marketable securities and other investments	$	40.7	$	40.7	$	40.9	$	40.9
Derivative financial instruments – net	(176.4)		(176.4)		(68.9)		(68.9)
Total long-term debt	(5,083.1)		(5,386.8)		(5,484.8)		(5,504.0)

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Valuation techniques are based on observable and unobservable inputs. Observable inputs reflect readily obtainable data from independent sources, while unobservable inputs reflect our market assumptions.

16

The following tables summarize the fair values and the levels within the fair value hierarchy in which the fair value measurements fall for our financial instruments.

	Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Fair Value at January 31, 2020
Marketable securities and other investments: (A)
Equity mutual funds	$	9.6	$	—	$	—	$	9.6
Municipal obligations	—		31.1		—		31.1
Money market funds	—		—		—		—
Derivative financial instruments: (B)
Commodity contracts – net	(7.5)		(0.3)		—		(7.8)
Foreign currency exchange contracts – net	—		0.3		—		0.3
Interest rate contracts	—		(168.9)		—		(168.9)
Total long-term debt (C)	(4,662.4)		(724.4)		—		(5,386.8)
Total financial instruments measured at fair value	$	(4,660.3)	$	(862.2)	$	—	$	(5,522.5)

	Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Fair Value at April 30, 2019
Marketable securities and other investments: (A)
Equity mutual funds	$	8.7	$	—	$	—	$	8.7
Municipal obligations	—		31.7		—		31.7
Money market funds	0.5		—		—		0.5
Derivative financial instruments: (B)
Commodity contracts – net	(20.7)		(0.3)		—		(21.0)
Foreign currency exchange contracts – net	(0.1)		1.3		—		1.2
Interest rate contracts	—		(49.1)		—		(49.1)
Total long-term debt (C)	(4,646.6)		(857.4)		—		(5,504.0)
Total financial instruments measured at fair value	$	(4,658.2)	$	(873.8)	$	—	$	(5,532.0)

(A)Marketable securities and other investments consist of funds maintained for the payment of benefits associated with nonqualified retirement plans. The funds include equity securities listed in active markets, municipal obligations valued by a third party using valuation techniques that utilize inputs that are derived principally from or corroborated by observable market data, and money market funds with maturities of three months or less. Based on the short-term nature of these money market funds, carrying value approximates fair value. As of January 31, 2020, our municipal obligations are scheduled to mature as follows: $0.3 in 2020, $1.0 in 2021, $1.5 in 2022, $1.0 in 2023, and the remaining $27.3 in 2024 and beyond.

(B)Level 1 commodity and foreign currency exchange derivatives are valued using quoted market prices for identical instruments in active markets. Level 2 commodity and foreign currency exchange derivatives are valued using quoted prices for similar assets or liabilities in active markets. The Level 2 interest rate contracts are valued using standard valuation techniques, the income approach, and observable Level 2 market expectations at the measurement date to convert future amounts to a single discounted present value. Level 2 inputs for the valuation of the interest rate contracts are limited to prices that are observable for the asset or liability. For additional information, see Note 11: Derivative Financial Instruments.

(C)Long-term debt is composed of public Senior Notes classified as Level 1 and the Term Loan classified as Level 2. The public Senior Notes are traded in an active secondary market and valued using quoted prices. The fair value of the Term Loan is based on the net present value of each interest and principal payment calculated utilizing an interest rate derived from an estimated yield curve obtained from independent pricing sources for similar types of term loan borrowing arrangements. For additional information, see Note 9: Debt and Financing Arrangements.

During the third quarter of 2020 and 2019, we recognized impairment charges of $52.4 and $107.2, respectively, related to certain indefinite-lived trademarks in the U.S. Retail Pet Foods segment, which were included as a noncash charge in our Condensed Statements of Consolidated Income. We utilized Level 3 inputs based on management's best estimates and assumptions to estimate the fair value of the indefinite-lived trademarks. For additional information, see Note 8: Goodwill and Other Intangible Assets.

17

Note 13: Leases

We lease certain warehouses, manufacturing facilities, office space, equipment, and vehicles, primarily through operating lease agreements. We have elected to not recognize leases with a term of 12 months or less on the balance sheet. Instead, we recognize the related lease expense on a straight-line basis over the lease term.

Although the majority of our right-of-use asset and lease liability balances consist of leases with renewal options, we generally are not reasonably certain to exercise them, and therefore, the optional periods do not typically impact the lease term. Certain leases also include termination provisions or options to purchase the leased property. Since we are not reasonably certain to exercise these types of options, minimum lease payments do not include any amounts related to these termination or purchase options. Our lease agreements generally do not contain residual value guarantees or restrictive covenants that are material.

We determine if an agreement is or contains a lease at inception by evaluating whether an identified asset exists that we control over the term of the arrangement. A lease commences when the lessor makes the identified asset available for our use. We generally account for lease and non-lease components as a single lease component. Minimum lease payments do not include variable lease payments other than those that depend on an index or rate.

For the majority of our leases, the interest rate implicit in the lease cannot be readily determined, so we utilize our incremental borrowing rate to present value lease payments using information available at the lease commencement date. We consider our credit rating and the current economic environment in determining this collateralized rate. For the initial implementation of the lease standard, the incremental borrowing rate at May 1, 2019, was used to calculate all operating lease liabilities.

The following table sets forth the right-of-use assets and lease liabilities recognized in the Condensed Consolidated Balance Sheet.

	January 31, 2020
Operating lease right-of-use assets	$	168.0
Operating lease liabilities:
Current operating lease liabilities	$	41.7
Noncurrent operating lease liabilities	133.5
Total operating lease liabilities	$	175.2
Finance lease right-of-use assets:
Machinery and equipment	$	13.4
Accumulated depreciation	(6.9)
Total property, plant, and equipment	$	6.5
Finance lease liabilities:
Other current liabilities	$	2.2
Other noncurrent liabilities	3.7
Total finance lease liabilities	$	5.9

The following table summarizes the components of lease expense.

	Three Months Ended January 31, 2020		Nine Months Ended January 31, 2020
Operating lease cost	$	13.2	$	38.5
Finance lease cost:
Amortization of right-of-use assets	0.7		2.3
Interest on lease liabilities	0.1		0.2
Variable lease cost	5.0		17.6
Short-term lease cost	8.5		25.9
Sublease income	(1.1)		(3.4)
Net lease cost	$	26.4	$	81.1

18

The following table sets forth cash flow and noncash information related to leases.

	Nine Months Ended January 31, 2020
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	38.8
Operating cash flows from finance leases	0.2
Financing cash flows from finance leases	2.1
Right-of-use assets obtained in exchange for new lease liabilities:
Operating leases	56.6
Finance leases	2.4

The following table summarizes the maturity of our lease liabilities by fiscal year.

	January 31, 2020
	Operating Leases		Finance Leases
2020 (remainder of the year)	$	12.3	$	0.7
2021	43.8		2.2
2022	40.5		1.6
2023	34.6		0.9
2024	22.8		0.7
2025 and beyond	34.8		0.2
Total undiscounted minimum lease payments	$	188.8	$	6.3
Less: Imputed interest	13.6		0.4
Lease liabilities	$	175.2	$	5.9

As of April 30, 2019, our minimum operating lease obligations were as follows: $43.0 in 2020, $36.7 in 2021, $30.5 in 2022, $24.8 in 2023, and $12.3 in 2024.

The following table sets forth the weighted average remaining lease term and discount rate.

	January 31, 2020
Weighted average remaining lease term (in years):
Operating leases	4.8
Finance leases	3.4
Weighted average discount rate:
Operating leases	3.1	%
Finance leases	3.0	%

Note 14: Income Taxes

The effective tax rates for the three months ended January 31, 2020 and 2019, were 22.7 and 22.8 percent, respectively, and for the nine months ended January 31, 2020 and 2019, were 24.0 and 26.1 percent, respectively. During the three and nine months ended January 31, 2020 and 2019, the effective tax rates varied from the U.S. statutory income tax rate of 21.0 percent primarily due to the impact of state income taxes. The effective tax rate for the nine months ended January 31, 2019, was also unfavorably impacted by additional income tax expense related to the sale of the U.S. baking business.

Within the next 12 months, it is reasonably possible that we could decrease our unrecognized tax benefits by an additional $2.6, primarily as a result of expiring statute of limitations periods.

As of January 31, 2020, the undistributed earnings of our foreign subsidiaries remain permanently reinvested.

19

Note 15: Accumulated Other Comprehensive Income (Loss)

The components of accumulated other comprehensive income (loss), including the reclassification adjustments for items that are reclassified from accumulated other comprehensive income (loss) to net income, are shown below.

	Foreign Currency Translation Adjustment		Net Gains (Losses) on Cash Flow Hedging Derivatives (A)		Pension and Other Postretirement Liabilities (B)		Unrealized  Gain (Loss) on Available- for-Sale Securities		Accumulated Other Comprehensive Income (Loss)
Balance at May 1, 2019	$	(35.5)	$	(40.4)	$	(110.0)	$	4.1	$	(181.8)
Reclassification adjustments	—		0.3		5.2		—		5.5
Current period credit (charge)	2.6		(119.8)		—		1.2		(116.0)
Income tax benefit (expense)	—		27.5		(1.2)		(0.3)		26.0
Balance at January 31, 2020	$	(32.9)	$	(132.4)	$	(106.0)	$	5.0	$	(266.3)

	Foreign Currency Translation Adjustment		Net Gains (Losses) on Cash Flow Hedging Derivatives (A)		Pension and Other Postretirement Liabilities (B)		Unrealized Gain (Loss) on Available- for-Sale Securities		Accumulated Other Comprehensive Income (Loss)
Balance at May 1, 2018	$	(16.4)	$	(2.9)	$	(101.0)	$	3.6	$	(116.7)
Reclassification adjustments	—		0.3		6.0		—		6.3
Current period credit (charge)	(10.1)		(37.6)		(2.4)		(0.5)		(50.6)
Income tax benefit (expense)	—		8.5		(0.9)		0.1		7.7
Balance at January 31, 2019	$	(26.5)	$	(31.7)	$	(98.3)	$	3.2	$	(153.3)

(A)The reclassification from accumulated other comprehensive income (loss) to interest expense was related to terminated interest rate contracts. The current period credit (charge) relates to the unrealized gains (losses) on the interest rate contracts entered into in November 2018 and June 2018. For additional information, see Note 11: Derivative Financial Instruments.

(B)Amortization of net losses and prior service costs was reclassified from accumulated other comprehensive income (loss) to other income (expense) – net.

Note 16: Contingencies

We, like other food manufacturers, are from time to time subject to various administrative, regulatory, and other legal proceedings arising in the ordinary course of business. We are currently a defendant in a variety of such legal proceedings, including certain lawsuits related to the alleged price-fixing of shelf stable tuna products prior to 2011 by a business previously owned by, but divested prior to our acquisition of, Big Heart Pet Brands, the significant majority of which were settled and paid during the second half of 2019. While we cannot predict with certainty the ultimate results of these proceedings or potential settlements associated with these or other matters, we have accrued losses for certain contingent liabilities that we have determined are probable and reasonably estimable at January 31, 2020. Based on the information known to date, with the exception of the matter discussed below, we do not believe the final outcome of these proceedings would have a material adverse effect on our financial position, results of operations, or cash flows.

On May 9, 2011, an organization named Council for Education and Research on Toxics (“Plaintiff” or “CERT”) filed a lawsuit in the Superior Court of the State of California, County of Los Angeles, against us and additional defendants who manufacture, package, distribute, or sell packaged coffee. The lawsuit is CERT v. Brad Barry LLC, et al., and was a tag along to a 2010 lawsuit against companies selling “ready-to-drink” coffee based on the same claims. Both cases have since been consolidated and now include nearly eighty defendants, which constitute the great majority of the coffee industry in California. The Plaintiff alleges that we and the other defendants failed to provide warnings for our coffee products of exposure to the chemical acrylamide as required under California Health and Safety Code Section 25249.5, the California Safe Drinking Water and Toxic Enforcement Act of 1986 (better known as “Proposition 65”). The Plaintiff seeks equitable relief, including providing warnings to consumers of coffee products, as well as civil penalties in the amount of the statutory maximum of $2,500 per day per violation of Proposition 65. The Plaintiff asserts that every consumed cup of coffee, absent a compliant warning, is equivalent to a violation under Proposition 65.

As part of a joint defense group organized to defend against the lawsuit, we dispute the claims of the Plaintiff. Acrylamide is not added to coffee but is inherently present in all coffee in small amounts (measured in parts per billion) as a byproduct of the coffee bean roasting process. We have asserted multiple affirmative defenses. Trial of the first phase of the case commenced on

20

September 8, 2014, and was limited to three affirmative defenses shared by all defendants. On September 1, 2015, the trial court issued a final ruling adverse to the defendants on all Phase 1 defenses. Trial of the second phase of the case commenced in the fall of calendar year 2017. On March 28, 2018, the trial court issued a proposed ruling adverse to the defendants on the Phase 2 defense, our last remaining defense to liability. The trial court finalized and affirmed its Phase 2 ruling on May 7, 2018, and therefore, the third phase of the trial regarding remedies issues was scheduled to commence on October 15, 2018. The trial did not proceed on the scheduled date as further described below.

On June 15, 2018, the state agency responsible for administering the Proposition 65 program, the California Office of Environmental Health Hazard Assessment (“OEHHA”), issued a proposed regulation clarifying that cancer warnings are not required for coffee under Proposition 65. The California Court of Appeals granted the defendants’ requests to stay the trial on remedies until a final determination was made on OEHHA’s proposed regulation. During the interim period, the California Office of Administrative Law approved the proposed regulation on June 3, 2019, and the regulation went into effect on October 1, 2019. In response to CERT's objection, the defendants amended their answer to raise the regulation as a complete defense to the claims. CERT unsuccessfully challenged the defendants' right to assert the regulation as an affirmative defense but continues to challenge the validity of the regulation. During the third quarter of 2020, CERT filed several motions seeking judgment in its favor as a matter of law, and the defendants also filed their own motion. Briefing on all motions is expected to continue into March 2020.

At this stage of the proceedings, prior to and without knowing whether the regulation will stand as a defense or the trial on remedies issues will move forward in light of the challenge, we are unable to predict or reasonably estimate the potential loss or effect on our operations. Accordingly, no loss contingency has been recorded for this matter as of January 31, 2020, as the likelihood of loss is not considered probable or estimable. The trial court has discretion to impose zero penalties against us or to impose significant statutory penalties if the case proceeds. Significant labeling or warning requirements that could potentially be imposed by the trial court may increase our costs and adversely affect sales of our coffee products, as well as involve substantial expense and operational disruption, which could have a material adverse impact on our financial position, results of operations, or cash flows. Furthermore, a future appellate court decision could reverse the earlier trial court rulings should the regulation be held invalid. The outcome and the financial impact of settlement, the trial, or the appellate court rulings of the case, if any, cannot be predicted at this time.

Note 17: Common Shares

The following table sets forth common share information.

	January 31, 2020	April 30, 2019
Common shares authorized	300.0	300.0
Common shares outstanding	114.0	113.7
Treasury shares	32.5	32.8

Repurchase Program: During the nine months ended January 31, 2020 and 2019, we did not repurchase any common shares under a repurchase plan authorized by the Board of Directors (the “Board”). Share repurchases during the nine months ended January 31, 2020 and 2019, consisted of shares repurchased from stock plan recipients in lieu of cash payments. At January 31, 2020, we had approximately 3.6 million common shares available for repurchase pursuant to the Board’s authorizations.

21

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

(Dollars and shares in millions, unless otherwise noted, except per share data)

This discussion and analysis deals with comparisons of material changes in the unaudited condensed consolidated financial statements for the three and nine months ended January 31, 2020 and 2019. All comparisons presented are to the corresponding period of the prior year, unless otherwise noted.

On May 14, 2018, we acquired the equity of Ainsworth in an all-cash transaction, which was funded by debt and valued at $1.9 billion. Ainsworth was a leading producer, distributor, and marketer of premium pet food and pet snacks, predominantly within the U.S. We expected to achieve annual cost synergies related to this acquisition of approximately $55.0 by the end of 2020, which was fully realized as of January 31, 2020.

On August 31, 2018, we sold our U.S. baking business to Brynwood Partners VII L.P. and Brynwood Partners VIII L.P., subsidiaries of Brynwood Partners, an unrelated party. The transaction included products that were primarily sold in U.S. retail channels under the Pillsbury, Martha White, Hungry Jack, White Lily, and Jim Dandy brands, along with all relevant trademarks and licensing agreements, and our manufacturing facility in Toledo, Ohio. This business generated net sales of approximately $370.0 in 2018, primarily in the U.S. Retail Consumer Foods segment. The transaction did not include our baking business in Canada. We received proceeds from the divestiture of $369.5, which were net of cash transaction costs and included a working capital adjustment. During 2019, we recognized a pre-tax gain of $27.7 related to this transaction, of which $1.0 was recognized during the third quarter associated with the working capital adjustment that was finalized during the fourth quarter. The gain was included in other operating expense (income) – net within the Condensed Statement of Consolidated Income.

We are the owner of all trademarks referenced herein, except for the following, which are used under license: Dunkin’^TM and Dunkin’ Donuts are trademarks of DD IP Holder LLC, and Rachael Ray is a trademark of Ray Marks II LLC. The Dunkin’ and Dunkin’ Donuts brands are licensed to us for packaged coffee products, including K-Cup^® pods, sold in retail channels such as grocery stores, mass merchandisers, club stores, and drug stores. Information in this document does not pertain to products for sale in Dunkin’ restaurants. K-Cup^® is a trademark of Keurig Green Mountain, Inc., used with permission.

Results of Operations

	Three Months Ended January 31,								Nine Months Ended January 31,
	2020			2019			% Increase (Decrease)		2020			2019			% Increase (Decrease)
Net sales	$	1,972.3		$	2,011.9		(2)	%	$	5,709.0		$	5,935.9		(4)	%
Gross profit	$	760.0		$	773.8		(2)		$	2,213.6		$	2,223.3		—
% of net sales	38.5		%	38.5		%			38.8		%	37.5		%
Operating income	$	289.0		$	217.6		33		$	876.4		$	775.0		13
% of net sales	14.7		%	10.8		%			15.4		%	13.1		%
Net income:
Net income	$	187.4		$	121.4		54		$	553.2		$	442.9		25
Net income per common share – assuming dilution	$	1.64		$	1.07		53		$	4.85		$	3.89		25
Adjusted gross profit (A)	$	752.3		$	776.7		(3)		$	2,176.0		$	2,248.3		(3)
% of net sales	38.1		%	38.6		%			38.1		%	37.9		%
Adjusted operating income (A)	$	395.8		$	406.2		(3)		$	1,077.5		$	1,139.0		(5)
% of net sales	20.1		%	20.2		%			18.9		%	19.2		%
Adjusted income: (A)
Income	$	268.5		$	256.7		5		$	705.7		$	705.6		—
Earnings per share – assuming dilution	$	2.35		$	2.26		4		$	6.19		$	6.20		—

(A)We use non-GAAP financial measures to evaluate our performance. Refer to “Non-GAAP Financial Measures” in this discussion and analysis for a reconciliation to the comparable GAAP financial measure.

22

Net Sales

	Three Months Ended January 31,								Nine Months Ended January 31,
	2020		2019		Increase (Decrease)		%		2020		2019		Increase (Decrease)		%
Net sales	$	1,972.3	$	2,011.9	$	(39.6)	(2)	%	$	5,709.0	$	5,935.9	$	(226.9)	(4)	%
Ainsworth acquisition	—		—		—		—		(25.4)		—		(25.4)		—
Baking divestiture	—		—		—		—		—		(105.9)		105.9		2
Foreign currency exchange	(1.3)		—		(1.3)		—		2.3		—		2.3		—
Net sales excluding acquisition, divestiture, and foreign currency exchange (A)	$	1,971.0	$	2,011.9	$	(40.9)	(2)	%	$	5,685.9	$	5,830.0	$	(144.1)	(2)	%

Amounts may not add due to rounding.

(A)Net sales excluding acquisition, divestiture, and foreign currency exchange is a non-GAAP financial measure used to evaluate performance internally. This measure provides useful information because it enables comparison of results on a year-over-year basis.

Net sales in the third quarter of 2020 decreased $39.6, or 2 percent, reflecting unfavorable volume/mix in the U.S. Retail Pet Foods segment, primarily driven by dog food. Lower net price realization for the remaining segments was primarily driven by lower net pricing for coffee and peanut butter, which was mostly offset by favorable volume/mix for coffee and Smucker’s Uncrustables^®.

Net sales in the first nine months of 2020 decreased $226.9, or 4 percent, reflecting $105.9 of noncomparable net sales in the prior year related to the U.S. baking business, partially offset by incremental net sales in the current year of $25.4 related to the Ainsworth acquisition. Net sales excluding acquisition, divestiture, and foreign currency exchange decreased $144.1, or 2 percent. Lower net price realization impacted net sales by 2 percentage points, primarily due to lower net pricing for coffee and peanut butter, partially offset by higher pricing for pet food and pet snacks. Unfavorable volume/mix impacted net sales by 1 percentage point, primarily driven by declines for private label dog food, as well as the Natural Balance brand, partially offset by gains for the Smucker’s and Dunkin’ Donuts brands.

Operating Income

The following table presents the components of operating income as a percentage of net sales.

	Three Months Ended January 31,				Nine Months Ended January 31,
	2020		2019		2020		2019
Gross profit	38.5	%	38.5	%	38.8	%	37.5	%
Selling, distribution, and administrative expenses:
Marketing	6.1	%	6.7	%	6.6	%	6.9	%
Selling	2.9		2.9		3.3		3.2
Distribution	3.7		3.2		3.6		3.3
General and administrative	5.5		5.7		5.8		5.7
Total selling, distribution, and administrative expenses	18.2	%	18.5	%	19.3	%	19.2	%
Amortization	3.0		3.0		3.1		3.0
Other intangible assets impairment charges	2.7		5.3		0.9		1.8
Other special project costs	0.2		0.9		0.2		0.9
Other operating expense (income) – net	(0.1)		(0.1)		—		(0.5)
Operating income	14.7	%	10.8	%	15.4	%	13.1	%

Amounts may not add due to rounding.

Gross profit decreased $13.8, or 2 percent, in the third quarter of 2020, primarily driven by unfavorable volume/mix and an unfavorable net impact of lower prices and lower costs. Operating income increased $71.4, or 33 percent, primarily reflecting a $54.8 decrease in intangible asset impairment charges, a $15.5 decrease in special project costs, and a $14.2 decrease in selling, distribution, and administrative (“SD&A”) expenses, partially offset by the decline in gross profit. During the third quarter of 2020, we recognized a noncash impairment charge of $52.4 associated with the Natural Balance brand within the U.S. Retail Pet Foods segment. For further information on this charge, refer to “Critical Accounting Estimates and Policies” in this discussion and analysis.

23

Our non-GAAP adjustments include amortization expense and impairment charges related to intangible assets, integration and restructuring costs, and unallocated gains and losses on commodity and foreign currency exchange derivatives. Refer to “Non-GAAP Financial Measures” in this discussion and analysis for further information. Gross profit excluding non-GAAP adjustments (“adjusted gross profit”) decreased $24.4, or 3 percent, in the third quarter of 2020, as compared to prior year, further reflecting a $10.6 unfavorable change related to the exclusion of unallocated derivative gains and losses, as compared to GAAP gross profit. Operating income excluding non-GAAP adjustments (“adjusted operating income”) decreased $10.4, or 3 percent, as compared to prior year, further reflecting the change related to the exclusion of impairment charges and special project costs, as compared to GAAP operating income.

Gross profit decreased $9.7 in the first nine months of 2020, primarily driven by the noncomparable impact related to the U.S. baking business divestiture and unfavorable volume/mix, mostly offset by a favorable net impact of lower prices and lower costs and the noncomparable benefit of Ainsworth. The favorable net impact of price and cost was mostly driven by a favorable change in the impact of derivative gains and losses. Operating income increased $101.4, or 13 percent, primarily due to the $54.8 decrease in intangible asset impairment charges, a $42.0 decrease in special project costs, and a $37.9 decrease in SD&A expenses, partially offset by the impact of the $27.6 pre-tax gain related to the sale of the U.S. baking business in the prior year and the decline in gross profit.

Adjusted gross profit decreased $72.3, or 3 percent, in the first nine months of 2020, as compared to the prior year, further reflecting a $62.6 unfavorable change related to the exclusion of unallocated derivative gains and losses, as compared to GAAP gross profit. Adjusted operating income decreased $61.5, or 5 percent, as compared to the prior year, further reflecting the change related to the exclusion of impairment charges and special project costs, as compared to GAAP operating income.

Interest Expense

Net interest expense decreased $6.5, or 13 percent, in the third quarter of 2020, and decreased $15.2, or 10 percent, in the first nine months of 2020, primarily as a result of reduced debt, as compared to the prior year, driven by repayments made during the last twelve months.

Income Taxes

Income taxes increased $19.3, or 54 percent, in the third quarter of 2020, and increased $18.3, or 12 percent, in the first nine months of 2020. The 2020 effective tax rates were 22.7 percent for the third quarter and 24.0 percent for the first nine months. The 2019 effective tax rates were 22.8 percent for the third quarter and 26.1 percent for the first nine months.

During the current year and the prior year, the effective tax rates varied from the U.S. statutory tax rate of 21.0 percent, primarily due to the impact of state income taxes. The effective tax rate for the first nine months of the prior year was also unfavorably impacted by the income tax expense associated with the sale of the U.S. baking business. We anticipate a full-year effective tax rate for 2020 to be approximately 24.0 percent. For further information, refer to Note 14: Income Taxes.

Integration Activities

We expect to incur approximately $50.0 in total integration costs related to the Ainsworth acquisition, the majority of which are expected to be cash charges. Of the total anticipated integration costs, we expect approximately one-third to be employee-related costs. We have incurred total cumulative integration costs of $42.0, of which $3.3 and $9.9 were incurred in the third quarter and first nine months of 2020, respectively. All remaining integration costs are expected to be incurred by the end of 2020. For further information, refer to Note 4: Integration and Restructuring Costs.

Segment Results

We have four reportable segments: U.S. Retail Pet Foods, U.S. Retail Coffee, U.S. Retail Consumer Foods, and International and Away From Home. The U.S. Retail Pet Foods segment primarily includes the domestic sales of Rachael Ray Nutrish, Meow Mix, Milk-Bone, Natural Balance, Kibbles ’n Bits, 9Lives, Nature’s Recipe, and Pup-Peroni branded products; the U.S. Retail Coffee segment primarily includes the domestic sales of Folgers, Dunkin’ Donuts, and Café Bustelo branded coffee; and the U.S. Retail Consumer Foods segment primarily includes the domestic sales of Smucker’s, Jif, and Crisco branded products. The International and Away From Home segment comprises products distributed domestically and in foreign countries through retail channels and foodservice distributors and operators (e.g., restaurants, lodging, schools and universities, health care operators).

24

	Three Months Ended January 31,								Nine Months Ended January 31,
	2020			2019			% Increase (Decrease)		2020			2019			% Increase (Decrease)
Net sales:
U.S. Retail Pet Foods	$	721.9		$	759.0		(5)	%	$	2,101.7		$	2,158.3		(3)	%
U.S. Retail Coffee	558.8			561.6			—		1,567.9			1,596.0			(2)
U.S. Retail Consumer Foods	422.9			422.7			—		1,251.2			1,367.9			(9)
International and Away From Home	268.7			268.6			—		788.2			813.7			(3)
Segment profit:
U.S. Retail Pet Foods	$	146.0		$	147.9		(1)	%	$	403.1		$	372.2		8	%
U.S. Retail Coffee	189.5			183.7			3		500.9			505.8			(1)
U.S. Retail Consumer Foods	84.2			95.9			(12)		256.6			327.5			(22)
International and Away From Home	49.0			52.5			(7)		131.7			152.6			(14)
Segment profit margin:
U.S. Retail Pet Foods	20.2		%	19.5		%			19.2		%	17.2		%
U.S. Retail Coffee	33.9			32.7					31.9			31.7
U.S. Retail Consumer Foods	19.9			22.7					20.5			23.9
International and Away From Home	18.2			19.5					16.7			18.8

U.S. Retail Pet Foods

The U.S. Retail Pet Foods segment net sales in the third quarter of 2020 decreased $37.1, reflecting unfavorable volume/mix, which reduced net sales by 5 percentage points and was primarily driven by the Natural Balance brand and private label dog food. Net price realization was neutral, as list price increases implemented during the second half of the prior year were mostly offset by increased trade spend. Segment profit decreased $1.9, as unfavorable volume/mix was mostly offset by an $8.1 recovery from a legal settlement related to a prior year supplier issue, synergy realization, and reduced marketing expense.

The U.S. Retail Pet Foods segment net sales in the first nine months of 2020 decreased $56.6, including the impact of two weeks of incremental Ainsworth sales in the current year. Excluding the incremental Ainsworth business, net sales decreased $82.0, reflecting a $59.6 decline related to private label products. Volume/mix reduced net sales by 5 percentage points, primarily driven by private label dog food and the Natural Balance brand. Net price realization contributed 1 percentage point, primarily related to the Meow Mix, 9Lives, and Kibbles ’n Bits brands, reflecting the list price increases implemented during the second half of the prior year, partially offset by increased trade spend. Segment profit increased $30.9, reflecting a $10.9 unfavorable fair value purchase accounting adjustment in the prior year and the benefit from the incremental Ainsworth sales. Profit improvement was also driven by synergy realization, higher net pricing, reduced marketing expense, and the recovery from a legal settlement related to a prior year supplier issue, partially offset by unfavorable volume/mix and higher input costs.

U.S. Retail Coffee

The U.S. Retail Coffee segment net sales decreased $2.8 in the third quarter of 2020, reflecting lower net price realization, mostly offset by favorable volume/mix. Lower net pricing on the Folgers and Dunkin’ Donuts brands reduced net sales by 5 percentage points, which reflected increased promotional activity across both brands, primarily supported by lower green coffee costs. The favorable volume/mix increased net sales by 5 percentage points, due to growth of the Dunkin’ Donuts, Café Bustelo and Folgers brands. Segment profit increased $5.8, primarily due to favorable volume/mix and reduced marketing expense, partially offset by the unfavorable net impact of lower net pricing and lower input costs.

The U.S. Retail Coffee segment net sales decreased $28.1 in the first nine months of 2020, reflecting lower net price realization, partially offset by favorable volume/mix. Lower net pricing, which reduced net sales by 4 percentage points, reflected promotional activity across all brands, primarily supported by lower green coffee costs. The favorable volume/mix, which increased net sales by 3 percentage points, was primarily driven by the Dunkin’ Donuts and Café Bustelo brands. Segment profit decreased $4.9, primarily due to the net unfavorable impact of lower net pricing and lower green coffee costs, partially offset by decreased marketing expense and favorable volume/mix.

25

U.S. Retail Consumer Foods

The U.S. Retail Consumer Foods segment net sales in the third quarter of 2020 was comparable to the prior year, as favorable volume/mix was offset by lower net price realization. Favorable volume/mix contributed 4 percentage points to net sales, primarily related to growth for Smucker’s Uncrustables and the Jif brand. Lower net pricing reduced net sales by 4 percentage points, primarily driven by a list price decrease on the Jif brand in the fourth quarter of the prior year, partially offset by decreased trade spend. Segment profit decreased $11.7, which included a $7.5 write-off of equipment related to the discontinuation of Jif Power Ups^®. Excluding this impact, segment profit decreased $4.2, primarily reflecting an unfavorable net impact of lower pricing and lower input costs, partially offset by favorable volume/mix.

The U.S. Retail Consumer Foods segment net sales decreased $116.7 in the first nine months of 2020, driven by a $102.2 noncomparable impact of the U.S. baking business. Excluding the noncomparable impact of the divested business, net sales decreased 1 percent. Lower net price realization reduced net sales by 3 percentage points, primarily driven by the list price decrease on the Jif brand, partially offset by decreased trade spend. Favorable volume/mix contributed 2 percentage points to net sales, primarily related to growth for Smucker’s Uncrustables and the Jif brand, partially offset by a decline for the Crisco brand. Segment profit decreased $70.9, primarily reflecting $44.3 of segment profit in the prior year related to the divested business, of which $27.6 represented the pre-tax gain related to the sale. Excluding the impact of the divestiture, segment profit decreased 9 percent, driven primarily by the unfavorable net impact of lower pricing and lower input costs and the write-off of equipment related to the discontinuation of Jif Power Ups, partially offset by the favorable volume/mix and decreased marketing expense.

International and Away From Home

The International and Away From Home segment net sales in the third quarter of 2020 was comparable to the prior year, as a favorable foreign currency impact on net sales was offset by unfavorable net price realization and unfavorable volume/mix. Segment profit decreased $3.5, primarily reflecting the unfavorable volume/mix.

The International and Away From Home segment net sales decreased $25.5 in the first nine months of 2020, including a noncomparable impact of $3.7 of net sales in the prior year related to the divested U.S. baking business. Unfavorable volume/mix reduced net sales by 2 percentage points, primarily driven by increased shipments in the prior year related to the closing of facilities in Mexico and transition to a distributor export model, in addition to declines for the Folgers and Jif brands. These declines were partially offset by gains for the Smucker’s brand. Lower net price realization reduced net sales by 1 percentage point, primarily related to the Folgers and Jif brands. Foreign currency exchange had a $2.3 unfavorable impact on net sales. Segment profit decreased $20.9, primarily reflecting the unfavorable volume/mix and lower net pricing.

Financial Condition – Liquidity and Capital Resources

Liquidity

Our principal source of funds is cash generated from operations, supplemented by borrowings against our commercial paper program and revolving credit facility. At January 31, 2020, total cash and cash equivalents was $74.4, compared to $101.3 at April 30, 2019.

26

The following table presents selected cash flow information.

	Nine Months Ended January 31,
	2020		2019
Net cash provided by (used for) operating activities	$	967.1	$	867.0
Net cash provided by (used for) investing activities	(177.6)		(1,822.8)
Net cash provided by (used for) financing activities	(816.1)		973.6
Net cash provided by (used for) operating activities	$	967.1	$	867.0
Additions to property, plant, and equipment	(192.9)		(267.2)
Free cash flow (A)	$	774.2	$	599.8

(A)Free cash flow is a non-GAAP financial measure used by management to evaluate the amount of cash available for debt repayment, dividend distribution, acquisition opportunities, share repurchases, and other corporate purposes.

The $100.1 increase in cash provided by operating activities for the first nine months of 2020 was primarily driven by higher net income adjusted for noncash items in the current year. The cash required to fund working capital decreased compared to the prior year, excluding the impact of the realization of a $30.0 income tax refund received in 2019. The decrease in working capital requirements was primarily driven by a reduction in trade receivables due to lower sales, in addition to lower payments for accounts payable items driven by working capital initiatives. These decreases were partially offset by an increase in inventory levels compared to the prior year.

Cash used for investing activities in the first nine months of 2020 consisted of $192.9 in capital expenditures, partially offset by a $15.0 decrease in our derivative cash margin account balances. Cash used for investing activities in the first nine months of 2019 consisted of $1.9 billion related to the Ainsworth acquisition, $267.2 in capital expenditures, and a $22.8 increase in our derivative cash margin account balances, partially offset by net proceeds from the divestiture of the U.S. baking business of $371.4.

Cash used for financing activities in the first nine months of 2020 consisted primarily of long-term debt repayments of $400.0, dividend payments of $296.7, and a net decrease in short-term borrowings of $122.6. Cash provided by financing activities in the first nine months of 2019 consisted primarily of $1.5 billion in long-term debt proceeds and a $360.0 net increase in short-term borrowings, partially offset by long-term debt repayments of $600.0 and dividend payments of $281.4. 

We, like other food manufacturers, are from time to time subject to various administrative, regulatory, and other legal proceedings arising in the ordinary course of business. We are currently a defendant in a variety of such legal proceedings, including certain lawsuits related to the alleged price-fixing of shelf stable tuna products prior to 2011 by a business previously owned by, but divested prior to our acquisition of, Big Heart Pet Brands, the significant majority of which were settled and paid during the second half of 2019. While we cannot predict with certainty the ultimate results of these proceedings or potential settlements associated with these or other matters, we have accrued losses for certain contingent liabilities that we have determined are probable and reasonably estimable at January 31, 2020. Based on the information known to date, with the exception of the matter discussed below, we do not believe the final outcome of these proceedings would have a material adverse effect on our financial position, results of operations, or cash flows.

In addition to the legal proceedings discussed above, we are currently a defendant in CERT v. Brad Barry LLC, et al., which alleges that we, in addition to nearly eighty other defendants who manufacture, package, distribute, or sell coffee, failed to provide warnings for our coffee products of exposure to the chemical acrylamide as required under Proposition 65. As part of a joint defense group organized to defend against the lawsuit, we dispute these claims. Acrylamide is not added to coffee, but is inherently present in all coffee in small amounts (measured in parts per billion) as a byproduct of the coffee bean roasting process. The outcome and the financial impact of the case, if any, cannot be predicted at this time. Accordingly, no loss contingency has been recorded for this matter as of January 31, 2020, as the likelihood of loss is not considered probable or estimable. However, if we are required to pay significant statutory penalties or to add warning labels to any of our products or place warnings in certain locations where our products are sold as a result of Proposition 65, our business and financial results could be adversely impacted, and sales of those products could suffer not only in those locations but elsewhere. For additional information, see Note 16: Contingencies.

27

Capital Resources

The following table presents our capital structure.

	January 31, 2020		April 30, 2019
Current portion of long-term debt	$	499.8	$	798.5
Short-term borrowings	310.0		426.0
Long-term debt, less current portion	4,583.3		4,686.3
Total debt	$	5,393.1	$	5,910.8
Shareholders’ equity	8,170.4		7,970.5
Total capital	$	13,563.5	$	13,881.3

In April 2018, we entered into a Term Loan with a syndicate of banks and an available commitment amount of $1.5 billion. The full amount of the Term Loan was drawn on May 14, 2018, to partially finance the Ainsworth acquisition. Borrowings under the Term Loan bear interest on the prevailing U.S. Prime Rate or LIBOR, based on our election, and are payable either on a quarterly basis or at the end of the borrowing term. The Term Loan matures on May 14, 2021, and does not require scheduled amortization payments. Voluntary prepayments are permitted without premium or penalty. As of January 31, 2020, we have prepaid $800.0 on the Term Loan to date, including $100.0 in 2020. The interest rate on the Term Loan at January 31, 2020, was 2.45 percent. In November 2019, we entered into an amendment to the Term Loan that decreased the applicable margins on LIBOR, based on our long-term unsecured debt rating. This amendment did not have a material impact on our condensed consolidated financial statements.

We have available a $1.8 billion unsecured revolving credit facility with a group of 11 banks that matures in September 2022. Additionally, we participate in a commercial paper program under which we can issue short-term, unsecured commercial paper not to exceed $1.8 billion at any time. The commercial paper program is backed by our revolving credit facility and reduces what we can borrow under the revolving credit facility by the amount of commercial paper outstanding. Commercial paper will be used as a continuing source of short-term financing for general corporate purposes. As of January 31, 2020, we had $310.0 of short-term borrowings outstanding, all of which were issued under our commercial paper program, at a weighted-average interest rate of 1.79 percent.

We are in compliance with all of our debt covenants. For additional information on our long-term debt, sources of liquidity, and debt covenants, see Note 9: Debt and Financing Arrangements.

During the third quarter of 2020, we did not repurchase any common shares under a repurchase plan authorized by the Board. At January 31, 2020, approximately 3.6 million common shares remain available for repurchase pursuant to the Board’s authorizations. There is no guarantee as to the exact number of shares that may be repurchased or when such purchases may occur.

Absent any material acquisitions or other significant investments, we believe that cash on hand, combined with cash provided by operations, borrowings available under our commercial paper program and revolving credit facility, and access to capital markets, will be sufficient to meet our cash requirements for the next 12 months, including capital expenditures, the payment of quarterly dividends, principal and interest payments on debt outstanding, and share repurchases.

During the first nine months of 2020, we returned $39.7 of international cash to the U.S., primarily driven by a reduction in our capital investment in certain foreign subsidiaries in conjunction with a restructuring of our international holding and operating entities. No foreign withholding taxes were applicable, and state income taxes were not significant. As of January 31, 2020, total cash and cash equivalents of $64.5 was held by our foreign subsidiaries, primarily in Canada. The undistributed earnings of our foreign subsidiaries remain permanently reinvested.

Non-GAAP Financial Measures

We use non-GAAP financial measures, including: net sales excluding acquisition, divestiture, and foreign currency exchange; adjusted gross profit; adjusted operating income; adjusted income; adjusted earnings per share; and free cash flow, as key measures for purposes of evaluating performance internally. We believe that investors’ understanding of our performance is enhanced by disclosing these performance measures. Furthermore, these non-GAAP financial measures are used by management in preparation of the annual budget and for the monthly analyses of our operating results. The Board also utilizes certain non-GAAP financial measures as components for measuring performance for incentive compensation purposes.

28

Non-GAAP measures exclude certain items affecting comparability that can significantly affect the year-over-year assessment of operating results, which include amortization expense and impairment charges related to intangible assets, integration and restructuring costs (“special project costs”), and unallocated gains and losses on commodity and foreign currency exchange derivatives (“unallocated derivative gains and losses”), as well as the related tax impact of these exclusions. The special project costs in the following table relate to specific integration and restructuring projects, and the unallocated derivative gains and losses reflect the changes in fair value of our commodity and foreign currency exchange contracts. Additionally, income taxes, as adjusted is calculated using an adjusted effective income tax rate that is applied to adjusted income before income taxes. While this adjusted effective income tax rate does not generally differ materially from our GAAP effective income tax rate, certain items can significantly impact our adjusted effective income tax rate.

These non-GAAP financial measures are not intended to replace the presentation of financial results in accordance with U.S. GAAP. Rather, the presentation of these non-GAAP financial measures supplements other metrics we use to internally evaluate our businesses and facilitate the comparison of past and present operations and liquidity. These non-GAAP financial measures may not be comparable to similar measures used by other companies and may exclude certain nondiscretionary expenses and cash payments. The following table reconciles certain non-GAAP measures to the comparable GAAP financial measure. See page 23 for a reconciliation of net sales adjusted for certain noncomparable items to the comparable GAAP financial measure.

	Three Months Ended January 31,				Nine Months Ended January 31,
	2020		2019		2020		2019
Gross profit reconciliation:
Gross profit	$	760.0	$	773.8	$	2,213.6	$	2,223.3
Unallocated derivative losses (gains)	(7.7)		2.9		(37.6)		25.0
Adjusted gross profit	$	752.3	$	776.7	$	2,176.0	$	2,248.3
Operating income reconciliation:
Operating income	$	289.0	$	217.6	$	876.4	$	775.0
Amortization	58.8		59.7		176.4		179.9
Other intangible assets impairment charges	52.4		107.2		52.4		107.2
Unallocated derivative losses (gains)	(7.7)		2.9		(37.6)		25.0
Other special project costs	3.3		18.8		9.9		51.9
Adjusted operating income	$	395.8	$	406.2	$	1,077.5	$	1,139.0
Net income reconciliation:
Net income	$	187.4	$	121.4	$	553.2	$	442.9
Income tax expense	55.1		35.8		175.1		156.8
Amortization	58.8		59.7		176.4		179.9
Other intangible assets impairment charges	52.4		107.2		52.4		107.2
Unallocated derivative losses (gains)	(7.7)		2.9		(37.6)		25.0
Other special project costs	3.3		18.8		9.9		51.9
Adjusted income before income taxes	$	349.3	$	345.8	$	929.4	$	963.7
Income taxes, as adjusted	80.8		89.1		223.7		258.1
Adjusted income	$	268.5	$	256.7	$	705.7	$	705.6
Weighted-average shares – assuming dilution	114.0		113.8		114.0		113.7
Adjusted earnings per share – assuming dilution	$	2.35	$	2.26	$	6.19	$	6.20

Off-Balance Sheet Arrangements and Contractual Obligations

We do not have material off-balance sheet arrangements, financings, or other relationships with unconsolidated entities or other persons, also known as variable interest entities. Transactions with related parties are in the ordinary course of business and not material to our results of operations, financial condition, or cash flows.

As of January 31, 2020, there were no material changes to our future contractual obligations as previously reported in our

Annual Report on Form 10-K for the year ended April 30, 2019.

29

Critical Accounting Estimates and Policies

A discussion of our critical accounting estimates and policies can be found in the “Management’s Discussion and Analysis” section of our Annual Report on Form 10-K for the year ended April 30, 2019. There were no material changes to the information previously disclosed, with the exception of the item discussed below.

During the third quarter of 2020, we began our annual planning cycle, which was not complete as of January 31, 2020; however, certain brand-level decisions were made during the quarter that we evaluated to determine whether the carrying value of certain indefinite-lived intangible assets more likely than not exceeded fair value. As a result, we recognized an impairment charge of $52.4 related to the Natural Balance brand within the U.S. Retail Pet Foods segment due to a decline in current year and long-term net sales expectations and the royalty rate used in the interim analysis, primarily driven by the market environment and re-positioning of this brand within the Pet Foods brand portfolio. This charge was included as a noncash charge in our Condensed Statement of Consolidated Income. Additionally, we reassessed the long-term strategic expectations for the Natural Balance brand and will reclassify this brand as a finite-lived intangible asset as of February 1, 2020, resulting in annual amortization expense of $4.5.

As of January 31, 2020, there were no other indicators of impairment, and as a result, we do not believe that our reporting units or any of our remaining indefinite-lived intangible assets are more likely than not impaired. However, the goodwill and indefinite-lived trademarks within the U.S. Retail Pet Foods segment, inclusive of the recently acquired Ainsworth business, remain susceptible to future impairment charges due to the narrow differences between fair value and carrying value. Any significant adverse change in our near or long-term projections or macroeconomic conditions could result in future impairment charges. The carrying values of the goodwill and indefinite-lived intangible assets within the U.S. Retail Pet Foods segment were $2.4 billion and $1.4 billion, respectively, as of January 31, 2020.

During the third quarter of 2019, we recognized a noncash impairment charge of $107.2 related to certain indefinite-lived intangible assets within the U.S. Retail Pet Foods segment.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

(Dollars in millions, unless otherwise noted)

The following discussions about our market risk disclosures involve forward-looking statements. Actual results could differ from those projected in the forward-looking statements. We are exposed to market risk related to changes in interest rates, foreign currency exchange rates, and commodity prices.

Interest Rate Risk: The fair value of our cash and cash equivalents at January 31, 2020, approximates carrying value. We are exposed to interest rate risk with regard to existing debt consisting of fixed- and variable-rate maturities. Our interest rate exposure primarily includes U.S. Treasury rates, LIBOR, and commercial paper rates in the U.S. The Financial Conduct Authority in the United Kingdom has stated that it will not require banks to submit LIBOR beyond 2021. We do not anticipate a significant impact to our financial position as a result of this action given our current mix of variable- and fixed-rate debt.

We utilize derivative instruments to manage interest rate risk associated with anticipated debt transactions, as well as to manage changes in the fair value of our long-term debt. At the inception of an interest rate contract, the instrument is evaluated and documented for qualifying hedge accounting treatment. If the contract is designated as a cash flow hedge, the mark-to-market gains or losses on the contract are deferred and included as a component of accumulated other comprehensive income (loss), and reclassified to interest expense in the period during which the hedged transaction affects earnings. If the contract is designated as a fair value hedge, the contract is recognized at fair value on the balance sheet, and changes in the fair value are recognized in interest expense. Generally, changes in the fair value of the contract are equal to changes in the fair value of the underlying debt and have no net impact on earnings.

We entered into interest rate contracts in November 2018 and June 2018, with notional values of $300.0 and $500.0, respectively, to manage our exposure to interest rate volatility associated with anticipated debt financing in 2020. These interest rate contracts are designated as cash flow hedges, and as a result, unrealized losses of $168.9 were deferred in accumulated other comprehensive income (loss) at January 31, 2020. A hypothetical 10 percent decrease in treasury rates at January 31, 2020, would result in an incremental loss of $20.4 on the fair value of these interest rate contracts.

In 2015, we terminated the interest rate swap on the Senior Notes due October 15, 2021, which was designated as a fair value hedge and used to hedge against the changes in the fair value of the debt. As a result of the early termination, we received $58.1 in cash, which included $4.6 of accrued and prepaid interest and a $53.5 benefit that is deferred as a component of the carrying

30

value of the long-term debt and is being recognized ratably as a reduction to interest expense over the remaining life of the related debt. At January 31, 2020, the remaining benefit of $14.3 was recorded as an increase in the long-term debt balance.

In measuring interest rate risk by the amount of net change in the fair value of our financial liabilities, a hypothetical 100 basis-point decrease in interest rates at January 31, 2020, would increase the fair value of our long-term debt by $305.8.

Foreign Currency Exchange Risk: We have operations outside the U.S. with foreign currency denominated assets and liabilities, primarily denominated in Canadian currency. Because we have foreign currency denominated assets and liabilities, financial exposure may result, primarily from the timing of transactions and the movement of exchange rates. The foreign currency balance sheet exposures as of January 31, 2020, are not expected to result in a significant impact on future earnings or cash flows.

We utilize foreign currency derivatives to manage the effect of foreign currency exchange fluctuations on future cash payments primarily related to purchases of certain raw materials and finished goods. The contracts generally have maturities of less than one year. We do not qualify instruments used to manage foreign currency exchange exposures for hedge accounting treatment. Therefore, the change in value of these instruments is immediately recognized in cost of products sold. Based on our hedged foreign currency positions as of January 31, 2020, a hypothetical 10 percent change in exchange rates would not materially impact the fair value.

Revenues from customers outside the U.S., subject to foreign currency exchange, represented 5 percent of net sales during the nine months ended January 31, 2020. Thus, certain revenues and expenses have been, and are expected to be, subject to the effect of foreign currency fluctuations, and these fluctuations may have an impact on operating results.

Commodity Price Risk: We use certain raw materials and other commodities that are subject to price volatility caused by supply and demand conditions, political and economic variables, weather, investor speculation, and other unpredictable factors. To manage the volatility related to anticipated commodity purchases, we use derivatives with maturities of generally less than one year. We do not qualify commodity derivatives for hedge accounting treatment, and as a result, the gains and losses on all commodity derivatives are immediately recognized in cost of products sold.

The following sensitivity analysis presents our potential loss of fair value resulting from a hypothetical 10 percent change in market prices related to commodities.

	January 31, 2020		April 30, 2019
High	$	38.7	$	51.6
Low	13.3		25.3
Average	26.1		37.0

The estimated fair value was determined using quoted market prices and was based on our net derivative position by commodity for the previous four quarters. The calculations are not intended to represent actual losses in fair value that we expect to incur. In practice, as markets move, we actively manage our risk and adjust hedging strategies as appropriate. The commodities hedged have a high inverse correlation to price changes of the derivative instrument. Thus, we would expect that over time any gain or loss in the estimated fair value of its derivatives would generally be offset by an increase or decrease in the estimated fair value of the underlying exposures.

31

Certain Forward-Looking Statements

Certain statements included in this Quarterly Report on Form 10-Q contain forward-looking statements within the meaning of federal securities laws. The forward-looking statements may include statements concerning our current expectations, estimates, assumptions, and beliefs concerning future events, conditions, plans, and strategies that are not historical fact. Any statement that is not historical in nature is a forward-looking statement and may be identified by the use of words and phrases such as “expect,” “anticipate,” “believe,” “intend,” “will,” “plan,” and similar phrases.

Federal securities laws provide a safe harbor for forward-looking statements to encourage companies to provide prospective information. We are providing this cautionary statement in connection with the safe harbor provisions. Readers are cautioned not to place undue reliance on any forward-looking statements, as such statements are by nature subject to risks, uncertainties, and other factors, many of which are outside of our control and could cause actual results to differ materially from such statements and from our historical results and experience. These risks and uncertainties include, but are not limited to, the following:

•our ability to achieve cost savings related to our cost management programs in the amounts and within the time frames currently anticipated;

•our ability to generate sufficient cash flow to meet our cash deleveraging objectives;

•volatility of commodity, energy, and other input costs;

•risks associated with derivative and purchasing strategies we employ to manage commodity pricing and interest rate risks;

•the availability of reliable transportation on acceptable terms;

•our ability to implement and realize the full benefit of price changes, and the impact of the timing of the price changes to profits and cash flow in a particular period;

•the success and cost of marketing and sales programs and strategies intended to promote growth in our businesses, including product innovation;

•general competitive activity in the market, including competitors’ pricing practices and promotional spending levels;

•the impact of food security concerns involving either our products or our competitors’ products;

•the impact of accidents, extreme weather, and natural disasters;

•the concentration of certain of our businesses with key customers and suppliers, including single-source suppliers of certain key raw materials and finished goods, and our ability to manage and maintain key relationships;

•the timing and amount of capital expenditures and share repurchases;

•impairments in the carrying value of goodwill, other intangible assets, or other long-lived assets or changes in useful lives of other intangible assets;

•the impact of new or changes to existing governmental laws and regulations and their application, including tariffs;

•the outcome of tax examinations, changes in tax laws, and other tax matters;

•foreign currency and interest rate fluctuations; and

•risks related to other factors described under “Risk Factors” in other reports and statements we have filed with the SEC.

Readers are cautioned not to unduly rely on such forward-looking statements, which speak only as of the date made, when evaluating the information presented in this Quarterly Report on Form 10-Q. We do not undertake any obligation to update or revise these forward-looking statements to reflect new events or circumstances subsequent to the filing of this Quarterly Report on Form 10-Q.

32

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures. Management, including the principal executive officer and principal financial officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) or 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of January 31, 2020 (the “Evaluation Date”). Based on that evaluation, the principal executive officer and principal financial officer have concluded that, as of the Evaluation Date, our disclosure controls and procedures were effective in ensuring that information required to be disclosed in reports that we file or submit under the Exchange Act is (1) recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms, and (2) accumulated and communicated to management, including the chief executive officer and chief financial officer, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Controls. During the first quarter of 2020, we began using a new integrated software solution to plan, authorize, and record trade promotion-related activities, as well as initiate payments associated with our trade programs. Additionally, in connection with the adoption of ASU 2016-02, Leases (Topic 842), as described in Note 2: Recently Issued Accounting Standards and Note 13: Leases, we implemented a new software solution that is used to record right-of-use assets and lease liabilities and prepare disclosures related to the new standard. As a result of the implementation of these systems, new controls and processes were executed during the first quarter of 2020.

There have been no changes in our internal control over financial reporting during the three months ended January 31, 2020, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

33

PART II. OTHER INFORMATION

Item 1. Legal Proceedings.

Information required for Part II, Item 1 is incorporated by reference to the discussion in Note 16: Contingencies in Part I, Item 1 in this Quarterly Report on Form 10-Q.

Item 1A. Risk Factors.

Our business, operations, and financial condition are subject to various risks and uncertainties. The risk factors described in “Part I, Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended April 30, 2019, as revised below, should be carefully considered, together with the other information contained or incorporated by reference in this Quarterly Report on Form 10-Q and in our other filings with the SEC, in connection with evaluating the Company, our business, and the forward-looking statements contained in this Quarterly Report on Form 10-Q. Additional risks and uncertainties not presently known to us or that we currently deem immaterial also may affect us. The occurrence of any of these known or unknown risks could have a material adverse impact on our business, financial condition, and results of operations.

The risk factor described below updates the risk factors disclosed in “Part I, Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended April 30, 2019, to include information on an interim impairment analysis, which was performed during the third quarter of 2020.

• A material impairment in the carrying value of acquired goodwill or other intangible assets could negatively affect our consolidated operating results and net worth.

A significant portion of our assets is goodwill and other intangible assets, the majority of which are not amortized but are reviewed for impairment at least annually on February 1, and more often if indicators of impairment exist. At April 30, 2019, the carrying value of goodwill and other intangible assets totaled $13.0 billion, compared to total assets of $16.7 billion and total shareholders’ equity of $8.0 billion. If the carrying value of these assets exceeds the current estimated fair value, the asset would be considered impaired, and this would result in a noncash charge to earnings, which could be material. Events and conditions that could result in impairment include a sustained drop in the market price of our common shares, increased competition or loss of market share, obsolescence, product claims that result in a significant loss of sales or profitability over the product life, deterioration in macroeconomic conditions, or declining financial performance in comparison to projected results.

As of January 31, 2020, the carrying values of the goodwill and indefinite-lived intangible assets within the U.S. Retail Pet Foods segment were $2.4 billion and $1.4 billion, respectively. These intangible assets are susceptible to future impairment charges due to narrow differences between fair value and carrying value as a result of recent impairment charges and the acquisition of Ainsworth in May 2018. To date, we have recognized $465.0 million of impairment charges related to the goodwill and indefinite-lived intangible assets acquired as part of the Big Heart Pet Brands acquisition in 2015, which includes an impairment charge of $52.4 recognized during the third quarter of 2020 related to the Natural Balance brand. These impairment charges are primarily the result of reductions in our long-term net sales and profitability projections.

We do not believe that our Pet Foods reporting unit or any of the remaining indefinite-lived trademarks within the U.S. Retail Pet Foods segment are more likely than not impaired as of January 31, 2020. However, further changes to the assumptions regarding the future performance of the U.S. Retail Pet Foods segment or its brands, an adverse change to macroeconomic conditions, or a change to other assumptions could result in additional impairment losses in the future, which could be significant. As of April 30, 2019, the estimated fair value was substantially in excess of the carrying value for the majority of the remaining reporting units and material indefinite-lived intangible assets, and in all instances, the estimated fair value exceeded the carrying value by greater than 10 percent, with the exception of the Natural Foods reporting unit, which has no remaining goodwill as a result of the impairment charge recorded during the fourth quarter of 2019. For further information, refer to Note 8: Goodwill and Other Intangible Assets.

34

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

Purchases of Equity Securities by the Issuer and Affiliated Purchasers: The following table presents the total number of shares of common stock purchased during the third quarter of 2020, the average price paid per share, the number of shares that were purchased as part of a publicly announced repurchase program, if any, and the approximate dollar value of the maximum number of shares that may yet be purchased under the share repurchase program:

	(a)	(b)		(c)	(d)
Period	Total Number of Shares Purchased	Average Price Paid Per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Maximum Number (or Approximate Dollar Value) of Shares That May Yet Be Purchased Under the Plans or Programs
November 1, 2019 - November 30, 2019	—	$	—	—	3,586,598
December 1, 2019 - December 31, 2019	1,300	105.22		—	3,586,598
January 1, 2020 - January 31, 2020	5,880	105.00		—	3,586,598
Total	7,180	$	105.04	—	3,586,598

(a)Shares in this column include shares repurchased from stock plan recipients in lieu of cash payments.

(d) As of January 31, 2020, there were 3,586,598 common shares remaining available for future repurchase pursuant to the Board’s authorizations.

Item 6. Exhibits.

See the Index of Exhibits that appears on Page No. 37 of this report.

35

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

February 27, 2020	THE J. M. SMUCKER COMPANY
	/s/ Mark T. Smucker
	By: MARK T. SMUCKER
	President and Chief Executive Officer
	/s/ Mark R. Belgya
	By: MARK R. BELGYA
	Vice Chair and Chief Financial Officer

36

INDEX OF EXHIBITS

The following exhibits are either attached or incorporated herein by reference to another filing with the SEC.

Exhibit Number	Exhibit Description
3.1	Amended Regulations of The J. M. Smucker Company (as Amended January 17, 2020)
10.1	Separation Agreement, effective as of January 4, 2020, between the Company and Kevin G. Jackson*
10.2	Separation Agreement, effective as of January 10, 2020, between the Company and David J. Lemmon*
10.3	The J. M. Smucker Company Executive Severance Plan*
10.4	Amendment No. 1 to Credit Agreement dated as of November 14, 2019, to the Term Loan Credit Agreement, dated as of April 27, 2018, among the Company, as borrower, the lenders party thereto, and Bank of America, N.A., as administrative agent
31.1	Certifications of Mark T. Smucker pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act, as amended
31.2	Certifications of Mark R. Belgya pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act, as amended
32	Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of The Sarbanes-Oxley Act of 2002
101.INS	XBRL Instance Document - The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
101.SCH	XBRL Taxonomy Extension Schema Document
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document
101.LAB	XBRL Taxonomy Extension Label Linkbase Document
104	The cover page of this Quarterly Report on Form 10-Q for the quarter ended January 31, 2020, formatted in Inline XBRL

* Management contract or compensatory plan or arrangement

37

EX-10.1

Exhibit 10.1

CONFIDENTIAL

November 13, 2019

VIA HAND DELIVERY

Kevin G. Jackson

RE: Separation from Employment

Dear Kevin:

As we have discussed, your employment with The J. M. Smucker Company (the “Company”) will end effective December 6, 2019 (“Separation Date”). However, you will cease being an Elected Officer of the Company on, and your last day in the office will be, November 13, 2019, after which date you should not report to the office unless instructed otherwise in writing by the Company. While your last day in the office will be today, you are expected to: remain available upon request by the Company to provide transitional support through your Separation Date; ensure that your interactions and engagement with employees and third parties through your Separation Date are not disparaging and contribute to a positive rather than disruptive work environment; and adhere to the Company’s policies, including the Basic Beliefs, through your Separation Date. In addition, should the Company accelerate your Separation Date because of a determination in its discretion that you have not met any of the conditions in this paragraph, you will not be eligible to receive the severance package described below.

The severance package outlined below is to assist you with your transition to new employment. Please carefully review the terms of this letter agreement (the “Separation Agreement” or “Agreement”) and the payments and benefits offered in it, as the severance is being offered to you in exchange for you agreeing to a waiver and release of claims. The “Waiver and Release Payments and Benefits” offered in Section 2 of this letter will remain open to you until the close of business on December 27, 2019.

Any benefits provided to you as an employee of the Company will cease as of your Separation Date, except as may otherwise be provided under a particular plan. Assuming you are enrolled in the Company’s health and welfare benefits plan as of your Separation Date, your medical benefits will continue through the end of the month during which your employment terminates. You will receive a separate letter from the Company’s health plan administrator explaining your COBRA rights.

1. Pay and Vacation. The following are not conditioned on you signing off on a waiver and release of claims:

(a)  Pay. Provided that you remain employed and available upon request by the Company through your Separation Date, the Company will continue to pay you your base pay and provide you with your current Company benefits through your Separation Date, subject to normal withholdings and deductions.

(b) Vacation. You will be paid for all vacation earned through your Separation Date, less any vacation days taken.

Page 2

Kevin G. Jackson

November 13, 2019

(c) Expense Reimbursements. You will be reimbursed for all reasonably incurred business expenses, in accordance with Company policy, and any expenses for financial planning services or tax return preparation, in accordance with the benefit approved by the Executive Compensation Committee (“Financial Planning Benefit”), which Financial Planning Benefit is available for your use through April 15, 2020. As a reminder, all receipts for expense reimbursement, including the Financial Planning Benefit, must be submitted to Marc Serrilli, Vice President, Total Rewards, no later than April 15, 2020, in order to be reimbursed; otherwise, you will forfeit your right to reimbursement.

(d) Final Paycheck. You will receive your final paycheck and any applicable vacation payment the next pay date following your Separation Date unless otherwise required by law.

2. Waiver and Release Payments and Benefits. The following payments and benefits are being offered to you in addition to the pay and vacation in Section 1. Because you would not otherwise be entitled to them, your receipt of the payments and benefits in this Section 2 will be conditioned upon you: signing this Agreement; adhering, during the remainder of your employment, to all applicable Company policies; meeting, up to and including your Separation Date, the Company’s performance expectations for your position; complying with the other terms of this Agreement; and agreeing to the Waiver and Release described in subparagraph (f). In the event the Company discovers, at any time, including after your Separation Date, that you did not meet any of these conditions, you will be ineligible to receive the Waiver and Release Payments and Benefits set forth in this Section 2. In such event, you agree that you will: (a) forfeit any outstanding payment amount(s) due pursuant to this Section 2, and (b) repay to the Company, at your expense, any payment amount(s) already paid to you pursuant to this Section 2 within five (5) business days of notification to you by the Company of your ineligibility to receive the payment amount(s) set forth in this Section.

(a) Lump-Sum Payment. Provided that the Company receives this executed Agreement back from you and you comply with all requirements and obligations set forth in this Agreement, you will receive a lump-sum severance payment in the gross amount of $420,000.00, which is equivalent to 12 months of your current base salary, and which will be taxed as a supplemental wage and will not be subject to 401(k) contribution elections and deductions.

(b) Restricted Shares. Provided that the Company receives this executed Agreement back from you and you comply with all requirements and obligations set forth in this Agreement, you will vest in the two oldest unvested restricted stock grants that are at least two years old as of your Separation Date (i.e., the awards granted on June 8, 2016, and June 15, 2017, respectively). All remaining unvested restricted stock grants or option grants are forfeited as of your Separation Date.

(c) Annual Cash Incentive. Provided that the Company receives this executed Agreement back from you and you comply with all requirements and obligations set forth in this Agreement, you will be eligible for a pro-rated incentive payment for Fiscal Year 2020 ("FY 20"), which will be taxed as a supplemental wage and will be subject to 401(k) contribution elections and deductions, based on service during FY 20. Any actual incentive payment for FY 20 will be paid in accordance with normal Company payout practices.

(d) Medical Coverage. Provided that the Company receives this executed Agreement back from you and you comply with all requirements and obligations set forth in this Agreement, you may also be eligible to receive an additional lump sum payment based on your Company-sponsored medical coverage in effect on your Separation Date: i.e., the Company will provide a one-time lump sum payment equal to approximately 12 months of COBRA premiums for the medical plan option you are enrolled in as of your Separation Date, at the COBRA premium rate effective as of your Separation Date.

(e) Outplacement Assistance. Provided that the Company receives this executed Agreement back from you and you comply with all requirements and obligations set forth in this Agreement, RiseSmart will provide you Company-paid outplacement assistance for six months following

Page 3

Kevin G. Jackson

November 13, 2019

the Effective Date of this Agreement, as defined in Section 8 below. A representative from RiseSmart will contact you regarding its services after the Effective Date of this Agreement.

(f) Reduction of Non-Compete Restrictions. As you know, you entered into an Amended and Restated Change in Control Severance Agreement, dated April 20, 2018 (the “CIC Agreement”), which, pursuant to Section 9 of the CIC Agreement, imposes certain restrictive covenants during your employment with the Company and for a period of 18 months following the date of your termination of employment for any reason. However, provided that the Company receives this executed Agreement back from you and you comply with all requirements and obligations set forth in this Agreement, the Company agrees to reduce the term of the Non-Competition Period (as such term is defined in Section 9.1(A) of the CIC Agreement) from 18 months to 12 months following your Separation Date.

(g) Waiver and Release. By accepting the payments and benefits being offered by the Company in Sections 2(a)–(f) above and signing this Agreement, you acknowledge and agree that the commitments of the Company to you in this Section 2 are in addition to anything to which you are otherwise entitled upon your separation and are in exchange for your waiver and release as follows:

You, for yourself, and your heirs, executors, administrators, successors and assigns, hereby release and forever discharge the Company, its subsidiaries, affiliates and their respective officers, directors, agents, representatives, shareholders, employees (current and former), employee benefit plans, and any and all other persons, firms, corporations and other legal entities associated with the Company (collectively referred to as the “Released Parties”), of and from any and all claims, demands, actions, causes of action, debts, damages, expenses, suits, contracts, agreements, penalties, costs and liabilities of any kind, nature or description, whether direct or indirect, known or unknown, in law or in equity, in contract, tort or otherwise, which you ever had, now have or may have against any of the Released Parties as of the date of execution of this Agreement, whether known or unknown, suspected or unsuspected, or which may be based upon pre-existing acts, claims or events occurring at any time up to the Effective Date of this Agreement, including, but not limited to, claims arising under Title VII of the Civil Rights Act of 1964 or state or local civil rights or equal employment opportunity statutes, claims arising under the Americans with Disabilities Act, claims arising under the Age Discrimination in Employment Act of 1967 (“ADEA”), as amended by the Older Workers Benefit Protection Act (“OWBPA”), claims arising under The Worker Adjustment Retraining and Notification Act of 1988 (“WARN”) and any state law equivalents, claims arising under the Employee Retirement Income Security Act, claims arising under the Fair Credit Reporting Act or any state law equivalent, claims for breach of express or implied contract, breach of promise, promissory estoppel, loss of income, back pay, reinstatement, front pay, impairment of earning capacity, wrongful termination, discrimination, damage to reputation, fraud, violation of public policy, retaliation, negligent or intentional infliction of mental or emotional distress, intentional tort or any other federal, state or local common law or statutory claims, and all other claims and rights, whether in law or equity. It is the intention of the parties that this paragraph will be construed as broadly as possible; however, this paragraph does not include claims arising under state workers’ compensation laws, state unemployment laws, any claims that arise after the signing of this Agreement, claims for the enforcement of this Agreement, and any claims that cannot be waived as a matter of law. This paragraph also does not affect your right to file a charge with the Equal Employment Opportunity Commission or a similar state or local agency, or with the National Labor Relations Board, or to provide information to or assist such agency in any proceeding. In addition, nothing in this Agreement is intended to or will prevent, impede, or interfere with your non-waivable right, without prior notice to the Company, to provide information to the government, participate in investigations, file a complaint, testify in proceedings regarding the Company’s past or future conduct, or engage in any future activities protected under the whistleblower statutes, or to receive and fully retain a monetary award from a government-administered whistleblower award program for providing information directly to a government agency.

You further waive any right to become, and promise not to voluntarily become, a member of any class in a case in which any claim or claims are asserted against any of the Released Parties involving any act or event occurring through the date of your execution of this Agreement. You also agree that by signing this Agreement, you are relinquishing any right to receive any personal monetary relief or personal

Page 4

Kevin G. Jackson

November 13, 2019

equitable relief with respect to any class filed by you or on your behalf, in which any claim(s) are asserted against any of the Released Parties involving any act or event through the date of your execution of this Agreement, except as otherwise set forth herein. If any such claim is brought on your behalf, or if you learn that you are named as a member of any class in a case in which any such claims are asserted, then you will, except as otherwise allowed by law, withdraw in writing and with prejudice from said claim or class.

(h) You will receive the payments and benefits noted above in this Section 2 within the time period set forth in Section 9 below only if you sign and return this Agreement to Mandy Johnson, The J. M. Smucker Company, One Strawberry Lane, Orrville, Ohio 44667 by December 27, 2019, and you comply with the requirements and obligations contained in this Agreement. To be clear, if you do not return this Agreement, signed, by December 27, 2019 ordo not comply with the requirements and obligations contained in this Agreement, then the offer of severance will expire by its own terms, and you will not be entitled to receive any of the Waiver and Release Payments and Benefits.

3. Representation as toNo Additional Monies Owed.You represent, warrant, and acknowledge that the Company owes you no wages, commissions, bonuses, overtime, sick pay, shift differential, personal leave pay, severance pay, vacation pay, or other compensation or benefits or form of remuneration of any kind or nature, other than that specifically provided for in this Agreement. You further acknowledge that you were paid for all time worked during your employment with the Company.

4. Return, Retention & Preservation of Property. You agree to immediately return all Company property (and any copies of such property) of whatsoever kind and character, including, without limitation, any Company car, badges, keys, credit cards, documents, computers, computer software, discs and media, policy and procedures manuals, and all other tangible or intangible property of the Company. You also acknowledge your obligations under and agree to abide by the Company’s document retention, litigation hold and other policies concerning the preservation, retention, non-destruction and return of Company documents and property. You acknowledge that the return, retention and preservation of Company property, including documents pursuant to the Company’s retention, litigation hold, and other policies and procedures is required of you, whether or not you sign this Agreement. You further acknowledge that it is your compliance with this paragraph by December 27, 2019, that is one of the conditions precedent to the Company’s obligation to pay you the Waiver and Release Payments and Benefits, meaning that if you do not return all such Company property by that date, the Company will have no obligation to pay you any of the Waiver and Release Payments and Benefits, even if you have signed or do ultimately sign this Agreement, but you will still be required to return all Company property on a date thereafter.

5. Cooperation and Notice. You agree to cooperate with the Company to provide any assistance or continued assistance deemed necessary by the Company and/or its counsel in connection with its defense of any current or future lawsuits. “Assistance or continued assistance” means providing timely assistance and cooperation as reasonably requested by the Company and/or its outside counsel, taking into accountyour other business and personal obligations, and actively participate in the defense of the lawsuits, including, but not limited to, providing continued factual background and context, providing truthful testimony by affidavit, declaration, at trial, deposition or otherwise. This will also include reviewing and signing documents, participating in interviews and witness preparation, as well as traveling to and appearing in any necessary depositions or trials.

Any changes to your address should be promptly communicated to the Company’s Chief Legal Counsel. The Company will provide reasonable reimbursement for appropriate expenses associated with this Section, including documented uncompensated lost work time, if any. Unless otherwise prohibited by law, you agree to timely notify the Company’s Chief Legal Counselof all subpoenas issued to you or contact made with you by any government official or law enforcement agency relating in any way to the Company or your employment with the Company and provide a copy of any subpoena upon receipt. Nothing in this Section will prevent you from communicating with government officials or law enforcement or participating in any government or law enforcement investigation.

Page 5

Kevin G. Jackson

November 13, 2019

6. No Disparagement, Non-Disclosure and Confidentiality. You agree not to criticize, disparage, or otherwise demean in any way the Company or its respective affiliates, officers, directors, employees, or the Company’s products. Unless otherwise permitted by law, you further agree not to engage in conduct that is or could be disruptive to the Company’s work environment or its employees, including, but not limited to, behavior that is or could be perceived as harassing or retaliatory in nature. You will not disclose the fact of this Agreement or any of its terms to any third parties other than your immediate family members (and only if they agree to be bound by the confidential nature of this Agreement), tax advisors and authorities, accountants, and attorneys or as otherwise required by law.

You also acknowledge that you owe a continuing duty to the Company to maintain the confidentiality of the confidential and proprietary information of the Company. You agree that you will not disclose to any third party or use, directly or indirectly, for yourself or for the benefit of any third party any Confidential Information of the Company or any of its affiliates. For purposes of this Agreement, “Confidential Information” generally includes information which is not publicly available. Confidential Information includes, but is not limited to pending acquisitions by the Company, recipes, formulas, laboratory notebooks, research and test data, patent activities, business strategies, pending contracts, market surveys, customer lists, customer information, pricing information, margins, product cost information, raw material cost information, financial projections and reports, budgets, personnel files, internal memoranda, policies, data processing programs, and accounting procedures.

Nothing in this Agreement will prohibit or restrict you from responding to any inquiry, or providing testimony, about this Agreement or its underlying facts and circumstances by or before any federal, state, or local administrative or regulatory agency or authority, or otherwise communicating with any such agency or authority, or from participating or cooperating in any investigation conducted by any governmental agency or authority. Likewise, nothing in this Agreement is intended to or will prevent you from engaging in protected whistleblowing rights, including reporting a possible violation of federal or other applicable law or regulation to any governmental agency or entity, including, but not limited to, the Department of Justice, the Securities and Exchange Commission (the “SEC”), the U.S. Congress, or any governmental agency Inspector General. This Agreement does not limit your right to receive an award (including, without limitation, a monetary reward) for information provided to the SEC, and you do not need the prior authorization of anyone at the Company to make any such reports or disclosures, nor are you required to notify the Company that you have made such reports or disclosures. Further, in accordance with the Defend Trade Secrets Act of 2016, you will not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that: (a) is made (i) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney; and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or (b) is made in a complaint or other document that is filed under seal in a lawsuit or other proceeding. If you file a lawsuit for retaliation for reporting a suspected violation of law, you may disclose certain trade secrets to your attorney and use the trade secret information in the court proceeding if you: (a) file any document containing the trade secret under seal; and (b) do not disclose the trade secret, except pursuant to court order.

7. References. It is the general policy of the Company to provide only neutral references in response to employment inquiries. Thus, unless otherwise agreed to by the parties, you agree to direct all inquiries concerning your employment with the Company, including inquiries from prospective employers,to the Human Resources Department, which will provide a neutral reference, meaning the dates of your employment and positions held.

8. Consideration Time and Revocation Period. This Agreement was first given to you on November 13, 2019. You have 21 calendar days during which to review and consider this offer. If you wish to accept this Agreement, you must sign and return it on or beforeDecember 27, 2019 (“Consideration Period”) to: The J. M. Smucker Company, attn: Mandy Johnson, One Strawberry Lane, Orrville, Ohio 44667. However, you cannot sign and return it before your Separation Date, as defined on page 1 of this Agreement. In the event you sign and return the Agreement before December 27, 2019, you certify, by such execution, that you knowingly and voluntarily waive the right to the full 21 days, for reasons personal to you, with no pressure by the Company to do so.

Page 6

Kevin G. Jackson

November 13, 2019

Any discussions or negotiations over the terms of this Agreement will not extend or require a new 21-day period for your consideration of this Release Agreement.

You understand that you may revoke this Agreement for a period of seven calendar days following your execution of the Agreement. You understand that any revocation, in order to be effective, must be: (1) in writing and postmarked within seven days of your execution of the Agreement and addressed to: The J. M. Smucker Company, attn: Mandy Johnson One Strawberry Lane, Orrville, Ohio 44667; and (2) sent via certified mail, return receipt requested, to show proof of mailing. Unless revoked as provided herein, this Agreement will become fully effective and binding on the eighth day following signing (the “Effective Date”).

9. Payments and/or Benefits. If the Company has received this executed Agreement within the Consideration Period, you comply with all conditions precedent to your receipt of the Waiver and Release Payments and Benefits, as outlined in Section 2 of this Agreement, you comply with all obligations set forth in this Agreement, and you do not revoke this Agreement within the seven-day revocation period, then this Agreement will become fully and finally effective and the Waiver and Release Payments and Benefits provided by the terms of Section 2 will be made/provided to you in January 2020, following the Company’s receipt of this executed Agreement andexpiration of the seven-day revocation period.

10. Breach of Agreement. In the event of a breach by you of any provision of this Agreement or the Company’s determination as to your ineligibility to receive the Waiver and Release Payments and Benefits, as outlined in Section 2, and without limiting in any way remedies for such breach, you will forfeit any outstanding payment due under this Agreement and will repay to the Company any amount(s) already paid or provided to you pursuant to Section 2. You further agree to indemnify and hold harmless the Company from and against any and all losses, liabilities, damages, and expenses, including reasonable attorneys’ fees, that the Company may incur or suffer arising out of, or in connection with, any breach of a representation or agreement by you, including your obligations under this Agreement, or the Company’s efforts to recoup from you any Waiver and Release Payments and Benefits made to you in the event of your ineligibility to receive said amounts.

11. Governing Law. This Agreement is entered into in the State of Ohio, and the laws of the State of Ohio will apply to any dispute concerning it, excluding the conflict-of-law principles thereof. Furthermore, any action regarding this Agreement or its enforcement will be subject to the exclusive jurisdiction of the courts of the State of Ohio.

12. Complete Agreement and Modification. In executing this Agreement, you are doing so knowingly and voluntarily and agree that you have not relied upon any oral statements by the Company or its representatives, and that this Agreement constitutes the entire agreement between the Company and you pertaining to the subject matter hereof. This Agreement may not be changed or altered, except by a writing signed by the Company and you.

13. Severability. Should any provision of this Agreement be declared or determined by any court to be illegal or invalid, the remaining parts, terms or provisions will not be affected thereby, and any illegal or invalid part, term or provision will be deemed not to be a part of this Agreement.

14. 409A. This Agreement is intended to comply with Section 409A, to the extent applicable, or an exemption thereunder, and will be construed and administered in accordance with Section 409A. Notwithstanding the foregoing, the Company makes no representations that the payments and benefits provided under this Agreement comply with Section 409A, and in no event will the Company be liable for all or any portion of any taxes, penalties, interest, or other expenses that may be incurred by the Executive on account of non-compliance with Section 409A.

Page 7

Kevin G. Jackson

November 13, 2019

We thank you for your service and wish you much success in the future.

Very Truly Yours,

THE J. M. SMUCKER COMPANY

/s/ Mark T. Smucker

Mark T. Smucker

President and Chief Executive Officer

You expressly represent that you have read and fully understand the terms and significance of this Agreement and execute it knowingly and voluntarily and that you understand that this Agreement has binding legal effect.

					/s/ KGJ
					Employee's Initials
Accepted and agreed this
27th	day of	December	, 20	19
/s/ Kevin G. Jackson
Kevin G. Jackson

EX-10.2

Exhibit 10.2

CONFIDENTIAL

November 13, 2019

VIA HAND DELIVERY

David Lemmon

RE: Separation from Employment

Dear David:

        As we have discussed, your employment with The J. M. Smucker Company (the “Company”) will end effective December 6, 2019 (“Separation Date”). However, you will cease being an Elected Officer of the Company on, and your last day in the office will be November 13, 2019, after which date you should not report to the office unless instructed otherwise in writing by the Company. While your last day in the office will be today, you are expected to: remain available upon request by the Company to provide transitional support through your Separation Date; ensure that your interactions and engagement with employees and third parties through your Separation Date are not disparaging and contribute to a positive rather than disruptive work environment; and adhere to the Company’s policies, including the Basic Beliefs, through your Separation Date. Should the Company accelerate your Separation Date because of a determination in its discretion that you have not met any of the conditions in this paragraph, you will not be eligible to receive the severance package described below.

        The severance package outlined below is to assist you with your transition to new employment. Please carefully review the terms of this letter agreement (the “Separation Agreement” or “Agreement”) and the payments and benefits offered in it, as the severance is being offered to you in exchange for you agreeing to a waiver and release of claims. The “Waiver and Release Payments and Benefits” offered in Section 2 of this letter will remain open to you until the close of business on January 3, 2020.

        Any benefits provided to you as an employee of the Company will cease as of your Separation Date, except as may otherwise be provided under a particular plan. Assuming you are enrolled in the Company’s health and welfare benefits plan as of your Separation Date, your medical benefits will continue through the end of the month during which your employment terminates. You will receive a separate letter from the Company’s health plan administrator explaining your COBRA rights.

        1. Pay and Vacation. The following are not conditioned on you signing off on a waiver and release of claims:

         (a) Pay. Provided that you remain employed and available upon request by the Company through your Separation Date, the Company will continue to pay you your base pay and provide you with your current Company benefits through your Separation Date, subject to normal withholdings and deductions.

         (b) Vacation. You will be paid for all vacation earned through your Separation Date, less any vacation days taken.

Page 2

David Lemmon

November 13, 2019

         (c) Expense Reimbursements. You will be reimbursed for all reasonably incurred business expenses, in accordance with Company policy, and any expenses for financial planning services or tax return preparation, in accordance with the benefit approved by the Executive Compensation Committee (“Financial Planning Benefit”), which Financial Planning Benefit is available for your use through April 15, 2020. As a reminder, all receipts for expense reimbursement must be submitted to Marc Serilli, Vice President, Total Rewards, no later than April 15, 2020, in order to be reimbursed; otherwise, you will forfeit your right to reimbursement.

(d) Final Paycheck. You will receive your final paycheck and any applicable vacation payment the next pay date following your Separation Date unless otherwise required by law. Your final paycheck will be reduced by $5,921.00, which is comprised of: (i) $4,341.00, which you previously incorrectly submitted as a non-taxable benefit even though it was taxable, and which the Company will repay to you in the correct amount, less applicable tax withholdings; and (ii) $1,580.00, which you incorrectly previously submitted as , but which does not qualify for, the Financial Planning Benefit approved by the Executive Compensation Committee.

        2. Waiver and Release Payments and Benefits. The following payments and benefits are being offered to you in addition to the pay and vacation in Section 1. Because you would not otherwise be entitled to them, your receipt of the payments and benefits in this Section 2 will be conditioned upon you: signing this Agreement; adhering, during the remainder of your employment, to all applicable Company policies; meeting, up to and including your Separation Date, the Company’s performance expectations for your position; complying with the other terms of this Agreement; and agreeing to the Waiver and Release described in subparagraph (h). In the event the Company discovers, at any time, including after your Separation Date, that you did not meet any of these conditions, you will be ineligible to receive the Waiver and Release Payments and Benefits set forth in this Section 2. In such event, you agree that you will: (a) forfeit any outstanding payment amount(s) due pursuant to this Section 2, and (b) repay to the Company, at your expense, any payment amount(s) already paid to you pursuant to this Section 2 within five (5) business days of notification to you by the Company of your ineligibility to receive the payment amount(s) set forth in this Section.

(a) Lump-Sum Payment. Provided that the Company receives this executed Agreement back from you and you comply with all requirements and obligations set forth in this Agreement, you will receive a lump-sum severance payment in the gross amount of $527,000.00, minus all personal expenses erroneously charged to the Company credit card, which gross amount is equivalent to 12 months of your current base salary, and which will be taxed as a supplemental wage and will not be subject to 401(k) contribution elections and deductions.

(b) Restricted Shares. Provided that the Company receives this executed Agreement back from you and you comply with all requirements and obligations set forth in this Agreement, including those set forth in Section 4, you will vest in the two oldest unvested restricted stock grants that are at least two years old as of your Separation Date (i.e., the awards granted on June 8, 2016, and June 15, 2017, respectively). In addition, you will vest in the special, one-time award that was granted to you on September 1, 2016, as a retirement transition benefit and for which you would ordinarily not be eligible prior to the scheduled vesting date of September 1, 2026, and satisfaction of all other eligibility criteria. All remaining unvested restricted stock grants or option grants are forfeited as of your Separation Date.

(c) Annual Cash Incentive. Provided that the Company receives this executed Agreement back from you and you comply with all requirements and obligations set forth in this Agreement, you will receive a pro-rated incentive payment for Fiscal Year 2020 ("FY 20") in an amount equal to $230,563, which will be taxed as a supplemental wage and will be subject to 401(k) contribution elections and deductions, based on service during FY 20. The actual incentive payment for FY 20 will be paid in accordance with normal Smucker payout practices.

Page 3

David Lemmon

November 13, 2019

(d) Medical Coverage. Provided that the Company receives this executed Agreement back from you and you comply with all requirements and obligations set forth in this Agreement, you will receive an additional lump sum payment based on your Company-sponsored medical coverage in effect on your Separation Date: i.e., the Company will provide a one-time lump sum payment of $6,000 which is equal to approximately 12 months of COBRA premiums for the medical plan option you are enrolled in as of your Separation Date, at the COBRA premium rate effective as of your Separation Date.

(e) Housing Allowance. Provided that the Company receives this executed Agreement back from you and you comply with all requirements and obligations set forth in this Agreement, you will receive an additional lump sum payment in the gross amount of $20,000, which will be taxed as a supplemental wage and will not be subject to 401(k) contribution elections and deductions, representing two months of a housing allowance for purposes of additional transitional support.

(f) Outplacement Assistance. Provided that the Company receives this executed Agreement back from you and you comply with all requirements and obligations set forth in this Agreement, you will receive Company-paid outplacement assistance for the lesser of $5,000 of expenses or six months following the Effective Date of this Agreement, as defined in Section 8 below. You may work directly with Knightsbridge – Canada to coordinate these services after the Effective Date of this Agreement.

(g) Relocation Reimbursement and Allowance.  According to the terms of the Company’s relocation program, you would be required to repay the relocation expenses the Company provided you or paid on your behalf (an estimated value of $7,729 as of today's date).  Provided that the Company receives the executed Severance Agreement back from you and all other conditions for severance have been met, the Company will (i) waive its right to recover all relocation expenses, meaning that your repayment obligations will be forgiven; and (ii) provide you with a one-time, lump-sum relocation allowance in the total gross amount of $85,000, which amount shall be subject to tax withholdings and which allowance is intended to cover costs you may incur in selling your home in Ohio and moving to another home, including closing costs, storage costs, shipping costs, etc.

(h) Reduction of Non-Compete Restrictions. As you know, you entered into an Amended and Restated Change in Control Severance Agreement, dated April 20, 2018 (the “CIC Agreement”), which, pursuant to Section 9 of the CIC Agreement, imposes certain restrictive covenants during your employment with the Company and for a period of 18 months following the date of your termination of employment for any reason. However, provided that the Company receives this executed Agreement back from you and you comply with all requirements and obligations set forth in this Agreement, the Company agrees to reduce the term of the Non-Competition Period (as such term is defined in Section 9.1(A) of the CIC Agreement) from 18 months to 12 months following your Separation Date. In addition, you are encouraged to discuss with the Company any live opportunities you may be interested in exploring, so the Company can decide whether or not the restrictive covenants set forth in the CIC Agreement apply to such opportunities.

(i)Waiver and Release. By accepting the payments and benefits being offered by the Company in Sections 2(a)–(g) above and signing this Agreement, you acknowledge and agree that the commitments of the Company to you in this Section 2 are in addition to anything to which you are otherwise entitled upon your separation and are in exchange for your waiver and release as follows:

You, for yourself, and your heirs, executors, administrators, successors and assigns, hereby release and forever discharge the Company, its subsidiaries, affiliates and their respective officers, directors, agents, representatives, shareholders, employees (current and former), employee benefit plans, and any and all other persons, firms, corporations and other legal entities associated with the Company (collectively referred to as the “Released Parties”), of and from any and all claims, demands, actions, causes of action, debts, damages, expenses, suits, contracts, agreements, penalties, costs and liabilities

Page 4

David Lemmon

November 13, 2019

of any kind, nature or description, whether direct or indirect, known or unknown, in law or in equity, in contract, tort or otherwise, which you ever had, now have or may have against any of the Released Parties as of the date of execution of this Agreement, whether known or unknown, suspected or unsuspected, or which may be based upon pre-existing acts, claims or events occurring at any time up to the Effective Date of this Agreement, including, but not limited to, claims arising under Title VII of the Civil Rights Act of 1964 or state or local civil rights or equal employment opportunity statutes, claims arising under the Americans with Disabilities Act, claims arising under the Age Discrimination in Employment Act of 1967 (“ADEA”), as amended by the Older Workers Benefit Protection Act (“OWBPA”), claims arising under The Worker Adjustment Retraining and Notification Act of 1988 (“WARN”) and any state law equivalents, claims arising under the Employee Retirement Income Security Act, claims arising under the Fair Credit Reporting Act or any state law equivalent, claims for breach of express or implied contract, breach of promise, promissory estoppel, loss of income, back pay, reinstatement, front pay, impairment of earning capacity, wrongful termination, discrimination, damage to reputation, fraud, violation of public policy, retaliation, negligent or intentional infliction of mental or emotional distress, intentional tort or any other federal, state or local common law or statutory claims, and all other claims and rights, whether in law or equity. It is the intention of the parties that this paragraph will be construed as broadly as possible; however, this paragraph does not include claims arising under state workers’ compensation laws, state unemployment laws, any claims that arise after the signing of this Agreement, claims for the enforcement of this Agreement, and any claims that cannot be waived as a matter of law. This paragraph also does not affect your right to file a charge with the Equal Employment Opportunity Commission or a similar state or local agency, or with the National Labor Relations Board, or to provide information to or assist such agency in any proceeding. In addition, nothing in this Agreement is intended to or shall prevent, impede, or interfere with your non-waivable right, without prior notice to the Company, to provide information to the government, participate in investigations, file a complaint, testify in proceedings regarding the Company’s past or future conduct, or engage in any future activities protected under the whistleblower statutes, or to receive and fully retain a monetary award from a government-administered whistleblower award program for providing information directly to a government agency.

You further waive any right to become, and promise not to voluntarily become, a member of any class in a case in which any claim or claims are asserted against any of the Released Parties involving any act or event occurring through the date of your execution of this Agreement. You also agree that by signing this Agreement, you are relinquishing any right to receive any personal monetary relief or personal equitable relief with respect to any class filed by you or on your behalf, in which any claim(s) are asserted against any of the Released Parties involving any act or event through the date of your execution of this Agreement, except as otherwise set forth herein. If any such claim is brought on your behalf, or if you learn that you are named as a member of any class in a case in which any such claims are asserted, then you shall, except as otherwise allowed by law, withdraw in writing and with prejudice from said claim or class.

(i) You will receive the payments and benefits noted above in this Section 2 within the time period set forth in Section 9 below only if you sign and return this Agreement to Mandy Johnson, The J. M. Smucker Company, One Strawberry Lane, Orrville, Ohio 44667 by January 3, 2020, and you comply with the requirements and obligations contained in this Agreement, including, but not limited to those set forth in Sections 2 and 4of this Agreement. To be clear, if you do not return this Agreement, signed, anddo not comply with the requirements and obligations contained in this Agreement, including those set forth in Sections 2 and 4 of this Agreement, by January 3, 2020, then the offer of severance will expire by its own terms, and you will not be entitled to receive any of the Waiver and Release Payments and Benefits.

3. Representation as to No Additional Monies Owed.You represent, warrant, and acknowledge that the Company owes you no wages, commissions, bonuses, overtime, sick pay, shift differential, personal leave pay, severance pay, vacation pay, or other compensation or benefits or form of remuneration of any kind or nature, other than that specifically provided for in this Agreement. You further acknowledge that you were paid for all time worked during your employment with the Company.

Page 5

David Lemmon

November 13, 2019

4. Return, Retention & Preservation of Property. You already have returned or agree to immediately return all Company property (and any copies of such property) of whatsoever kind and character, including, without limitation, any Company car, badges, keys, credit cards, documents, computers, computer software, discs and media, policy and procedures manuals, and all other tangible or intangible property of the Company. You also acknowledge your obligations under and agree to abide by the Company’s document retention, litigation hold and other policies concerning the preservation, retention, non-destruction and return of Company documents and property. You acknowledge that the return, retention and preservation of Company property, including documents pursuant to the Company’s retention, litigation hold, and other policies and procedures is required of you, whether or not you sign this Agreement. You further acknowledge that it is your compliance with this paragraph by January 3, 2020, that is one of the conditions precedent to the Company’s obligation to pay you the Waiver and Release Payments and Benefits, meaning that if you do not return all such Company property by that date, the Company will have no obligation to pay you any of the Waiver and Release Payments and Benefits, even if you have signed or do ultimately sign this Agreement, but you will still be required to return all Company property on a date thereafter.

5.         Cooperation and Notice.     You agree to cooperate with the Company to provide any assistance or continued assistance deemed necessary by the Company and/or its counsel in connection with its defense of any current or future lawsuits.  “Assistance or continued assistance” means making yourself available to provide timely assistance and cooperation as reasonably requested by the Company and/or its outside counsel, taking into accountyour other business and personal obligations, and actively participate in the defense of the lawsuits, including, but not limited to, providing continued factual background and context, providing truthful testimony by affidavit, declaration, at trial, deposition or otherwise.  This will also include making yourself available as reasonably practical to review and sign documents, participate in interviews and witness preparation, as well as travel to and appear in any necessary depositions or trials. In connection with any cooperation provided under this Section 5, the Company will reimburse you for reasonable travel and other expenses incurred related to any such cooperation, in accordance with the Company’s standard travel and expense policies. 

Any changes to your address should be promptly communicated to the Company.  The Company shall provide reasonable reimbursement for appropriate expenses associated with this Section, including documented uncompensated lost work time, if any.  Unless otherwise prohibited by law, you agree to timely notify Smucker corporate legalof all subpoenas issued to you or contact made with you by any government official or law enforcement agency relating in any way to the Company or your employment with the Company and provide a copy of any subpoena upon receipt.  Nothing in this Section shall prevent you from communicating with government officials or law enforcement or participating in any government or law enforcement investigation.

6. Non-Disparagement, Non‑Disclosure, Confidentiality, Non-Competition and Non-Solicitation. You agree not to criticize, disparage, or otherwise demean in any way the Company or its respective affiliates, officers, directors, employees, or the Company’s products. Unless otherwise permitted by law, you further agree not to engage in conduct that is or could be disruptive to the Company’s work environment or its employees, including, but not limited to, behavior that is or could be perceived as harassing or retaliatory in nature. You shall not disclose the fact of this Agreement or any of its terms to any third parties other than your immediate family members (and only if they agree to be bound by the confidential nature of this Agreement), tax advisors and authorities, accountants, and attorneys or as otherwise required by law.

Page 6

David Lemmon

November 13, 2019

In addition to the post-employment restrictive and confidentiality covenants currently in place,¹ you also acknowledge that you owe a continuing duty to the Company to maintain the confidentiality of the confidential and proprietary information of the Company. You agree that you will not disclose to any third party or use, directly or indirectly, for yourself or for the benefit of any third party any Confidential Information of the Company or any of its affiliates. For purposes of this Agreement, “Confidential Information” generally includes information which is not publicly available. Confidential Information includes, but is not limited to pending acquisitions by the Company, recipes, formulas, laboratory notebooks, research and test data, patent activities, business strategies, pending contracts, market surveys, customer lists, customer information, pricing information, margins, product cost information, raw material cost information, financial projections and reports, budgets, personnel files, internal memoranda, policies, data processing programs, and accounting procedures.

        You also acknowledge that you owe a continuing duty to the Company to maintain the confidentiality of the confidential and proprietary information of the Company. You agree that you will not disclose to any third party or use, directly or indirectly, for yourself or for the benefit of any third party any Confidential Information of the Company or any of its affiliates. For purposes of this Agreement, “Confidential Information” generally includes information which is not publicly available. Confidential Information includes, but is not limited to pending acquisitions by the Company, recipes, formulas, laboratory notebooks, research and test data, patent activities, business strategies, pending contracts, market surveys, customer lists, customer information, pricing information, margins, product cost information, raw material cost information, financial projections and reports, budgets, personnel files, internal memoranda, policies, data processing programs, and accounting procedures.

        Nothing in this Agreement shall prohibit or restrict you from responding to any inquiry, or providing testimony, about this Agreement or its underlying facts and circumstances by or before any federal, state, or local administrative or regulatory agency or authority, or otherwise communicating with any such agency or authority, or from participating or cooperating in any investigation conducted by any governmental agency or authority. Likewise, nothing in this Agreement is intended to or shall prevent you from engaging in protected whistleblowing rights, including reporting a possible violation of federal or other applicable law or regulation to any governmental agency or entity, including, but not limited to, the Department of Justice, the Securities and Exchange Commission (the “SEC”), the U.S. Congress, or any governmental agency Inspector General. This Agreement does not limit your right to receive an award (including, without limitation, a monetary reward) for information provided to the SEC, and you do not need the prior authorization of anyone at the Company to make any such reports or disclosures, nor are you required to notify the Company that you have made such reports or disclosures. Further, in accordance with the Defend Trade Secrets Act of 2016, you will not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that: (a) is made (i) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney; and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or (b) is made in a complaint or other document that is filed under seal in a lawsuit or other proceeding. If you file a lawsuit for retaliation for reporting a suspected violation of law, you may disclose certain trade secrets to your attorney and use the trade secret information in the court proceeding if you: (a) file any document containing the trade secret under seal; and (b) do not disclose the trade secret, except pursuant to court order.

___________________________

¹ As you know, you entered into an Amended and Restated Change in Control Severance Agreement, dated April 20, 2018 (the "CIC Agreement"), which, pursuant to Section 9, imposes certain restrictive covenants during your employment with the Company and for a period of 18 months following the date of your termination of employment for any reason. However, provided that the company receives this executed Agreement back from you and you comply with all requirements and obligations set forth in this Agreement, the Company agrees to reduce the term of the Non-Competition Period (as such term is defined in Section 9.1 (A) of the CIC Agreement) from 18 months to 12 months following your Separation Date.

Page 7

David Lemmon

November 13, 2019

        7. References. It is the general policy of the Company to provide only neutral references in response to employment inquiries. Thus, unless otherwise agreed to by the parties, you agree to direct all inquiries concerning your employment with the Company, including inquiries from prospective employers,to the Human Resources Department, which will provide a neutral reference, meaning the dates of your employment and positions held.

        8. Consideration Time and Revocation Period. This Agreement was first given to you on November 13, 2019. You have 21 calendar days during which to review and consider this offer. If you wish to accept this Agreement, you must sign and return it on or beforeJanuary 3, 2020 (“Consideration Period”) to: The J. M. Smucker Company, attn: Mandy Johnson, One Strawberry Lane, Orrville, Ohio 44667. However, you cannot sign and return it before your Separation Date, as defined on page 1 of this Agreement. In the event you sign and return the Agreement before January 3, 2020, you certify, by such execution, that you knowingly and voluntarily waive the right to the full 21 days, for reasons personal to you, with no pressure by the Company to do so.

Any discussions or negotiations over the terms of this Agreement will not extend or require a new 21-day period for your consideration of this Release Agreement.

        You understand that you may revoke this Agreement for a period of seven calendar days following your execution of the Agreement. You understand that any revocation, in order to be effective, must be: (1) in writing and postmarked within seven days of your execution of the Agreement and addressed to: The J. M. Smucker Company, attn: Mandy Johnson, One Strawberry Lane, Orrville, Ohio 44667; and (2) sent via certified mail, return receipt requested, to show proof of mailing. Unless revoked as provided herein, this Agreement will become fully effective and binding on the eighth day following signing (the “Effective Date”).

        9. Payments and/or Benefits. If the Company has received this executed Agreement within the Consideration Period, you comply with all conditions precedent to your receipt of the Waiver and Release Payments and Benefits, as outlined in Section 2 of this Agreement, you comply with all obligations set forth in this Agreement, including those set forth in Section 4 of this Agreement, by January 3, 2020, and you do not revoke this Agreement within the seven-day revocation period, then this Agreement shall become fully and finally effective and the Waiver and Release Payments and Benefits provided by the terms of Section 2 will be made/provided to you in January 2020, following the Company’s receipt of this executed Agreement andexpiration of the seven-day revocation period.

        10. Breach of Agreement. In the event of a breach by you of any provision of this Agreement or the Company’s determination as to your ineligibility to receive the Waiver and Release Payments and Benefits, as outlined in Section 2, and without limiting in any way remedies for such breach, you will forfeit any outstanding payment due under this Agreement and will repay to the Company any amount(s) already paid or provided to you pursuant to Section 2. You further agree to indemnify and hold harmless the Company from and against any and all losses, liabilities, damages, and expenses, including reasonable attorneys’ fees, that the Company may incur or suffer arising out of, or in connection with, any breach of a representation or agreement by you, including your obligations under this Agreement, or the Company’s efforts to recoup from you any Waiver and Release Payments and Benefits made to you in the event of your ineligibility to receive said amounts.

11. Governing Law. This Agreement is entered into in the State of Ohio, and the laws of the State of Ohio will apply to any dispute concerning it, excluding the conflict-of-law principles thereof. Furthermore, any action regarding this Agreement or its enforcement shall be subject to the exclusive jurisdiction of the courts of the State of Ohio.

12. Complete Agreement and Modification. In executing this Agreement, you are doing so knowingly and voluntarily and agree that you have not relied upon any oral statements by the Company or its representatives, and that this Agreement constitutes the entire agreement between the Company and

Page 8

David Lemmon

November 13, 2019

you pertaining to the subject matter hereof. This Agreement may not be changed or altered, except by a writing signed by the Company and you.

13. Severability. Should any provision of this Agreement be declared or determined by any court to be illegal or invalid, the remaining parts, terms or provisions shall not be affected thereby, and any illegal or invalid part, term or provision shall be deemed not to be a part of this Agreement.

14. 409A. This Agreement is intended to comply with Section 409A, to the extent applicable, or an exemption thereunder, and shall be construed and administered in accordance with Section 409A. Notwithstanding the foregoing, the Company makes no representations that the payments and benefits provided under this Agreement comply with Section 409A, and in no event shall the Company be liable for all or any portion of any taxes, penalties, interest, or other expenses that may be incurred by the Executive on account of non-compliance with Section 409A.

We thank you for your service and wish you much success in the future.

Very Truly Yours,

THE J. M. SMUCKER COMPANY

/s/ Mark T. Smucker

Mark T. Smucker

President and Chief Executive Officer

Page 9

David Lemmon

November 13, 2019

You expressly represent that you have read and fully understand the terms and significance of this Agreement and execute it knowingly and voluntarily and that you understand that this Agreement has binding legal effect.

					/s/ DL
					Employee's Initials
Accepted and agreed this
2nd	day of	January	, 20	20
/s/ David Lemmon
David Lemmon

EX-31.1

Exhibit 31.1

RULE 13a-14(a)/15d-14(a) CERTIFICATIONS

I, Mark T. Smucker, President and Chief Executive Officer of The J. M. Smucker Company, certify that:

(1)I have reviewed this quarterly report on Form 10-Q of The J. M. Smucker Company;

(2)Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

(3)Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, and cash flows of the registrant as of, and for, the periods presented in this report;

(4)The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

(5)The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: February 27, 2020

/s/ Mark T. Smucker
Name:	Mark T. Smucker
Title:	President and Chief Executive Officer

EX-31.2

Exhibit 31.2

RULE 13a-14(a)/15d-14(a) CERTIFICATIONS

I, Mark R. Belgya, Vice Chair and Chief Financial Officer of The J. M. Smucker Company, certify that:

(1)I have reviewed this quarterly report on Form 10-Q of The J. M. Smucker Company;

(2)Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

(3)Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, and cash flows of the registrant as of, and for, the periods presented in this report;

(4)The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

(5)The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: February 27, 2020

/s/ Mark R. Belgya
Name:	Mark R. Belgya
Title:	Vice Chair and Chief Financial Officer

EX-32

Exhibit 32

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of The J. M. Smucker Company (the “Company”) for the quarter ended January 31, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned officers of the Company certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to such officer’s knowledge:

(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods expressed in the Report.

/s/ Mark T. Smucker
Name:	Mark T. Smucker
Title:	President and Chief Executive Officer
/s/ Mark R. Belgya
Name:	Mark R. Belgya
Title:	Vice Chair and Chief Financial Officer

Date: February 27, 2020

The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350 and is not being filed as part of the Report or as a separate disclosure document.

XML

Derivative Financial Instruments (Details 3) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jan. 31, 2020	Jan. 31, 2019	Jan. 31, 2020	Jan. 31, 2019
Price Risk Derivatives [Abstract]
Net gains (losses) on mark-to-market valuation of unallocated derivative positions	$ (7.0)	$ (25.6)	$ (5.6)	$ (54.2)
Less: Net gains (losses) on derivative positions reclassified to segment operating profit	(14.7)	(22.7)	(43.2)	(29.2)
Unallocated derivative gains (losses)	$ 7.7	$ (2.9)	$ 37.6	$ (25.0)

XML

Pensions and Other Postretirement Benefits (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jan. 31, 2020	Jan. 31, 2019	Jan. 31, 2020	Jan. 31, 2019
Defined Benefit Pension Plans
Components of net periodic benefit cost
Service Cost	$ 0.4	$ 0.6	$ 1.2	$ 1.7
Interest Cost	5.2	5.9	15.7	17.6
Expected Return on Plan Assets	(6.0)	(6.8)	(18.1)	(20.3)
Amortization of net actuarial loss (gain)	2.0	2.0	6.0	6.1
Amortization of prior service cost (credit)	0.2	0.2	0.6	0.7
Curtailment loss (gain)	0.0	0.3	0.0	0.3
Settlement loss (gain)	0.0	4.2	0.0	4.2
Net Periodic Benefit Cost	1.8	6.4	5.4	10.3
Other Postretirement Benefits
Components of net periodic benefit cost
Service Cost	0.4	0.5	1.3	1.4
Interest Cost	0.5	0.6	1.7	1.8
Expected Return on Plan Assets	0.0	0.0	0.0	0.0
Amortization of net actuarial loss (gain)	(0.1)	(0.1)	(0.2)	(0.4)
Amortization of prior service cost (credit)	(0.2)	(0.4)	(0.8)	(1.0)
Curtailment loss (gain)	0.0	0.0	0.0	0.0
Settlement loss (gain)	0.0	0.0	0.0	0.0
Net Periodic Benefit Cost	$ 0.6	$ 0.6	$ 2.0	$ 1.8

XML

Other Financial Instruments and Fair Value Measurements (Details 1) - Fair value measurements recurring [Member] - USD ($) $ in Millions		Jan. 31, 2020	Apr. 30, 2019
Financial assets (liabilities) measured at fair value on a recurring basis
Total long-term debt	[1]	$ (5,386.8)	$ (5,504.0)
Total financial instruments measured at fair value		(5,522.5)	(5,532.0)
Equity mutual funds
Financial assets (liabilities) measured at fair value on a recurring basis
Other investments	[2]	9.6	8.7
Municipal obligations
Financial assets (liabilities) measured at fair value on a recurring basis
Other investments	[2]	31.1	31.7
Money market funds
Financial assets (liabilities) measured at fair value on a recurring basis
Other investments	[2]	0.0	0.5
Commodity contracts - net
Financial assets (liabilities) measured at fair value on a recurring basis
Derivative financial instruments	[3]	(7.8)	(21.0)
Foreign currency exchange contracts - net
Financial assets (liabilities) measured at fair value on a recurring basis
Derivative financial instruments	[3]	0.3	1.2
Interest rate contracts
Financial assets (liabilities) measured at fair value on a recurring basis
Derivative financial instruments	[3]	(168.9)	(49.1)
Fair Value, Inputs, Level 1 [Member]
Financial assets (liabilities) measured at fair value on a recurring basis
Total long-term debt	[1]	(4,662.4)	(4,646.6)
Total financial instruments measured at fair value		(4,660.3)	(4,658.2)
Fair Value, Inputs, Level 1 [Member] | Equity mutual funds
Financial assets (liabilities) measured at fair value on a recurring basis
Other investments	[2]	9.6	8.7
Fair Value, Inputs, Level 1 [Member] | Municipal obligations
Financial assets (liabilities) measured at fair value on a recurring basis
Other investments	[2]	0.0	0.0
Fair Value, Inputs, Level 1 [Member] | Money market funds
Financial assets (liabilities) measured at fair value on a recurring basis
Other investments	[2]	0.0	0.5
Fair Value, Inputs, Level 1 [Member] | Commodity contracts - net
Financial assets (liabilities) measured at fair value on a recurring basis
Derivative financial instruments	[3]	(7.5)	(20.7)
Fair Value, Inputs, Level 1 [Member] | Foreign currency exchange contracts - net
Financial assets (liabilities) measured at fair value on a recurring basis
Derivative financial instruments	[3]	0.0	(0.1)
Fair Value, Inputs, Level 1 [Member] | Interest rate contracts
Financial assets (liabilities) measured at fair value on a recurring basis
Derivative financial instruments	[3]	0.0	0.0
Fair Value, Inputs, Level 2 [Member]
Financial assets (liabilities) measured at fair value on a recurring basis
Total long-term debt	[1]	(724.4)	(857.4)
Total financial instruments measured at fair value		(862.2)	(873.8)
Fair Value, Inputs, Level 2 [Member] | Equity mutual funds
Financial assets (liabilities) measured at fair value on a recurring basis
Other investments	[2]	0.0	0.0
Fair Value, Inputs, Level 2 [Member] | Municipal obligations
Financial assets (liabilities) measured at fair value on a recurring basis
Other investments	[2]	31.1	31.7
Fair Value, Inputs, Level 2 [Member] | Money market funds
Financial assets (liabilities) measured at fair value on a recurring basis
Other investments	[2]	0.0	0.0
Fair Value, Inputs, Level 2 [Member] | Commodity contracts - net
Financial assets (liabilities) measured at fair value on a recurring basis
Derivative financial instruments	[3]	(0.3)	(0.3)
Fair Value, Inputs, Level 2 [Member] | Foreign currency exchange contracts - net
Financial assets (liabilities) measured at fair value on a recurring basis
Derivative financial instruments	[3]	0.3	1.3
Fair Value, Inputs, Level 2 [Member] | Interest rate contracts
Financial assets (liabilities) measured at fair value on a recurring basis
Derivative financial instruments	[3]	(168.9)	(49.1)
Fair Value, Inputs, Level 3 [Member]
Financial assets (liabilities) measured at fair value on a recurring basis
Total long-term debt	[1]	0.0	0.0
Total financial instruments measured at fair value		0.0	0.0
Fair Value, Inputs, Level 3 [Member] | Equity mutual funds
Financial assets (liabilities) measured at fair value on a recurring basis
Other investments	[2]	0.0	0.0
Fair Value, Inputs, Level 3 [Member] | Municipal obligations
Financial assets (liabilities) measured at fair value on a recurring basis
Other investments	[2]	0.0	0.0
Fair Value, Inputs, Level 3 [Member] | Money market funds
Financial assets (liabilities) measured at fair value on a recurring basis
Other investments	[2]	0.0	0.0
Fair Value, Inputs, Level 3 [Member] | Commodity contracts - net
Financial assets (liabilities) measured at fair value on a recurring basis
Derivative financial instruments	[3]	0.0	0.0
Fair Value, Inputs, Level 3 [Member] | Foreign currency exchange contracts - net
Financial assets (liabilities) measured at fair value on a recurring basis
Derivative financial instruments	[3]	0.0	0.0
Fair Value, Inputs, Level 3 [Member] | Interest rate contracts
Financial assets (liabilities) measured at fair value on a recurring basis
Derivative financial instruments	[3]	$ 0.0	$ 0.0

[1] Long-term debt is composed of public Senior Notes classified as Level 1 and the Term Loan classified as Level 2. The public Senior Notes are traded in an active secondary market and valued using quoted prices. The fair value of the Term Loan is based on the net present value of each interest and principal payment calculated utilizing an interest rate derived from an estimated yield curve obtained from independent pricing sources for similar types of term loan borrowing arrangements. For additional information, see Note 9: Debt and Financing Arrangements.

[2] Marketable securities and other investments consist of funds maintained for the payment of benefits associated with nonqualified retirement plans. The funds include equity securities listed in active markets, municipal obligations valued by a third party using valuation techniques that utilize inputs that are derived principally from or corroborated by observable market data, and money market funds with maturities of three months or less. Based on the short-term nature of these money market funds, carrying value approximates fair value. As of January 31, 2020, our municipal obligations are scheduled to mature as follows: $0.3 in 2020, $1.0 in 2021, $1.5 in 2022, $1.0 in 2023, and the remaining $27.3 in 2024 and beyond.

[3] Level 1 commodity and foreign currency exchange derivatives are valued using quoted market prices for identical instruments in active markets. Level 2 commodity and foreign currency exchange derivatives are valued using quoted prices for similar assets or liabilities in active markets. The Level 2 interest rate contracts are valued using standard valuation techniques, the income approach, and observable Level 2 market expectations at the measurement date to convert future amounts to a single discounted present value. Level 2 inputs for the valuation of the interest rate contracts are limited to prices that are observable for the asset or liability. For additional information, see Note 11: Derivative Financial Instruments.

XML

Integration and Restructuring Costs (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jan. 31, 2020	Jan. 31, 2019	Jan. 31, 2020	Jan. 31, 2019	Apr. 30, 2019
Organization Optimization Program [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Cost Incurred to Date					$ 74.6
Restructuring and Related Cost, Incurred Cost	$ 0.0	$ 11.1	$ 0.0	$ 28.0
Restructuring and Related Cost, Noncash Charge Incurred to Date					15.2
Restructuring and Related Cost, Incurred Noncash Charge		1.2		2.2
Organization Optimization Program [Member] | Employee-related costs [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Cost Incurred to Date					48.7
Restructuring Reserve					0.8
Organization Optimization Program [Member] | Other Restructuring [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Cost Incurred to Date					25.9
Ainsworth [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Expected Cost	50.0		50.0
Restructuring and Related Cost, Cost Incurred to Date	42.0		42.0
Restructuring and Related Cost, Incurred Cost	3.3	7.7	9.9	23.9
Restructuring and Related Cost, Noncash Charge Incurred to Date	4.6		4.6
Restructuring and Related Cost, Incurred Noncash Charge	0.1	1.0	0.5	2.8
Ainsworth [Member] | Employee-related costs [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Cost Incurred to Date	17.2		17.2
Restructuring and Related Cost, Incurred Cost	0.3	5.4	1.7	13.2
Restructuring Reserve	0.3		0.3		$ 1.6
Ainsworth [Member] | Other Restructuring [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Cost Incurred to Date	24.8		24.8
Restructuring and Related Cost, Incurred Cost	$ 3.0	$ 2.3	$ 8.2	$ 10.7

XML

Pensions and Other Postretirement Benefits (Tables)

9 Months Ended

Jan. 31, 2020

Retirement Benefits [Abstract]

Net periodic benefit cost

The components of our net periodic benefit cost for defined benefit pension and other postretirement benefit plans are shown below.

	Three Months Ended January 31,
	Defined Benefit Pension Plans				Other Postretirement Benefits
	2020		2019		2020		2019
Service cost	$	0.4	$	0.6	$	0.4	$	0.5
Interest cost	5.2		5.9		0.5		0.6
Expected return on plan assets	(6.0)		(6.8)		—		—
Amortization of net actuarial loss (gain)	2.0		2.0		(0.1)		(0.1)
Amortization of prior service cost (credit)	0.2		0.2		(0.2)		(0.4)
Curtailment loss (gain)	—		0.3		—		—
Settlement loss (gain)	—		4.2		—		—
Net periodic benefit cost	$	1.8	$	6.4	$	0.6	$	0.6

	Nine Months Ended January 31,
	Defined Benefit Pension Plans				Other Postretirement Benefits
	2020		2019		2020		2019
Service cost	$	1.2	$	1.7	$	1.3	$	1.4
Interest cost	15.7		17.6		1.7		1.8
Expected return on plan assets	(18.1)		(20.3)		—		—
Amortization of net actuarial loss (gain)	6.0		6.1		(0.2)		(0.4)
Amortization of prior service cost (credit)	0.6		0.7		(0.8)		(1.0)
Curtailment loss (gain)	—		0.3		—		—
Settlement loss (gain)	—		4.2		—		—
Net periodic benefit cost	$	5.4	$	10.3	$	2.0	$	1.8

XML

Accumulated Other Comprehensive Income (Loss) (Tables)

9 Months Ended

Jan. 31, 2020

Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]

Components of accumulated other comprehensive income (loss)

The components of accumulated other comprehensive income (loss), including the reclassification adjustments for items that are reclassified from accumulated other comprehensive income (loss) to net income, are shown below.

	Foreign Currency Translation Adjustment		Net Gains (Losses) on Cash Flow Hedging Derivatives (A)		Pension and Other Postretirement Liabilities (B)		Unrealized  Gain (Loss) on Available- for-Sale Securities		Accumulated Other Comprehensive Income (Loss)
Balance at May 1, 2019	$	(35.5)	$	(40.4)	$	(110.0)	$	4.1	$	(181.8)
Reclassification adjustments	—		0.3		5.2		—		5.5
Current period credit (charge)	2.6		(119.8)		—		1.2		(116.0)
Income tax benefit (expense)	—		27.5		(1.2)		(0.3)		26.0
Balance at January 31, 2020	$	(32.9)	$	(132.4)	$	(106.0)	$	5.0	$	(266.3)

	Foreign Currency Translation Adjustment		Net Gains (Losses) on Cash Flow Hedging Derivatives (A)		Pension and Other Postretirement Liabilities (B)		Unrealized Gain (Loss) on Available- for-Sale Securities		Accumulated Other Comprehensive Income (Loss)
Balance at May 1, 2018	$	(16.4)	$	(2.9)	$	(101.0)	$	3.6	$	(116.7)
Reclassification adjustments	—		0.3		6.0		—		6.3
Current period credit (charge)	(10.1)		(37.6)		(2.4)		(0.5)		(50.6)
Income tax benefit (expense)	—		8.5		(0.9)		0.1		7.7
Balance at January 31, 2019	$	(26.5)	$	(31.7)	$	(98.3)	$	3.2	$	(153.3)

(A)The reclassification from accumulated other comprehensive income (loss) to interest expense was related to terminated interest rate contracts. The current period credit (charge) relates to the unrealized gains (losses) on the interest rate contracts entered into in November 2018 and June 2018. For additional information, see Note 11: Derivative Financial Instruments.

(B)Amortization of net losses and prior service costs was reclassified from accumulated other comprehensive income (loss) to other income (expense) – net.

XML

Debt and Financing Arrangements

9 Months Ended

Jan. 31, 2020

Debt Disclosure [Abstract]

Debt and Financing Arrangements

Long-term debt consists of the following:

	January 31, 2020				April 30, 2019
	Principal Outstanding		Carrying Amount (A)		Principal Outstanding		Carrying Amount (A)
2.20% Senior Notes due December 6, 2019	$	—	$	—	$	300.0	$	299.5
2.50% Senior Notes due March 15, 2020	500.0		499.8		500.0		499.0
3.50% Senior Notes due October 15, 2021	750.0		762.9		750.0		768.4
3.00% Senior Notes due March 15, 2022	400.0		398.5		400.0		398.0
3.50% Senior Notes due March 15, 2025	1,000.0		995.8		1,000.0		995.2
3.38% Senior Notes due December 15, 2027	500.0		496.6		500.0		496.2
4.25% Senior Notes due March 15, 2035	650.0		643.8		650.0		643.5
4.38% Senior Notes due March 15, 2045	600.0		586.4		600.0		586.0
Term Loan Credit Agreement due May 14, 2021	700.0		699.3		800.0		799.0
Total long-term debt	$	5,100.0	$	5,083.1	$	5,500.0	$	5,484.8
Current portion of long-term debt	500.0		499.8		800.0		798.5
Total long-term debt, less current portion	$	4,600.0	$	4,583.3	$	4,700.0	$	4,686.3

(A) Represents the carrying amount included in the Condensed Consolidated Balance Sheets, which includes the impact of capitalized debt issuance costs, terminated interest rate contracts, and offering discounts.

We entered into interest rate contracts in November 2018 and June 2018, with notional values of $300.0 and $500.0, respectively, to manage our exposure to interest rate volatility associated with anticipated debt financing in 2020. These interest rate contracts are designated as cash flow hedges, and as a result, the mark-to-market gains or losses on these contracts are deferred and included as a component of accumulated other comprehensive income (loss) and reclassified to interest expense in the period during which the hedged transactions affect earnings. At January 31, 2020, unrealized losses of $168.9 were deferred in accumulated other comprehensive income (loss) for these derivative instruments. For additional information, see Note 11: Derivative Financial Instruments.

In April 2018, we entered into a senior unsecured delayed-draw Term Loan Credit Agreement (“Term Loan”) with a syndicate of banks and an available commitment amount of $1.5 billion. The full amount of the Term Loan was drawn on May 14, 2018, to partially finance the Ainsworth acquisition, as discussed in Note 3: Acquisition. Borrowings under the Term Loan bear interest on the prevailing U.S. Prime Rate or London Interbank Offered Rate (“LIBOR”), based on our election, and are payable either on a quarterly basis or at the end of the borrowing term. The Term Loan does not require scheduled amortization payments. Voluntary prepayments are permitted without premium or penalty. As of January 31, 2020, we have prepaid $800.0 on the Term Loan to date, including $100.0 in 2020. The interest rate on the Term Loan at January 31, 2020, was 2.45 percent. In November 2019, we entered into an amendment to the Term Loan that decreased the applicable margins on LIBOR, based on our long-term unsecured debt rating. This amendment did not have a material impact on our condensed consolidated financial statements.

All of our Senior Notes outstanding at January 31, 2020, are unsecured and interest is paid semiannually, with no required scheduled principal payments until maturity. We may prepay all or part of the Senior Notes at 100 percent of the principal amount thereof, together with the accrued and unpaid interest, and any applicable make-whole amount.

We have available a $1.8 billion unsecured revolving credit facility with a group of 11 banks that matures in September 2022. Borrowings under the revolving credit facility bear interest on the prevailing U.S. Prime Rate, LIBOR, or Canadian Dealer Offered Rate, based on our election. Interest is payable either on a quarterly basis or at the end of the borrowing term. We did not have a balance outstanding under the revolving credit facility at January 31, 2020, or April 30, 2019.

We participate in a commercial paper program under which we can issue short-term, unsecured commercial paper not to exceed $1.8 billion at any time. The commercial paper program is backed by our revolving credit facility and reduces what we can borrow under the revolving credit facility by the amount of commercial paper outstanding. Commercial paper will be used as a continuing source of short-term financing for general corporate purposes. As of January 31, 2020, and April 30, 2019, we had $310.0 and $426.0 of short-term borrowings outstanding, respectively, which were issued under our commercial paper program at weighted-average interest rates of 1.79 percent and 2.75 percent, respectively.

Interest paid totaled $18.3 and $24.4 for the three months ended January 31, 2020 and 2019, respectively, and $118.3 and $131.8, for the nine months ended January 31, 2020 and 2019, respectively. This differs from interest expense due to the timing of interest payments, effect of interest rate contracts, amortization of debt issuance costs and discounts, capitalized interest, and payment of other debt fees.

Our debt instruments contain certain financial covenant restrictions, including a leverage ratio and an interest coverage ratio. We are in compliance with all covenants.

XML

Divestiture

9 Months Ended

Jan. 31, 2020

Discontinued Operations and Disposal Groups [Abstract]

Divestiture

On August 31, 2018, we sold our U.S. baking business to Brynwood Partners VII L.P. and Brynwood Partners VIII L.P., subsidiaries of Brynwood Partners, an unrelated party. The transaction included products that were primarily sold in U.S. retail channels under the Pillsbury^®, Martha White^®, Hungry Jack^®, White Lily^®, and Jim Dandy^® brands, along with all relevant trademarks and licensing agreements, and our manufacturing facility in Toledo, Ohio. This business generated net sales of approximately $370.0 in 2018. The transaction did not include our baking business in Canada.

The operating results for this business were primarily included in the U.S. Retail Consumer Foods segment prior to the sale. We received proceeds from the divestiture of $369.5, which were net of cash transaction costs and included a working capital adjustment. During 2019, we recognized a pre-tax gain of $27.7 related to this transaction, of which $1.0 was recognized during the third quarter associated with the working capital adjustment that was finalized during the fourth quarter. The gain was included in other operating expense (income) – net within the Condensed Statement of Consolidated Income.

XML

Common Shares

9 Months Ended

Jan. 31, 2020

Stockholders' Equity Note [Abstract]

Common Shares

The following table sets forth common share information.

	January 31, 2020	April 30, 2019
Common shares authorized	300.0	300.0
Common shares outstanding	114.0	113.7
Treasury shares	32.5	32.8

Repurchase Program: During the nine months ended January 31, 2020 and 2019, we did not repurchase any common shares under a repurchase plan authorized by the Board of Directors (the “Board”). Share repurchases during the nine months ended January 31, 2020 and 2019, consisted of shares repurchased from stock plan recipients in lieu of cash payments. At January 31, 2020, we had approximately 3.6 million common shares available for repurchase pursuant to the Board’s authorizations.

XML

Leases

9 Months Ended

Jan. 31, 2020

Leases [Abstract]

Leases

We lease certain warehouses, manufacturing facilities, office space, equipment, and vehicles, primarily through operating lease agreements. We have elected to not recognize leases with a term of 12 months or less on the balance sheet. Instead, we recognize the related lease expense on a straight-line basis over the lease term.

Although the majority of our right-of-use asset and lease liability balances consist of leases with renewal options, we generally are not reasonably certain to exercise them, and therefore, the optional periods do not typically impact the lease term. Certain leases also include termination provisions or options to purchase the leased property. Since we are not reasonably certain to exercise these types of options, minimum lease payments do not include any amounts related to these termination or purchase options. Our lease agreements generally do not contain residual value guarantees or restrictive covenants that are material.

We determine if an agreement is or contains a lease at inception by evaluating whether an identified asset exists that we control over the term of the arrangement. A lease commences when the lessor makes the identified asset available for our use. We generally account for lease and non-lease components as a single lease component. Minimum lease payments do not include variable lease payments other than those that depend on an index or rate.

For the majority of our leases, the interest rate implicit in the lease cannot be readily determined, so we utilize our incremental borrowing rate to present value lease payments using information available at the lease commencement date. We consider our credit rating and the current economic environment in determining this collateralized rate. For the initial implementation of the lease standard, the incremental borrowing rate at May 1, 2019, was used to calculate all operating lease liabilities.

The following table sets forth the right-of-use assets and lease liabilities recognized in the Condensed Consolidated Balance Sheet.

	January 31, 2020
Operating lease right-of-use assets	$	168.0
Operating lease liabilities:
Current operating lease liabilities	$	41.7
Noncurrent operating lease liabilities	133.5
Total operating lease liabilities	$	175.2
Finance lease right-of-use assets:
Machinery and equipment	$	13.4
Accumulated depreciation	(6.9)
Total property, plant, and equipment	$	6.5
Finance lease liabilities:
Other current liabilities	$	2.2
Other noncurrent liabilities	3.7
Total finance lease liabilities	$	5.9

The following table summarizes the components of lease expense.

	Three Months Ended January 31, 2020		Nine Months Ended January 31, 2020
Operating lease cost	$	13.2	$	38.5
Finance lease cost:
Amortization of right-of-use assets	0.7		2.3
Interest on lease liabilities	0.1		0.2
Variable lease cost	5.0		17.6
Short-term lease cost	8.5		25.9
Sublease income	(1.1)		(3.4)
Net lease cost	$	26.4	$	81.1

The following table sets forth cash flow and noncash information related to leases.

	Nine Months Ended January 31, 2020
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	38.8
Operating cash flows from finance leases	0.2
Financing cash flows from finance leases	2.1
Right-of-use assets obtained in exchange for new lease liabilities:
Operating leases	56.6
Finance leases	2.4

The following table summarizes the maturity of our lease liabilities by fiscal year.

	January 31, 2020
	Operating Leases		Finance Leases
2020 (remainder of the year)	$	12.3	$	0.7
2021	43.8		2.2
2022	40.5		1.6
2023	34.6		0.9
2024	22.8		0.7
2025 and beyond	34.8		0.2
Total undiscounted minimum lease payments	$	188.8	$	6.3
Less: Imputed interest	13.6		0.4
Lease liabilities	$	175.2	$	5.9

As of April 30, 2019, our minimum operating lease obligations were as follows: $43.0 in 2020, $36.7 in 2021, $30.5 in 2022, $24.8 in 2023, and $12.3 in 2024.

The following table sets forth the weighted average remaining lease term and discount rate.

	January 31, 2020
Weighted average remaining lease term (in years):
Operating leases	4.8
Finance leases	3.4
Weighted average discount rate:
Operating leases	3.1	%
Finance leases	3.0	%

XML

Earnings per Share (Tables)

9 Months Ended

Jan. 31, 2020

Earnings Per Share [Abstract]

Computation of earnings per common share, basic and diluted

The following table sets forth the computation of net income per common share and net income per common share – assuming dilution under the two-class method.

	Three Months Ended January 31,				Nine Months Ended January 31,
	2020		2019		2020		2019
Net income	$	187.4	$	121.4	$	553.2	$	442.9
Less: Net income allocated to participating securities	1.1		0.6		3.2		2.3
Net income allocated to common stockholders	$	186.3	$	120.8	$	550.0	$	440.6
Weighted-average common shares outstanding	113.4		113.2		113.3		113.1
Add: Dilutive effect of stock options	—		—		—		—
Weighted-average common shares outstanding – assuming dilution	113.4		113.2		113.3		113.1
Net income per common share	$	1.64	$	1.07	$	4.85	$	3.89
Net income per common share – assuming dilution	$	1.64	$	1.07	$	4.85	$	3.89

XML

Income Taxes (Details Textual) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jan. 31, 2020	Jan. 31, 2019	Jan. 31, 2020	Jan. 31, 2019
Income Tax Disclosure [Abstract]
Effective Income Tax Rate Reconciliation, Percent	22.70%	22.80%	24.00%	26.10%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	21.00%	21.00%	21.00%	21.00%
Income Taxes (Textual) [Abstract]
Time Period Over Which it is Reasonably Possible That Company Could Increase or Decrease its Unrecognized Tax Benefits			12 months
Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit	$ 2.6		$ 2.6

XML

Leases (Details 2) $ in Millions	9 Months Ended
	Jan. 31, 2020 USD ($)
Leases [Abstract]
Operating Lease, Payments	$ 38.8
Finance Lease, Interest Payment on Liability	0.2
Finance Lease, Principal Payments	2.1
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	56.6
Right-of-Use Asset Obtained in Exchange for Finance Lease Liability	$ 2.4

XML

Debt and Financing Arrangements (Details Textual)	3 Months Ended		9 Months Ended		21 Months Ended
	Jan. 31, 2020 USD ($) Bank	Jan. 31, 2019 USD ($)	Jan. 31, 2020 USD ($) Bank	Jan. 31, 2019 USD ($)	Jan. 31, 2020 USD ($) Bank	Apr. 30, 2019 USD ($)	Nov. 30, 2018 USD ($)	Jun. 30, 2018 USD ($)	May 14, 2018 USD ($)
Debt and Financing Arrangements (Textual) [Abstract]
Debt instrument face amount	$ 5,100,000,000.0		$ 5,100,000,000.0		$ 5,100,000,000.0	$ 5,500,000,000.0
Repayments of long-term debt			400,000,000.0	$ 600,000,000.0
Interest paid	18,300,000	$ 24,400,000	118,300,000	$ 131,800,000
Short-term borrowings	$ 310,000,000.0		$ 310,000,000.0		$ 310,000,000.0	426,000,000.0
Senior Notes [Member]
Debt and Financing Arrangements (Textual) [Abstract]
Percentage of the principal amount thereof which company can prepay	100.00%		100.00%		100.00%
Term Loan Credit Agreement due May 14, 2021
Debt and Financing Arrangements (Textual) [Abstract]
Debt instrument face amount	$ 700,000,000.0		$ 700,000,000.0		$ 700,000,000.0	800,000,000.0			$ 1,500,000,000
Repayments of long-term debt			$ 100,000,000.0		$ 800,000,000.0
Long-term Debt, Weighted Average Interest Rate, at Point in Time	2.45%		2.45%		2.45%
Revolving Credit Facility [Member]
Debt and Financing Arrangements (Textual) [Abstract]
Number of banks | Bank	11		11		11
Outstanding balance under revolving credit facility	$ 0		$ 0		$ 0	$ 0
Revolving credit facility maximum borrowing capacity	$ 1,800,000,000		$ 1,800,000,000		$ 1,800,000,000
Commercial Paper [Member]
Debt and Financing Arrangements (Textual) [Abstract]
Commercial paper weighted-average interest rate	1.79%		1.79%		1.79%	2.75%
Commercial paper, borrowing capacity	$ 1,800,000,000		$ 1,800,000,000		$ 1,800,000,000
Short-term borrowings	310,000,000.0		310,000,000.0		310,000,000.0	$ 426,000,000.0
Interest rate contracts
Derivative Instruments, Gain (Loss) [Line Items]
Gross notional amount	$ 800,000,000.0		800,000,000.0		$ 800,000,000.0	$ 800,000,000.0	$ 300,000,000.0	$ 500,000,000.0
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax			$ (168,900,000)

XML

Reportable Segments (Details) - USD ($) $ in Millions	3 Months Ended				9 Months Ended
	Jan. 31, 2020		Jan. 31, 2019		Jan. 31, 2020		Jan. 31, 2019
Net sales:
Net sales	$ 1,972.3		$ 2,011.9		$ 5,709.0		$ 5,935.9
Segment profit:
Segment profit	468.7		480.0		1,292.3		1,358.1
Amortization	(58.8)		(59.7)		(176.4)		(179.9)
Other intangible assets impairment charges	(52.4)		(107.2)		(52.4)		(107.2)
Interest expense – net	(45.1)		(51.6)		(143.6)		(158.8)
Unallocated derivative gains (losses)	7.7		(2.9)		37.6		(25.0)
Other special project costs (A)	(3.3)	[1]	(18.8)	[1]	(9.9)	[1]	(51.9)	[2]
Corporate administrative expenses	(72.9)		(73.8)		(214.8)		(219.1)
Other income (expense) – net	(1.4)		(8.8)		(4.5)		(16.5)
Income Before Income Taxes	242.5		157.2		728.3		599.7
U.S. Retail Pet Foods [Member]
Net sales:
Net sales	721.9		759.0		2,101.7		2,158.3
Segment profit:
Segment profit	146.0		147.9		403.1		372.2
Other intangible assets impairment charges	(52.4)		(107.2)
U.S. Retail Coffee [Member]
Net sales:
Net sales	558.8		561.6		1,567.9		1,596.0
Segment profit:
Segment profit	189.5		183.7		500.9		505.8
U.S. Retail Consumer Foods [Member]
Net sales:
Net sales	422.9		422.7		1,251.2		1,367.9
Segment profit:
Segment profit	84.2		95.9		256.6		327.5
International and Away From Home [Member]
Net sales:
Net sales	268.7		268.6		788.2		813.7
Segment profit:
Segment profit	$ 49.0		$ 52.5		$ 131.7		$ 152.6

[1] Other special project costs includes integration and restructuring costs. For more information, see Note 4: Integration and Restructuring Costs.

[2] Other special project costs includes integration and restructuring costs. For more information, see Note 4: Integration and Restructuring Costs.

XML

Condensed Statements of Consolidated Shareholders' Equity (Unaudited) - USD ($) $ in Millions	Total	Common Shares	Additional Capital	Retained Income	Accumulated Other Comprehensive Income (Loss)
Balance at Apr. 30, 2018	$ 7,891.1	$ 28.9	$ 5,739.7	$ 2,239.2	$ (116.7)
Balance, shares at Apr. 30, 2018		113,572,840
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	133.0			133.0
Other comprehensive income (loss)	(2.1)				(2.1)
Comprehensive Income	130.9
Purchase of treasury shares	(4.7)	$ 0.0	(4.6)	(0.1)
Purchase of treasury shares, shares		(43,913)
Stock plans	10.0	$ 0.0	10.0
Stock plans, shares		243,521
Cash dividends declared	(96.5)			(96.5)
Other	0.0			0.0
Balance at Jul. 31, 2018	7,930.8	$ 28.9	5,745.1	2,275.6	(118.8)
Balance, shares at Jul. 31, 2018		113,772,448
Balance at Apr. 30, 2018	7,891.1	$ 28.9	5,739.7	2,239.2	(116.7)
Balance, shares at Apr. 30, 2018		113,572,840
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	442.9
Other comprehensive income (loss)	(36.6)
Comprehensive Income	406.3
Balance at Jan. 31, 2019	8,021.6	$ 28.9	5,753.4	2,392.6	(153.3)
Balance, shares at Jan. 31, 2019		113,758,456
Balance at Jul. 31, 2018	7,930.8	$ 28.9	5,745.1	2,275.6	(118.8)
Balance, shares at Jul. 31, 2018		113,772,448
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	188.5			188.5
Other comprehensive income (loss)	2.4				2.4
Comprehensive Income	190.9
Purchase of treasury shares	(0.3)	$ 0.0	(0.3)	0.0
Purchase of treasury shares, shares		(2,485)
Stock plans	5.1	$ 0.0	5.1
Stock plans, shares		(9,883)
Cash dividends declared	(96.5)			(96.5)
Other	0.0	$ 0.0		0.0
Balance at Oct. 31, 2018	8,030.0	$ 28.9	5,749.9	2,367.6	(116.4)
Balance, shares at Oct. 31, 2018		113,760,080
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	121.4			121.4
Other comprehensive income (loss)	(36.9)				(36.9)
Comprehensive Income	84.5
Purchase of treasury shares	(0.2)	$ 0.0	(0.2)	0.0
Purchase of treasury shares, shares		(1,746)
Stock plans	3.7	$ 0.0	3.7
Stock plans, shares		122
Cash dividends declared	(96.4)			(96.4)
Balance at Jan. 31, 2019	8,021.6	$ 28.9	5,753.4	2,392.6	(153.3)
Balance, shares at Jan. 31, 2019		113,758,456
Balance at Apr. 30, 2019	$ 7,970.5	$ 28.9	5,755.8	2,367.6	(181.8)
Balance, shares at Apr. 30, 2019	113,700,000	113,742,296
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	$ 154.6			154.6
Other comprehensive income (loss)	(34.9)				(34.9)
Comprehensive Income	119.7
Purchase of treasury shares	(2.9)	$ 0.0	(2.7)	(0.2)
Purchase of treasury shares, shares		(22,793)
Stock plans	20.5	$ 0.1	20.4
Stock plans, shares		330,289
Cash dividends declared	(100.1)			(100.1)
Other	0.0			0.0
Balance at Jul. 31, 2019	8,007.7	$ 29.0	5,773.5	2,421.9	(216.7)
Balance, shares at Jul. 31, 2019		114,049,792
Balance at Apr. 30, 2019	$ 7,970.5	$ 28.9	5,755.8	2,367.6	(181.8)
Balance, shares at Apr. 30, 2019	113,700,000	113,742,296
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	$ 553.2
Other comprehensive income (loss)	(84.5)
Comprehensive Income	468.7
Balance at Jan. 31, 2020	$ 8,170.4	$ 29.0	5,787.2	2,620.5	(266.3)
Balance, shares at Jan. 31, 2020	114,000,000.0	114,041,313
Balance at Jul. 31, 2019	$ 8,007.7	$ 29.0	5,773.5	2,421.9	(216.7)
Balance, shares at Jul. 31, 2019		114,049,792
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	211.2			211.2
Other comprehensive income (loss)	(31.7)				(31.7)
Comprehensive Income	179.5
Purchase of treasury shares	(0.6)	$ 0.0	(0.6)	0.0
Purchase of treasury shares, shares		(4,930)
Stock plans	8.8	$ 0.0	8.8
Stock plans, shares		14,882
Cash dividends declared	(100.1)			(100.1)
Other	0.0			0.0
Balance at Oct. 31, 2019	8,095.3	$ 29.0	5,781.7	2,533.0	(248.4)
Balance, shares at Oct. 31, 2019		114,059,744
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	187.4			187.4
Other comprehensive income (loss)	(17.9)				(17.9)
Comprehensive Income	169.5
Purchase of treasury shares	(0.8)	$ 0.0	(1.0)	0.2
Purchase of treasury shares, shares		(7,180)
Stock plans	6.5	$ 0.0	6.5
Stock plans, shares		(11,251)
Cash dividends declared	(100.1)			(100.1)
Other	0.0			0.0
Balance at Jan. 31, 2020	$ 8,170.4	$ 29.0	$ 5,787.2	$ 2,620.5	$ (266.3)
Balance, shares at Jan. 31, 2020	114,000,000.0	114,041,313

XML

Earnings per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended						9 Months Ended
	Jan. 31, 2020	Oct. 31, 2019	Jul. 31, 2019	Jan. 31, 2019	Oct. 31, 2018	Jul. 31, 2018	Jan. 31, 2020	Jan. 31, 2019
Earnings Per Share [Abstract]
Net income	$ 187.4	$ 211.2	$ 154.6	$ 121.4	$ 188.5	$ 133.0	$ 553.2	$ 442.9
Less: Net income allocated to participating securities	1.1			0.6			3.2	2.3
Net income allocated to common stockholders	$ 186.3			$ 120.8			$ 550.0	$ 440.6
Weighted-average common shares outstanding (in shares)	113.4			113.2			113.3	113.1
Add: Dilutive effect of stock options (in shares)	0.0			0.0			0.0	0.0
Weighted-average common shares outstanding - assuming dilution (in shares)	113.4			113.2			113.3	113.1
Net income per common share (in dollars per share)	$ 1.64			$ 1.07			$ 4.85	$ 3.89
Net Income - Assuming Dilution (in dollars per share)	$ 1.64			$ 1.07			$ 4.85	$ 3.89

XML

Condensed Statements of Consolidated Income (Unaudited) - USD ($) $ in Millions	3 Months Ended				9 Months Ended
	Jan. 31, 2020		Jan. 31, 2019		Jan. 31, 2020		Jan. 31, 2019
Income Statement [Abstract]
Net sales	$ 1,972.3		$ 2,011.9		$ 5,709.0		$ 5,935.9
Cost of products sold	1,212.3		1,238.1		3,495.4		3,712.6
Gross Profit	760.0		773.8		2,213.6		2,223.3
Selling, distribution, and administrative expenses	358.9		373.1		1,100.9		1,138.8
Amortization	58.8		59.7		176.4		179.9
Other intangible assets impairment charges	52.4		107.2		52.4		107.2
Other special project costs	3.3	[1]	18.8	[1]	9.9	[1]	51.9	[2]
Other operating expense (income) – net	(2.4)		(2.6)		(2.4)		(29.5)
Operating Income	289.0		217.6		876.4		775.0
Interest expense – net	(45.1)		(51.6)		(143.6)		(158.8)
Other income (expense) – net	(1.4)		(8.8)		(4.5)		(16.5)
Income Before Income Taxes	242.5		157.2		728.3		599.7
Income tax expense	55.1		35.8		175.1		156.8
Net Income	$ 187.4		$ 121.4		$ 553.2		$ 442.9
Earnings per common share:
Net Income (in dollars per share)	$ 1.64		$ 1.07		$ 4.85		$ 3.89
Net Income - Assuming Dilution (in dollars per share)	$ 1.64		$ 1.07		$ 4.85		$ 3.89

[1] Other special project costs includes integration and restructuring costs. For more information, see Note 4: Integration and Restructuring Costs.

[2] Other special project costs includes integration and restructuring costs. For more information, see Note 4: Integration and Restructuring Costs.

XML

Goodwill and Other Intangible Assets (Tables)

9 Months Ended

Jan. 31, 2020

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Finite-Lived Intangible Assets

The following table summarizes our other intangible assets and related accumulated amortization and impairment charges including foreign currency exchange adjustments.

	January 31, 2020						April 30, 2019
	Acquisition Cost		Accumulated Amortization/Impairment Charges/Foreign Currency Exchange		Net		Acquisition Cost		Accumulated Amortization/Impairment Charges/Foreign Currency Exchange		Net
Finite-lived intangible assets subject to amortization:
Customer and contractual relationships	$	4,471.1	$	1,302.8	$	3,168.3	$	4,471.1	$	1,156.8	$	3,314.3
Patents and technology	168.5		135.6		32.9		168.5		127.4		41.1
Trademarks	502.0		188.0		314.0		499.9		166.9		333.0
Total intangible assets subject to amortization	$	5,141.6	$	1,626.4	$	3,515.2	$	5,139.5	$	1,451.1	$	3,688.4
Indefinite-lived intangible assets not subject to amortization:
Trademarks	$	3,319.0	$	342.8	$	2,976.2	$	3,321.1	$	290.7	$	3,030.4
Total other intangible assets	$	8,460.6	$	1,969.2	$	6,491.4	$	8,460.6	$	1,741.8	$	6,718.8

Schedule of Indefinite-Lived Intangible Assets

The following table summarizes our other intangible assets and related accumulated amortization and impairment charges including foreign currency exchange adjustments.

	January 31, 2020						April 30, 2019
	Acquisition Cost		Accumulated Amortization/Impairment Charges/Foreign Currency Exchange		Net		Acquisition Cost		Accumulated Amortization/Impairment Charges/Foreign Currency Exchange		Net
Finite-lived intangible assets subject to amortization:
Customer and contractual relationships	$	4,471.1	$	1,302.8	$	3,168.3	$	4,471.1	$	1,156.8	$	3,314.3
Patents and technology	168.5		135.6		32.9		168.5		127.4		41.1
Trademarks	502.0		188.0		314.0		499.9		166.9		333.0
Total intangible assets subject to amortization	$	5,141.6	$	1,626.4	$	3,515.2	$	5,139.5	$	1,451.1	$	3,688.4
Indefinite-lived intangible assets not subject to amortization:
Trademarks	$	3,319.0	$	342.8	$	2,976.2	$	3,321.1	$	290.7	$	3,030.4
Total other intangible assets	$	8,460.6	$	1,969.2	$	6,491.4	$	8,460.6	$	1,741.8	$	6,718.8

XML

Recently Issued Accounting Standards (Policies)

9 Months Ended

Jan. 31, 2020

Accounting Changes and Error Corrections [Abstract]

Recently Issued Accounting Standards

In December 2019, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2019-12, Income Taxes (Topic 740) Simplifying the Accounting for Income Taxes, which removes certain exceptions for investments, intraperiod allocations and interim calculations, and adds guidance to reduce complexity in accounting for income taxes. ASU 2019-12 will be effective for us on May 1, 2021, with the option to early adopt at any time prior to the effective date. Accounting for franchise taxes will require adoption on a retrospective or modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the fiscal year of adoption. All other applicable provisions will require adoption on a retrospective, modified retrospective, or prospective basis, as required by ASU 2019-12. We do not anticipate that the adoption of this ASU will have a material impact on our financial statements and disclosures.

In August 2018, the FASB issued ASU 2018-15, Intangibles – Goodwill and Other – Internal-Use Software (Subtopic 350-40) Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract. ASU 2018-15 aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. ASU 2018-15 is effective for us on May 1, 2020, but we elected to early adopt on May 1, 2019, as permitted, on a prospective basis. During the nine months ended January 31, 2020, we capitalized implementation costs related to third-party cloud computing services of $3.4, which is reflected in other noncurrent assets in the Condensed Consolidated Balance Sheet.

In August 2018, the FASB also issued ASU 2018-14, Compensation – Retirement Benefits – Defined Benefit Plans – General (Subtopic 715-20) Disclosure Framework – Changes to the Disclosure Requirements for Defined Benefit Plans, which modifies the disclosure requirements for employers that sponsor defined benefit pension or other postretirement benefit plans. The guidance removes disclosures that are no longer considered cost beneficial and adds new, as well as clarifies certain other, disclosure requirements. ASU 2018-14 will be effective for us on May 1, 2020, with the option to early adopt at any time prior to the effective date, and it will require adoption on a retrospective basis. We do not anticipate that the adoption of this ASU will have a material impact on our disclosures.

In August 2018, the U.S. Securities and Exchange Commission (“SEC”) adopted the final rule under SEC Release No. 33-10532, Disclosure Update and Simplification, to eliminate or modify certain disclosure rules that are redundant, outdated, or duplicative of U.S. GAAP or other regulatory requirements. This rule was effective on November 5, 2018, and as a result, we adopted a portion of the amendments during 2019. This rule also amended the disclosure requirements related to the analysis of shareholders’ equity, which was expanded to the interim financial statements and was effective for us on May 1, 2019. While the new shareholders’ equity disclosure requirements impacted our interim financial statements beginning May 1, 2019, the amendments in this rule did not have a material impact on our other financial statements and disclosures.

In February 2016, in an effort to increase transparency and comparability among organizations, the FASB issued ASU 2016-02, Leases (Topic 842), which requires lessees to recognize a right-of-use asset and lease liability for all leases with a term of more than 12 months. We adopted the requirements of ASU 2016-02 and all related amendments on May 1, 2019, utilizing an optional transition method that allows for a cumulative-effect adjustment in the period of adoption with no restatement of prior periods. This transition method also does not require new lease disclosures for periods prior to the effective date. We elected certain practical expedients available under the guidance, including a package of practical expedients which allowed us to not reassess prior conclusions related to existing contracts containing leases, lease classification, and initial direct costs.

Adoption of ASU 2016-02 on May 1, 2019, resulted in the recognition of operating lease right-of-use assets and lease liabilities of $159.2 and $166.6, respectively, in the Condensed Consolidated Balance Sheet. The difference between the additional lease assets and lease liabilities was primarily due to an existing deferred rent balance that was reclassified to the operating lease liability. The new standard did not materially impact our Condensed Statement of Consolidated Income or Condensed Statement of Consolidated Cash Flows. The additional disclosures required are presented within Note 13: Leases.

XML

Income Taxes

9 Months Ended

Jan. 31, 2020

Income Tax Disclosure [Abstract]

Income Taxes

The effective tax rates for the three months ended January 31, 2020 and 2019, were 22.7 and 22.8 percent, respectively, and for the nine months ended January 31, 2020 and 2019, were 24.0 and 26.1 percent, respectively. During the three and nine months ended January 31, 2020 and 2019, the effective tax rates varied from the U.S. statutory income tax rate of 21.0 percent primarily due to the impact of state income taxes. The effective tax rate for the nine months ended January 31, 2019, was also unfavorably impacted by additional income tax expense related to the sale of the U.S. baking business.

Within the next 12 months, it is reasonably possible that we could decrease our unrecognized tax benefits by an additional $2.6, primarily as a result of expiring statute of limitations periods.

As of January 31, 2020, the undistributed earnings of our foreign subsidiaries remain permanently reinvested.

XML

Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Millions		9 Months Ended
		Jan. 31, 2020	Jan. 31, 2019
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Accumulated Other Comprehensive Income (Loss), Beginning Balance		$ (181.8)
Accumulated Other Comprehensive Income (Loss), Ending Balance		(266.3)
Foreign Currency Translation Adjustment [Member]
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Accumulated Other Comprehensive Income (Loss), Beginning Balance		(35.5)	$ (16.4)
Reclassification adjustments		0.0	0.0
Current period credit (charge)		2.6	(10.1)
Income tax benefit (expense)		0.0	0.0
Accumulated Other Comprehensive Income (Loss), Ending Balance		(32.9)	(26.5)
Net Gains (Losses) on Cash Flow Hedging Derivatives [Member]
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Accumulated Other Comprehensive Income (Loss), Beginning Balance	[1]	(40.4)	(2.9)
Reclassification adjustments	[1]	0.3	0.3
Current period credit (charge)	[1]	(119.8)	(37.6)
Income tax benefit (expense)	[1]	27.5	8.5
Accumulated Other Comprehensive Income (Loss), Ending Balance	[1]	(132.4)	(31.7)
Pension and Other Postretirement Liabilities [Member]
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Accumulated Other Comprehensive Income (Loss), Beginning Balance	[2]	(110.0)	(101.0)
Reclassification adjustments	[2]	5.2	6.0
Current period credit (charge)	[2]	0.0	(2.4)
Income tax benefit (expense)	[2]	(1.2)	(0.9)
Accumulated Other Comprehensive Income (Loss), Ending Balance	[2]	(106.0)	(98.3)
Unrealized Gain (Loss) on Available-for-Sale Securities [Member]
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Accumulated Other Comprehensive Income (Loss), Beginning Balance		4.1	3.6
Reclassification adjustments		0.0	0.0
Current period credit (charge)		1.2	(0.5)
Income tax benefit (expense)		(0.3)	0.1
Accumulated Other Comprehensive Income (Loss), Ending Balance		5.0	3.2
AOCI Attributable to Parent [Member]
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Accumulated Other Comprehensive Income (Loss), Beginning Balance		(181.8)	(116.7)
Reclassification adjustments		5.5	6.3
Current period credit (charge)		(116.0)	(50.6)
Income tax benefit (expense)		26.0	7.7
Accumulated Other Comprehensive Income (Loss), Ending Balance		$ (266.3)	$ (153.3)

[1] The reclassification from accumulated other comprehensive income (loss) to interest expense was related to terminated interest rate contracts. The current period credit (charge) relates to the unrealized gains (losses) on the interest rate contracts entered into in November 2018 and June 2018. For additional information, see Note 11: Derivative Financial Instruments.

[2] Amortization of net losses and prior service costs was reclassified from accumulated other comprehensive income (loss) to other income (expense) – net.

XML

Leases (Details 3) $ in Millions	Jan. 31, 2020 USD ($)
Operating Lease Liabilities, Payments Due [Abstract]
2020 (remainder of the year)	$ 12.3
2021	43.8
2022	40.5
2023	34.6
2024	22.8
2025 and beyond	34.8
Total undiscounted minimum lease payments	188.8
Less: Imputed interest	13.6
Total operating lease liabilities	175.2
Finance Lease Liabilities, Payments, Due [Abstract]
2020 (remainder of the year)	0.7
2021	2.2
2022	1.6
2023	0.9
2024	0.7
2025 and beyond	0.2
Total undiscounted minimum lease payments	6.3
Less: Imputed interest	0.4
Total finance lease liabilities	$ 5.9

XML

Divestiture (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended		12 Months Ended
	Jan. 31, 2019	Jan. 31, 2020	Jan. 31, 2019	Apr. 30, 2019	Apr. 30, 2018
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from divestiture		$ 0.0	$ 371.4
Gain on divestiture		$ 0.0	$ 27.6
U.S. Baking Business [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Annual net sales					$ 370.0
Proceeds from divestiture				$ 369.5
U.S. Baking Business [Member] | Other Operating Income (Expense) [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Gain on divestiture	$ 1.0			$ 27.7

XML

Condensed Statements of Consolidated Shareholders' Equity (Unaudited) (Parentheticals) - $ / shares	3 Months Ended
	Jan. 31, 2020	Oct. 31, 2019	Jul. 31, 2019	Jan. 31, 2019	Oct. 31, 2018	Jul. 31, 2018
Cash dividends declared (in dollars per share)	$ 0.88	$ 0.88	$ 0.88	$ 0.85	$ 0.85	$ 0.85

XML

Reportable Segments (Details Textual)	9 Months Ended
	Jan. 31, 2020 Industry Segment
Segment Reporting [Abstract]
Number of industries in which Company operates | Industry	1
Number of reportable segments | Segment	4

XML

Condensed Statements of Consolidated Comprehensive Income (Unaudited) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jan. 31, 2020	Jan. 31, 2019	Jan. 31, 2020	Jan. 31, 2019
Statement of Comprehensive Income [Abstract]
Net income	$ 187.4	$ 121.4	$ 553.2	$ 442.9
Other comprehensive income (loss):
Foreign currency translation adjustments	(2.5)	1.6	2.6	(10.1)
Cash flow hedging derivative activity, net of tax	(17.4)	(37.0)	(92.0)	(28.8)
Pension and other postretirement benefit plans activity, net of tax	1.5	(0.5)	4.0	2.7
Available-for-sale securities activity, net of tax	0.5	(1.0)	0.9	(0.4)
Total Other Comprehensive Income (Loss)	(17.9)	(36.9)	(84.5)	(36.6)
Comprehensive Income	$ 169.5	$ 84.5	$ 468.7	$ 406.3

XML

Debt and Financing Arrangements (Details) - USD ($)		Jan. 31, 2020	Apr. 30, 2019	May 14, 2018
Long-term debt
Debt instrument face amount		$ 5,100,000,000.0	$ 5,500,000,000.0
Total long-term debt	[1]	5,083,100,000	5,484,800,000
Current portion of long-term debt	[1]	499,800,000	798,500,000
Long-term debt, less current portion	[1]	$ 4,583,300,000	$ 4,686,300,000
2.20% Senior Notes due December 6, 2019
Long-term debt
Interest rate on notes		2.20%	2.20%
Debt instrument face amount		$ 0	$ 300,000,000.0
Senior Notes	[1]	$ 0	$ 299,500,000
2.50% Senior Notes due March 15, 2020
Long-term debt
Interest rate on notes		2.50%	2.50%
Debt instrument face amount		$ 500,000,000.0	$ 500,000,000.0
Senior Notes	[1]	$ 499,800,000	$ 499,000,000.0
3.50% Senior Notes due October 15, 2021
Long-term debt
Interest rate on notes		3.50%	3.50%
Debt instrument face amount		$ 750,000,000.0	$ 750,000,000.0
Senior Notes	[1]	$ 762,900,000	$ 768,400,000
3.00% Senior Notes due March 15, 2022
Long-term debt
Interest rate on notes		3.00%	3.00%
Debt instrument face amount		$ 400,000,000.0	$ 400,000,000.0
Senior Notes	[1]	$ 398,500,000	$ 398,000,000.0
3.50% Senior Notes due March 15, 2025
Long-term debt
Interest rate on notes		3.50%	3.50%
Debt instrument face amount		$ 1,000,000,000.0	$ 1,000,000,000.0
Senior Notes	[1]	$ 995,800,000	$ 995,200,000
3.38% Senior Notes due December 15, 2027
Long-term debt
Interest rate on notes		3.38%	3.38%
Debt instrument face amount		$ 500,000,000.0	$ 500,000,000.0
Senior Notes	[1]	$ 496,600,000	$ 496,200,000
4.25% Senior Notes due March 15, 2035
Long-term debt
Interest rate on notes		4.25%	4.25%
Debt instrument face amount		$ 650,000,000.0	$ 650,000,000.0
Senior Notes	[1]	$ 643,800,000	$ 643,500,000
4.38% Senior Notes due March 15, 2045
Long-term debt
Interest rate on notes		4.38%	4.38%
Debt instrument face amount		$ 600,000,000.0	$ 600,000,000.0
Senior Notes	[1]	586,400,000	586,000,000.0
Term Loan Credit Agreement due May 14, 2021
Long-term debt
Debt instrument face amount		700,000,000.0	800,000,000.0	$ 1,500,000,000
Term loan credit agreement carrying value	[1]	699,300,000	799,000,000.0
Current portion of long term debt
Long-term debt
Debt instrument face amount		500,000,000.0	800,000,000.0
Total long term debt, less current portion
Long-term debt
Debt instrument face amount		$ 4,600,000,000.0	$ 4,700,000,000.0

[1] Represents the carrying amount included in the Condensed Consolidated Balance Sheets, which includes the impact of capitalized debt issuance costs, terminated interest rate contracts, and offering discounts.

XML

Other Financial Instruments and Fair Value Measurements (Details Textual) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jan. 31, 2020	Jan. 31, 2019	Jan. 31, 2020	Jan. 31, 2019
Other Financial Instruments and Fair Value Measurements (Textual) [Abstract]
Company's Municipal bond mature in 2020	$ 0.3		$ 0.3
Company's Municipal bond mature in 2021	1.0		1.0
Company's Municipal bond mature in 2022	1.5		1.5
Company's Municipal bond mature in 2023	1.0		1.0
Company's Municipal bond mature in 2024 and beyond	27.3		27.3
Finite-Lived Intangible Assets [Line Items]
Other intangible assets impairment charges	52.4	$ 107.2	$ 52.4	$ 107.2
U.S. Retail Pet Foods [Member]
Finite-Lived Intangible Assets [Line Items]
Other intangible assets impairment charges	$ 52.4	$ 107.2

XML

Derivative Financial Instruments (Details 4) - USD ($) $ in Millions	Jan. 31, 2020	Apr. 30, 2019	Nov. 30, 2018	Jun. 30, 2018
Commodity contracts
Derivative Instruments, Gain (Loss) [Line Items]
Gross notional amount	$ 808.9	$ 544.8
Foreign currency exchange contracts
Derivative Instruments, Gain (Loss) [Line Items]
Gross notional amount	88.1	144.9
Interest rate contracts
Derivative Instruments, Gain (Loss) [Line Items]
Gross notional amount	$ 800.0	$ 800.0	$ 300.0	$ 500.0

XML

Derivative Financial Instruments (Details) - USD ($) $ in Millions	Jan. 31, 2020	Apr. 30, 2019
Other Current Assets [Member]
Fair value of derivative instruments [Line Items]
Derivatives Instruments, Assets	$ 9.0	$ 6.2
Other Current Assets [Member] | Designated as Hedging Instrument [Member]
Fair value of derivative instruments [Line Items]
Derivatives Instruments, Assets	0.0	0.0
Other Current Assets [Member] | Not designated as hedging instruments [Member]
Fair value of derivative instruments [Line Items]
Derivatives Instruments, Assets	9.0	6.2
Other Current Assets [Member] | Interest rate contracts | Designated as Hedging Instrument [Member]
Fair value of derivative instruments [Line Items]
Derivatives Instruments, Assets	0.0	0.0
Other Current Assets [Member] | Commodity contracts | Not designated as hedging instruments [Member]
Fair value of derivative instruments [Line Items]
Derivatives Instruments, Assets	8.6	4.8
Other Current Assets [Member] | Foreign currency exchange contracts | Not designated as hedging instruments [Member]
Fair value of derivative instruments [Line Items]
Derivatives Instruments, Assets	0.4	1.4
Other Current Liabilities [Member]
Fair value of derivative instruments [Line Items]
Derivatives Instruments, Liabilities	185.4	75.1
Other Current Liabilities [Member] | Designated as Hedging Instrument [Member]
Fair value of derivative instruments [Line Items]
Derivatives Instruments, Liabilities	168.9	49.1
Other Current Liabilities [Member] | Not designated as hedging instruments [Member]
Fair value of derivative instruments [Line Items]
Derivatives Instruments, Liabilities	16.5	26.0
Other Current Liabilities [Member] | Interest rate contracts | Designated as Hedging Instrument [Member]
Fair value of derivative instruments [Line Items]
Derivatives Instruments, Liabilities	168.9	49.1
Other Current Liabilities [Member] | Commodity contracts | Not designated as hedging instruments [Member]
Fair value of derivative instruments [Line Items]
Derivatives Instruments, Liabilities	16.4	25.8
Other Current Liabilities [Member] | Foreign currency exchange contracts | Not designated as hedging instruments [Member]
Fair value of derivative instruments [Line Items]
Derivatives Instruments, Liabilities	0.1	0.2
Other Noncurrent Assets [Member]
Fair value of derivative instruments [Line Items]
Derivatives Instruments, Assets	0.0	0.0
Other Noncurrent Assets [Member] | Designated as Hedging Instrument [Member]
Fair value of derivative instruments [Line Items]
Derivatives Instruments, Assets	0.0	0.0
Other Noncurrent Assets [Member] | Not designated as hedging instruments [Member]
Fair value of derivative instruments [Line Items]
Derivatives Instruments, Assets	0.0	0.0
Other Noncurrent Assets [Member] | Interest rate contracts | Designated as Hedging Instrument [Member]
Fair value of derivative instruments [Line Items]
Derivatives Instruments, Assets	0.0	0.0
Other Noncurrent Assets [Member] | Commodity contracts | Not designated as hedging instruments [Member]
Fair value of derivative instruments [Line Items]
Derivatives Instruments, Assets	0.0	0.0
Other Noncurrent Assets [Member] | Foreign currency exchange contracts | Not designated as hedging instruments [Member]
Fair value of derivative instruments [Line Items]
Derivatives Instruments, Assets	0.0	0.0
Other Noncurrent Liabilities [Member]
Fair value of derivative instruments [Line Items]
Derivatives Instruments, Liabilities	0.0	0.0
Other Noncurrent Liabilities [Member] | Designated as Hedging Instrument [Member]
Fair value of derivative instruments [Line Items]
Derivatives Instruments, Liabilities	0.0	0.0
Other Noncurrent Liabilities [Member] | Not designated as hedging instruments [Member]
Fair value of derivative instruments [Line Items]
Derivatives Instruments, Liabilities	0.0	0.0
Other Noncurrent Liabilities [Member] | Interest rate contracts | Designated as Hedging Instrument [Member]
Fair value of derivative instruments [Line Items]
Derivatives Instruments, Liabilities	0.0	0.0
Other Noncurrent Liabilities [Member] | Commodity contracts | Not designated as hedging instruments [Member]
Fair value of derivative instruments [Line Items]
Derivatives Instruments, Liabilities	0.0	0.0
Other Noncurrent Liabilities [Member] | Foreign currency exchange contracts | Not designated as hedging instruments [Member]
Fair value of derivative instruments [Line Items]
Derivatives Instruments, Liabilities	$ 0.0	$ 0.0

XML

Debt and Financing Arrangements (Tables)

9 Months Ended

Jan. 31, 2020

Debt Disclosure [Abstract]

Long-term debt

Long-term debt consists of the following:

	January 31, 2020				April 30, 2019
	Principal Outstanding		Carrying Amount (A)		Principal Outstanding		Carrying Amount (A)
2.20% Senior Notes due December 6, 2019	$	—	$	—	$	300.0	$	299.5
2.50% Senior Notes due March 15, 2020	500.0		499.8		500.0		499.0
3.50% Senior Notes due October 15, 2021	750.0		762.9		750.0		768.4
3.00% Senior Notes due March 15, 2022	400.0		398.5		400.0		398.0
3.50% Senior Notes due March 15, 2025	1,000.0		995.8		1,000.0		995.2
3.38% Senior Notes due December 15, 2027	500.0		496.6		500.0		496.2
4.25% Senior Notes due March 15, 2035	650.0		643.8		650.0		643.5
4.38% Senior Notes due March 15, 2045	600.0		586.4		600.0		586.0
Term Loan Credit Agreement due May 14, 2021	700.0		699.3		800.0		799.0
Total long-term debt	$	5,100.0	$	5,083.1	$	5,500.0	$	5,484.8
Current portion of long-term debt	500.0		499.8		800.0		798.5
Total long-term debt, less current portion	$	4,600.0	$	4,583.3	$	4,700.0	$	4,686.3

(A) Represents the carrying amount included in the Condensed Consolidated Balance Sheets, which includes the impact of capitalized debt issuance costs, terminated interest rate contracts, and offering discounts.

XML

Leases (Tables)

9 Months Ended

Jan. 31, 2020

Leases [Abstract]

Right-of-use assets and lease liabilities recognized in the Condensed Consolidated Balance Sheet

The following table sets forth the right-of-use assets and lease liabilities recognized in the Condensed Consolidated Balance Sheet.

	January 31, 2020
Operating lease right-of-use assets	$	168.0
Operating lease liabilities:
Current operating lease liabilities	$	41.7
Noncurrent operating lease liabilities	133.5
Total operating lease liabilities	$	175.2
Finance lease right-of-use assets:
Machinery and equipment	$	13.4
Accumulated depreciation	(6.9)
Total property, plant, and equipment	$	6.5
Finance lease liabilities:
Other current liabilities	$	2.2
Other noncurrent liabilities	3.7
Total finance lease liabilities	$	5.9

Components of lease expense

The following table summarizes the components of lease expense.

	Three Months Ended January 31, 2020		Nine Months Ended January 31, 2020
Operating lease cost	$	13.2	$	38.5
Finance lease cost:
Amortization of right-of-use assets	0.7		2.3
Interest on lease liabilities	0.1		0.2
Variable lease cost	5.0		17.6
Short-term lease cost	8.5		25.9
Sublease income	(1.1)		(3.4)
Net lease cost	$	26.4	$	81.1

Cash flow and noncash information related to leases

The following table sets forth cash flow and noncash information related to leases.

	Nine Months Ended January 31, 2020
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	38.8
Operating cash flows from finance leases	0.2
Financing cash flows from finance leases	2.1
Right-of-use assets obtained in exchange for new lease liabilities:
Operating leases	56.6
Finance leases	2.4

Maturity of operating lease liabilities by fiscal year

The following table summarizes the maturity of our lease liabilities by fiscal year.

	January 31, 2020
	Operating Leases		Finance Leases
2020 (remainder of the year)	$	12.3	$	0.7
2021	43.8		2.2
2022	40.5		1.6
2023	34.6		0.9
2024	22.8		0.7
2025 and beyond	34.8		0.2
Total undiscounted minimum lease payments	$	188.8	$	6.3
Less: Imputed interest	13.6		0.4
Lease liabilities	$	175.2	$	5.9

Maturity of finance lease liabilities by fiscal year

The following table summarizes the maturity of our lease liabilities by fiscal year.

	January 31, 2020
	Operating Leases		Finance Leases
2020 (remainder of the year)	$	12.3	$	0.7
2021	43.8		2.2
2022	40.5		1.6
2023	34.6		0.9
2024	22.8		0.7
2025 and beyond	34.8		0.2
Total undiscounted minimum lease payments	$	188.8	$	6.3
Less: Imputed interest	13.6		0.4
Lease liabilities	$	175.2	$	5.9

Weighted average remaining lease tern and discount rate

The following table sets forth the weighted average remaining lease term and discount rate.

	January 31, 2020
Weighted average remaining lease term (in years):
Operating leases	4.8
Finance leases	3.4
Weighted average discount rate:
Operating leases	3.1	%
Finance leases	3.0	%

XML

Acquisition (Details Textual) - USD ($)	May 14, 2018	Jan. 31, 2020	Apr. 30, 2019
Acquisition [Line Items]
Debt instrument face amount		$ 5,100,000,000.0	$ 5,500,000,000.0
Goodwill		6,312,800,000	6,310,900,000
Ainsworth [Member]
Acquisition [Line Items]
Payments to Acquire Businesses, Gross	$ 1,900,000,000
Commercial Paper	400,000,000.0
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill	1,300,000,000
Business Acquisition, Goodwill, Expected Tax Deductible Amount	446,000,000.0	392,900,000
Term Loan Credit Agreement due May 14, 2021
Acquisition [Line Items]
Debt instrument face amount	1,500,000,000	700,000,000.0	$ 800,000,000.0
Term Loan Credit Agreement due May 14, 2021 | Ainsworth [Member]
Acquisition [Line Items]
Debt instrument face amount	1,500,000,000
U.S. Retail Pet Foods [Member]
Acquisition [Line Items]
Goodwill		$ 2,400,000,000
U.S. Retail Pet Foods [Member] | Ainsworth [Member]
Acquisition [Line Items]
Goodwill	$ 617,800,000

XML

Pensions and Other Postretirement Benefits

9 Months Ended

Jan. 31, 2020

Retirement Benefits [Abstract]

Pensions and Other Postretirement Benefits

The components of our net periodic benefit cost for defined benefit pension and other postretirement benefit plans are shown below.

	Three Months Ended January 31,
	Defined Benefit Pension Plans				Other Postretirement Benefits
	2020		2019		2020		2019
Service cost	$	0.4	$	0.6	$	0.4	$	0.5
Interest cost	5.2		5.9		0.5		0.6
Expected return on plan assets	(6.0)		(6.8)		—		—
Amortization of net actuarial loss (gain)	2.0		2.0		(0.1)		(0.1)
Amortization of prior service cost (credit)	0.2		0.2		(0.2)		(0.4)
Curtailment loss (gain)	—		0.3		—		—
Settlement loss (gain)	—		4.2		—		—
Net periodic benefit cost	$	1.8	$	6.4	$	0.6	$	0.6

	Nine Months Ended January 31,
	Defined Benefit Pension Plans				Other Postretirement Benefits
	2020		2019		2020		2019
Service cost	$	1.2	$	1.7	$	1.3	$	1.4
Interest cost	15.7		17.6		1.7		1.8
Expected return on plan assets	(18.1)		(20.3)		—		—
Amortization of net actuarial loss (gain)	6.0		6.1		(0.2)		(0.4)
Amortization of prior service cost (credit)	0.6		0.7		(0.8)		(1.0)
Curtailment loss (gain)	—		0.3		—		—
Settlement loss (gain)	—		4.2		—		—
Net periodic benefit cost	$	5.4	$	10.3	$	2.0	$	1.8

XML

Reportable Segments

9 Months Ended

Jan. 31, 2020

Segment Reporting [Abstract]

Reportable Segments

We operate in one industry: the manufacturing and marketing of food and beverage products. We have four reportable segments: U.S. Retail Pet Foods, U.S. Retail Coffee, U.S. Retail Consumer Foods, and International and Away From Home.

The U.S. Retail Pet Foods segment primarily includes the domestic sales of Rachael Ray^TM Nutrish^®, Meow Mix^®, Milk-Bone^®, Natural Balance^®, Kibbles ’n Bits^®, 9Lives^®, Nature’s Recipe^®, and Pup-Peroni^® branded products; the U.S. Retail Coffee segment primarily includes the domestic sales of Folgers^®, Dunkin’ Donuts^®, and Café Bustelo^® branded coffee; and the U.S. Retail Consumer Foods segment primarily includes the domestic sales of Smucker’s^®, Jif^®, and Crisco^® branded products. The International and Away From Home segment comprises products distributed domestically and in foreign countries through retail channels and foodservice distributors and operators (e.g., restaurants, lodging, schools and universities, health care operators).

Segment profit represents net sales, less direct and allocable operating expenses, and is consistent with the way in which we manage our segments. However, we do not represent that the segments, if operated independently, would report operating profit equal to the segment profit set forth below, as segment profit excludes certain expenses such as corporate administrative expenses, unallocated gains and losses on commodity and foreign currency exchange derivative activities, as well as amortization expense and impairment charges related to intangible assets.

Commodity and foreign currency exchange derivative gains and losses are reported in unallocated derivative gains and losses outside of segment operating results until the related inventory is sold. At that time, we reclassify the hedge gains and losses from unallocated derivative gains and losses to segment profit, allowing our segments to realize the economic effect of the hedge without experiencing any mark-to-market volatility. We would expect that any gain or loss in the estimated fair value of the derivatives would generally be offset by a change in the estimated fair value of the underlying exposures.

	Three Months Ended January 31,				Nine Months Ended January 31,
	2020		2019		2020		2019
Net sales:
U.S. Retail Pet Foods	$	721.9	$	759.0	$	2,101.7	$	2,158.3
U.S. Retail Coffee	558.8		561.6		1,567.9		1,596.0
U.S. Retail Consumer Foods	422.9		422.7		1,251.2		1,367.9
International and Away From Home	268.7		268.6		788.2		813.7
Total net sales	$	1,972.3	$	2,011.9	$	5,709.0	$	5,935.9
Segment profit:
U.S. Retail Pet Foods	$	146.0	$	147.9	$	403.1	$	372.2
U.S. Retail Coffee	189.5		183.7		500.9		505.8
U.S. Retail Consumer Foods	84.2		95.9		256.6		327.5
International and Away From Home	49.0		52.5		131.7		152.6
Total segment profit	$	468.7	$	480.0	$	1,292.3	$	1,358.1
Amortization	(58.8)		(59.7)		(176.4)		(179.9)
Other intangible assets impairment charges	(52.4)		(107.2)		(52.4)		(107.2)
Interest expense – net	(45.1)		(51.6)		(143.6)		(158.8)
Unallocated derivative gains (losses)	7.7		(2.9)		37.6		(25.0)
Other special project costs (A)	(3.3)		(18.8)		(9.9)		(51.9)
Corporate administrative expenses	(72.9)		(73.8)		(214.8)		(219.1)
Other income (expense) – net	(1.4)		(8.8)		(4.5)		(16.5)
Income before income taxes	$	242.5	$	157.2	$	728.3	$	599.7

(A)Other special project costs includes integration and restructuring costs. For more information, see Note 4: Integration and Restructuring Costs.

The following table presents certain geographical information.

	Three Months Ended January 31,				Nine Months Ended January 31,
	2020		2019		2020		2019
Net sales:
United States	$	1,837.6	$	1,880.6	$	5,311.1	$	5,526.1
International:
Canada	$	108.7	$	106.7	$	318.9	$	319.2
All other international	26.0		24.6		79.0		90.6
Total international	$	134.7	$	131.3	$	397.9	$	409.8
Total net sales	$	1,972.3	$	2,011.9	$	5,709.0	$	5,935.9

The following table presents product category information.

	Three Months Ended January 31,				Nine Months Ended January 31,
	2020		2019		2020		2019		Primary Reportable Segment (A)
Coffee	$	650.7	$	653.5	$	1,824.5	$	1,867.3	U.S. Retail Coffee
Dog food	300.8		337.5		899.0		980.9		U.S. Retail Pet Foods
Cat food	223.9		218.9		633.6		615.2		U.S. Retail Pet Foods
Pet snacks	214.6		217.9		617.8		607.6		U.S. Retail Pet Foods
Peanut butter	180.0		188.5		533.3		574.6		U.S. Retail Consumer Foods
Fruit spreads	88.3		86.0		264.0		254.6		U.S. Retail Consumer Foods
Frozen handheld	82.6		67.3		247.5		210.5		U.S. Retail Consumer Foods
Shortening and oils	68.9		74.8		192.2		207.0		U.S. Retail Consumer Foods
Portion control	42.0		40.1		123.9		122.6		International and Away From Home
Juices and beverages	30.4		30.6		94.0		96.7		U.S. Retail Consumer Foods
Baking mixes and ingredients	19.6		21.9		59.3		164.6		International and Away From Home (B)
Other	70.5		74.9		219.9		234.3		International and Away From Home
Total net sales	$	1,972.3	$	2,011.9	$	5,709.0	$	5,935.9

(A)The primary reportable segment generally represents at least 75 percent of total net sales for each respective product category.

(B)During the three and nine months ended January 31, 2019, the primary reportable segment was U.S. Retail Consumer Foods, as the majority of the net sales within this category were related to the divested U.S. baking business. For more information, see Note 5: Divestiture.

XML

Reportable Segments (Tables)

9 Months Ended

Jan. 31, 2020

Segment Reporting [Abstract]

Income by segment

	Three Months Ended January 31,				Nine Months Ended January 31,
	2020		2019		2020		2019
Net sales:
U.S. Retail Pet Foods	$	721.9	$	759.0	$	2,101.7	$	2,158.3
U.S. Retail Coffee	558.8		561.6		1,567.9		1,596.0
U.S. Retail Consumer Foods	422.9		422.7		1,251.2		1,367.9
International and Away From Home	268.7		268.6		788.2		813.7
Total net sales	$	1,972.3	$	2,011.9	$	5,709.0	$	5,935.9
Segment profit:
U.S. Retail Pet Foods	$	146.0	$	147.9	$	403.1	$	372.2
U.S. Retail Coffee	189.5		183.7		500.9		505.8
U.S. Retail Consumer Foods	84.2		95.9		256.6		327.5
International and Away From Home	49.0		52.5		131.7		152.6
Total segment profit	$	468.7	$	480.0	$	1,292.3	$	1,358.1
Amortization	(58.8)		(59.7)		(176.4)		(179.9)
Other intangible assets impairment charges	(52.4)		(107.2)		(52.4)		(107.2)
Interest expense – net	(45.1)		(51.6)		(143.6)		(158.8)
Unallocated derivative gains (losses)	7.7		(2.9)		37.6		(25.0)
Other special project costs (A)	(3.3)		(18.8)		(9.9)		(51.9)
Corporate administrative expenses	(72.9)		(73.8)		(214.8)		(219.1)
Other income (expense) – net	(1.4)		(8.8)		(4.5)		(16.5)
Income before income taxes	$	242.5	$	157.2	$	728.3	$	599.7

(A)Other special project costs includes integration and restructuring costs. For more information, see Note 4: Integration and Restructuring Costs.

Geographical information

The following table presents certain geographical information.

	Three Months Ended January 31,				Nine Months Ended January 31,
	2020		2019		2020		2019
Net sales:
United States	$	1,837.6	$	1,880.6	$	5,311.1	$	5,526.1
International:
Canada	$	108.7	$	106.7	$	318.9	$	319.2
All other international	26.0		24.6		79.0		90.6
Total international	$	134.7	$	131.3	$	397.9	$	409.8
Total net sales	$	1,972.3	$	2,011.9	$	5,709.0	$	5,935.9

Product category information

The following table presents product category information.

	Three Months Ended January 31,				Nine Months Ended January 31,
	2020		2019		2020		2019		Primary Reportable Segment (A)
Coffee	$	650.7	$	653.5	$	1,824.5	$	1,867.3	U.S. Retail Coffee
Dog food	300.8		337.5		899.0		980.9		U.S. Retail Pet Foods
Cat food	223.9		218.9		633.6		615.2		U.S. Retail Pet Foods
Pet snacks	214.6		217.9		617.8		607.6		U.S. Retail Pet Foods
Peanut butter	180.0		188.5		533.3		574.6		U.S. Retail Consumer Foods
Fruit spreads	88.3		86.0		264.0		254.6		U.S. Retail Consumer Foods
Frozen handheld	82.6		67.3		247.5		210.5		U.S. Retail Consumer Foods
Shortening and oils	68.9		74.8		192.2		207.0		U.S. Retail Consumer Foods
Portion control	42.0		40.1		123.9		122.6		International and Away From Home
Juices and beverages	30.4		30.6		94.0		96.7		U.S. Retail Consumer Foods
Baking mixes and ingredients	19.6		21.9		59.3		164.6		International and Away From Home (B)
Other	70.5		74.9		219.9		234.3		International and Away From Home
Total net sales	$	1,972.3	$	2,011.9	$	5,709.0	$	5,935.9

(A)The primary reportable segment generally represents at least 75 percent of total net sales for each respective product category.

(B)During the three and nine months ended January 31, 2019, the primary reportable segment was U.S. Retail Consumer Foods, as the majority of the net sales within this category were related to the divested U.S. baking business. For more information, see Note 5: Divestiture.

XML

Contingencies

9 Months Ended

Jan. 31, 2020

Contingency [Abstract]

Contingencies

We, like other food manufacturers, are from time to time subject to various administrative, regulatory, and other legal proceedings arising in the ordinary course of business. We are currently a defendant in a variety of such legal proceedings, including certain lawsuits related to the alleged price-fixing of shelf stable tuna products prior to 2011 by a business previously owned by, but divested prior to our acquisition of, Big Heart Pet Brands, the significant majority of which were settled and paid during the second half of 2019. While we cannot predict with certainty the ultimate results of these proceedings or potential settlements associated with these or other matters, we have accrued losses for certain contingent liabilities that we have determined are probable and reasonably estimable at January 31, 2020. Based on the information known to date, with the exception of the matter discussed below, we do not believe the final outcome of these proceedings would have a material adverse effect on our financial position, results of operations, or cash flows.

On May 9, 2011, an organization named Council for Education and Research on Toxics (“Plaintiff” or “CERT”) filed a lawsuit in the Superior Court of the State of California, County of Los Angeles, against us and additional defendants who manufacture, package, distribute, or sell packaged coffee. The lawsuit is CERT v. Brad Barry LLC, et al., and was a tag along to a 2010 lawsuit against companies selling “ready-to-drink” coffee based on the same claims. Both cases have since been consolidated and now include nearly eighty defendants, which constitute the great majority of the coffee industry in California. The Plaintiff alleges that we and the other defendants failed to provide warnings for our coffee products of exposure to the chemical acrylamide as required under California Health and Safety Code Section 25249.5, the California Safe Drinking Water and Toxic Enforcement Act of 1986 (better known as “Proposition 65”). The Plaintiff seeks equitable relief, including providing warnings to consumers of coffee products, as well as civil penalties in the amount of the statutory maximum of $2,500 per day per violation of Proposition 65. The Plaintiff asserts that every consumed cup of coffee, absent a compliant warning, is equivalent to a violation under Proposition 65.

As part of a joint defense group organized to defend against the lawsuit, we dispute the claims of the Plaintiff. Acrylamide is not added to coffee but is inherently present in all coffee in small amounts (measured in parts per billion) as a byproduct of the coffee bean roasting process. We have asserted multiple affirmative defenses. Trial of the first phase of the case commenced on

September 8, 2014, and was limited to three affirmative defenses shared by all defendants. On September 1, 2015, the trial court issued a final ruling adverse to the defendants on all Phase 1 defenses. Trial of the second phase of the case commenced in the fall of calendar year 2017. On March 28, 2018, the trial court issued a proposed ruling adverse to the defendants on the Phase 2 defense, our last remaining defense to liability. The trial court finalized and affirmed its Phase 2 ruling on May 7, 2018, and therefore, the third phase of the trial regarding remedies issues was scheduled to commence on October 15, 2018. The trial did not proceed on the scheduled date as further described below.

On June 15, 2018, the state agency responsible for administering the Proposition 65 program, the California Office of Environmental Health Hazard Assessment (“OEHHA”), issued a proposed regulation clarifying that cancer warnings are not required for coffee under Proposition 65. The California Court of Appeals granted the defendants’ requests to stay the trial on remedies until a final determination was made on OEHHA’s proposed regulation. During the interim period, the California Office of Administrative Law approved the proposed regulation on June 3, 2019, and the regulation went into effect on October 1, 2019. In response to CERT's objection, the defendants amended their answer to raise the regulation as a complete defense to the claims. CERT unsuccessfully challenged the defendants' right to assert the regulation as an affirmative defense but continues to challenge the validity of the regulation. During the third quarter of 2020, CERT filed several motions seeking judgment in its favor as a matter of law, and the defendants also filed their own motion. Briefing on all motions is expected to continue into March 2020.

At this stage of the proceedings, prior to and without knowing whether the regulation will stand as a defense or the trial on remedies issues will move forward in light of the challenge, we are unable to predict or reasonably estimate the potential loss or effect on our operations. Accordingly, no loss contingency has been recorded for this matter as of January 31, 2020, as the likelihood of loss is not considered probable or estimable. The trial court has discretion to impose zero penalties against us or to impose significant statutory penalties if the case proceeds. Significant labeling or warning requirements that could potentially be imposed by the trial court may increase our costs and adversely affect sales of our coffee products, as well as involve substantial expense and operational disruption, which could have a material adverse impact on our financial position, results of operations, or cash flows. Furthermore, a future appellate court decision could reverse the earlier trial court rulings should the regulation be held invalid. The outcome and the financial impact of settlement, the trial, or the appellate court rulings of the case, if any, cannot be predicted at this time.

XML

Condensed Statements of Consolidated Cash Flows (Unaudited) - USD ($) $ in Millions	9 Months Ended
	Jan. 31, 2020	Jan. 31, 2019
Operating Activities
Net income	$ 553.2	$ 442.9
Adjustments to reconcile net income to net cash provided by (used for) operations:
Depreciation	156.7	154.1
Amortization	176.4	179.9
Other intangible assets impairment charges	52.4	107.2
Share-based compensation expense	19.8	16.5
Gain on divestiture	0.0	(27.6)
Other noncash adjustments – net	15.9	4.6
Defined benefit pension contributions	(1.1)	(20.1)
Changes in assets and liabilities, net of effect from acquisition and divestiture:
Trade receivables	26.7	(51.4)
Inventories	(48.0)	(18.8)
Other current assets	7.0	19.5
Accounts payable	12.3	(11.2)
Accrued liabilities	44.6	73.1
Income and other taxes	(40.9)	10.1
Other – net	(7.9)	(11.8)
Net Cash Provided by (Used for) Operating Activities	967.1	867.0
Investing Activities
Business acquired, net of cash acquired	0.0	(1,903.0)
Additions to property, plant, and equipment	(192.9)	(267.2)
Proceeds from divestiture	0.0	371.4
Other – net	15.3	(24.0)
Net Cash Provided by (Used for) Investing Activities	(177.6)	(1,822.8)
Financing Activities
Short-term borrowings (repayments) – net	(122.6)	360.0
Proceeds from long-term debt	0.0	1,500.0
Repayments of long-term debt	(400.0)	(600.0)
Quarterly dividends paid	(296.7)	(281.4)
Purchase of treasury shares	(4.3)	(5.2)
Proceeds from stock option exercises	7.0	0.0
Other – net	0.5	0.2
Net Cash Provided by (Used for) Financing Activities	(816.1)	973.6
Effect of exchange rate changes on cash	(0.3)	(3.9)
Net increase (decrease) in cash and cash equivalents	(26.9)	13.9
Cash and cash equivalents at beginning of period	101.3	192.6
Cash and Cash Equivalents at End of Period	$ 74.4	$ 206.5

XML

Reportable Segments (Details 1) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jan. 31, 2020	Jan. 31, 2019	Jan. 31, 2020	Jan. 31, 2019
Geographical information [Line Items]
Net sales	$ 1,972.3	$ 2,011.9	$ 5,709.0	$ 5,935.9
United States
Geographical information [Line Items]
Net sales	1,837.6	1,880.6	5,311.1	5,526.1
Canada
Geographical information [Line Items]
Net sales	108.7	106.7	318.9	319.2
All Other International [Member]
Geographical information [Line Items]
Net sales	26.0	24.6	79.0	90.6
International [Member]
Geographical information [Line Items]
Net sales	$ 134.7	$ 131.3	$ 397.9	$ 409.8

XML

Document and Entity Information - shares	9 Months Ended
	Jan. 31, 2020	Feb. 19, 2020
Entity Listings [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jan. 31, 2020
Document Transition Report	false
Entity File Number	1-5111
Entity Registrant Name	The J. M. Smucker Company
Entity Incorporation, State or Country Code	OH
Entity Tax Identification Number	34-0538550
Entity Address, Address Line One	One Strawberry Lane
Entity Address, City or Town	Orrville,
Entity Address, State or Province	OH
Entity Address, Postal Zip Code	44667-0280
City Area Code	(330)
Local Phone Number	682-3000
Title of 12(b) Security	Common shares, no par value
Trading Symbol	SJM
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Central Index Key	0000091419
Amendment Flag	false
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--04-30
Entity Common Stock, Shares Outstanding		114,037,925

XML

Goodwill and Other Intangible Assets (Details) - USD ($) $ in Millions	Jan. 31, 2020	Apr. 30, 2019
Finite-lived intangible assets subject to amortization:
Finite-lived intangible assets subject to amortization, Acquisition Cost	$ 5,141.6	$ 5,139.5
Accumulated Amortization, Impairment Charges, and Foreign Currency Exchange Expense for Finite Lived Assets	1,626.4	1,451.1
Finite-Lived Intangible Assets, Net	3,515.2	3,688.4
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Intangible Assets, Acquisition Cost	8,460.6	8,460.6
Total Other Intangible Assets Accumulated Amortization, Impairment Charges, and Foreign Currency Exchange	1,969.2	1,741.8
Intangible Assets, Net (Excluding Goodwill), Total	6,491.4	6,718.8
Trademarks
Indefinite-lived intangible assets not subject to amortization:
Indefinite-lived intangible assets not subject to amortization, Acquisition Costs	3,319.0	3,321.1
Accumulated Amortization, Impairment Charges, And Foreign Currency Exchange Expense For Indefinite Lived Assets	342.8	290.7
Indefinite-lived intangible assets not subject to amortization, Net	2,976.2	3,030.4
Customer and contractual relationships
Finite-lived intangible assets subject to amortization:
Finite-lived intangible assets subject to amortization, Acquisition Cost	4,471.1	4,471.1
Accumulated Amortization, Impairment Charges, and Foreign Currency Exchange Expense for Finite Lived Assets	1,302.8	1,156.8
Finite-Lived Intangible Assets, Net	3,168.3	3,314.3
Patents and technology
Finite-lived intangible assets subject to amortization:
Finite-lived intangible assets subject to amortization, Acquisition Cost	168.5	168.5
Accumulated Amortization, Impairment Charges, and Foreign Currency Exchange Expense for Finite Lived Assets	135.6	127.4
Finite-Lived Intangible Assets, Net	32.9	41.1
Trademarks
Finite-lived intangible assets subject to amortization:
Finite-lived intangible assets subject to amortization, Acquisition Cost	502.0	499.9
Accumulated Amortization, Impairment Charges, and Foreign Currency Exchange Expense for Finite Lived Assets	188.0	166.9
Finite-Lived Intangible Assets, Net	$ 314.0	$ 333.0

XML

Recently Issued Accounting Standards

9 Months Ended

Jan. 31, 2020

Accounting Changes and Error Corrections [Abstract]

Recently Issued Accounting Standards

In December 2019, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2019-12, Income Taxes (Topic 740) Simplifying the Accounting for Income Taxes, which removes certain exceptions for investments, intraperiod allocations and interim calculations, and adds guidance to reduce complexity in accounting for income taxes. ASU 2019-12 will be effective for us on May 1, 2021, with the option to early adopt at any time prior to the effective date. Accounting for franchise taxes will require adoption on a retrospective or modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the fiscal year of adoption. All other applicable provisions will require adoption on a retrospective, modified retrospective, or prospective basis, as required by ASU 2019-12. We do not anticipate that the adoption of this ASU will have a material impact on our financial statements and disclosures.

In August 2018, the FASB issued ASU 2018-15, Intangibles – Goodwill and Other – Internal-Use Software (Subtopic 350-40) Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract. ASU 2018-15 aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. ASU 2018-15 is effective for us on May 1, 2020, but we elected to early adopt on May 1, 2019, as permitted, on a prospective basis. During the nine months ended January 31, 2020, we capitalized implementation costs related to third-party cloud computing services of $3.4, which is reflected in other noncurrent assets in the Condensed Consolidated Balance Sheet.

In August 2018, the FASB also issued ASU 2018-14, Compensation – Retirement Benefits – Defined Benefit Plans – General (Subtopic 715-20) Disclosure Framework – Changes to the Disclosure Requirements for Defined Benefit Plans, which modifies the disclosure requirements for employers that sponsor defined benefit pension or other postretirement benefit plans. The guidance removes disclosures that are no longer considered cost beneficial and adds new, as well as clarifies certain other, disclosure requirements. ASU 2018-14 will be effective for us on May 1, 2020, with the option to early adopt at any time prior to the effective date, and it will require adoption on a retrospective basis. We do not anticipate that the adoption of this ASU will have a material impact on our disclosures.

In August 2018, the U.S. Securities and Exchange Commission (“SEC”) adopted the final rule under SEC Release No. 33-10532, Disclosure Update and Simplification, to eliminate or modify certain disclosure rules that are redundant, outdated, or duplicative of U.S. GAAP or other regulatory requirements. This rule was effective on November 5, 2018, and as a result, we adopted a portion of the amendments during 2019. This rule also amended the disclosure requirements related to the analysis of shareholders’ equity, which was expanded to the interim financial statements and was effective for us on May 1, 2019. While the new shareholders’ equity disclosure requirements impacted our interim financial statements beginning May 1, 2019, the amendments in this rule did not have a material impact on our other financial statements and disclosures.

In February 2016, in an effort to increase transparency and comparability among organizations, the FASB issued ASU 2016-02, Leases (Topic 842), which requires lessees to recognize a right-of-use asset and lease liability for all leases with a term of more than 12 months. We adopted the requirements of ASU 2016-02 and all related amendments on May 1, 2019, utilizing an optional transition method that allows for a cumulative-effect adjustment in the period of adoption with no restatement of prior periods. This transition method also does not require new lease disclosures for periods prior to the effective date. We elected certain practical expedients available under the guidance, including a package of practical expedients which allowed us to not reassess prior conclusions related to existing contracts containing leases, lease classification, and initial direct costs.

Adoption of ASU 2016-02 on May 1, 2019, resulted in the recognition of operating lease right-of-use assets and lease liabilities of $159.2 and $166.6, respectively, in the Condensed Consolidated Balance Sheet. The difference between the additional lease assets and lease liabilities was primarily due to an existing deferred rent balance that was reclassified to the operating lease liability. The new standard did not materially impact our Condensed Statement of Consolidated Income or Condensed Statement of Consolidated Cash Flows. The additional disclosures required are presented within Note 13: Leases.

XML

Leases Textual (Details) $ in Millions	Apr. 30, 2019 USD ($)
Leases [Abstract]
2020	$ 43.0
2021	36.7
2022	30.5
2023	24.8
2024	$ 12.3

XML

Leases (Details 1) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Jan. 31, 2020	Jan. 31, 2020
Leases [Abstract]
Operating lease cost	$ 13.2	$ 38.5
Finance Lease, Cost [Abstract]
Amortization of right-of-use assets	0.7	2.3
Interest on lease liabilities	0.1	0.2
Variable lease cost	5.0	17.6
Short-term lease cost	8.5	25.9
Sublease income	(1.1)	(3.4)
Net lease cost	$ 26.4	$ 81.1

XML

Other Financial Instruments and Fair Value Measurements (Details) - USD ($) $ in Millions		Jan. 31, 2020	Apr. 30, 2019
Carrying amount and fair value of financial instruments
Total long-term debt	[1]	$ (5,083.1)	$ (5,484.8)
Carrying Amount [Member]
Carrying amount and fair value of financial instruments
Marketable securities and other investments		40.7	40.9
Derivative financial instruments – net		(176.4)	(68.9)
Total long-term debt		(5,083.1)	(5,484.8)
Fair Value [Member]
Carrying amount and fair value of financial instruments
Marketable securities and other investments		40.7	40.9
Derivative financial instruments – net		(176.4)	(68.9)
Total long-term debt		$ (5,386.8)	$ (5,504.0)

[1] Represents the carrying amount included in the Condensed Consolidated Balance Sheets, which includes the impact of capitalized debt issuance costs, terminated interest rate contracts, and offering discounts.

XML

Derivative Financial Instruments (Details 2) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jan. 31, 2020	Jan. 31, 2019	Jan. 31, 2020	Jan. 31, 2019
Gains and losses recognized in cost of products sold on derivatives not designated as qualified hedging instruments
Total gains (losses) recognized in cost of products sold	$ (7.0)	$ (25.6)	$ (5.6)	$ (54.2)
Commodity contracts
Gains and losses recognized in cost of products sold on derivatives not designated as qualified hedging instruments
Total gains (losses) recognized in cost of products sold	(7.3)	(25.8)	(4.8)	(55.9)
Foreign currency exchange contracts
Gains and losses recognized in cost of products sold on derivatives not designated as qualified hedging instruments
Total gains (losses) recognized in cost of products sold	$ 0.3	$ 0.2	$ (0.8)	$ 1.7

XML

Goodwill and Other Intangible Assets

9 Months Ended

Jan. 31, 2020

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Other Intangible Assets

The following table summarizes our other intangible assets and related accumulated amortization and impairment charges including foreign currency exchange adjustments.

	January 31, 2020						April 30, 2019
	Acquisition Cost		Accumulated Amortization/Impairment Charges/Foreign Currency Exchange		Net		Acquisition Cost		Accumulated Amortization/Impairment Charges/Foreign Currency Exchange		Net
Finite-lived intangible assets subject to amortization:
Customer and contractual relationships	$	4,471.1	$	1,302.8	$	3,168.3	$	4,471.1	$	1,156.8	$	3,314.3
Patents and technology	168.5		135.6		32.9		168.5		127.4		41.1
Trademarks	502.0		188.0		314.0		499.9		166.9		333.0
Total intangible assets subject to amortization	$	5,141.6	$	1,626.4	$	3,515.2	$	5,139.5	$	1,451.1	$	3,688.4
Indefinite-lived intangible assets not subject to amortization:
Trademarks	$	3,319.0	$	342.8	$	2,976.2	$	3,321.1	$	290.7	$	3,030.4
Total other intangible assets	$	8,460.6	$	1,969.2	$	6,491.4	$	8,460.6	$	1,741.8	$	6,718.8

We review goodwill and other indefinite-lived intangible assets at least annually on February 1 for impairment, and more often if indicators of impairment exist.

During the third quarter of 2020, we began our annual planning cycle, which was not complete as of January 31, 2020; however, certain brand-level decisions were made during the quarter that we evaluated to determine whether the carrying value of certain indefinite-lived intangible assets more likely than not exceeded fair value. As a result, we recognized an impairment charge of $52.4 related to the Natural Balance brand within the U.S. Retail Pet Foods segment due to a decline in current year and long-term net sales expectations and the royalty rate used in the interim analysis, primarily driven by the market environment and re-positioning of this brand within the Pet Foods brand portfolio. This charge was included as a noncash charge in our Condensed Statement of Consolidated Income. Additionally, we reassessed the long-term strategic expectations for the Natural Balance brand and will reclassify this brand as a finite-lived intangible asset as of February 1, 2020, resulting in annual amortization expense of $4.5.

As of January 31, 2020, there were no other indicators of impairment, and as a result, we do not believe that our reporting units or any of our remaining indefinite-lived intangible assets are more likely than not impaired. However, the goodwill and indefinite-lived trademarks within the U.S. Retail Pet Foods segment, inclusive of the recently acquired Ainsworth business, remain susceptible to future impairment charges due to the narrow differences between fair value and carrying value. Any significant adverse change in our near or long-term projections or macroeconomic conditions could result in future impairment charges. The carrying values of the goodwill and indefinite-lived intangible assets within the U.S. Retail Pet Foods segment were $2.4 billion and $1.4 billion, respectively, as of January 31, 2020.

During the third quarter of 2019, we recognized a noncash impairment charge of $107.2 related to certain indefinite-lived intangible assets within the U.S. Retail Pet Foods segment.

XML

Integration and Restructuring Costs

9 Months Ended

Jan. 31, 2020

Restructuring and Related Activities [Abstract]

Integration and Restructuring Costs

Integration and restructuring costs primarily consist of employee-related costs and other transition and termination costs related to certain acquisition or restructuring activities. Employee-related costs include severance, retention bonuses, and relocation costs. Severance costs and retention bonuses are recognized over the estimated future service period of the affected employees, and relocation costs are expensed as incurred. Other transition and termination costs include fixed asset-related charges, contract and lease termination costs, professional fees, and other miscellaneous expenditures associated with the integration or restructuring activities, which are expensed as incurred. These integration and restructuring costs are not allocated to segment profit and are reported in other special project costs in the Condensed Statements of Consolidated Income. The obligation related to employee separation costs is included in other current liabilities in the Condensed Consolidated Balance Sheets.

Integration Costs: Total integration costs related to the acquisition of Ainsworth are anticipated to be approximately $50.0, the majority of which are expected to be cash charges. Of the total anticipated integration costs, we expect approximately one-third to be employee-related costs. All remaining integration costs are expected to be incurred by the end of 2020.

The following table summarizes our integration costs incurred related to the Ainsworth acquisition.

	Three Months Ended January 31,				Nine Months Ended January 31,				Total Costs Incurred to Date at January 31, 2020
	2020		2019		2020		2019
Employee-related costs	$	0.3	$	5.4	$	1.7	$	13.2	$	17.2
Other transition and termination costs	3.0		2.3		8.2		10.7		24.8
Total integration costs	$	3.3	$	7.7	$	9.9	$	23.9	$	42.0

Noncash charges of $0.1 and $1.0 were included in the integration costs incurred during the three months ended January 31, 2020 and 2019, respectively, and $0.5 and $2.8 during the nine months ended January 31, 2020 and 2019, respectively. Cumulative noncash charges incurred to date were $4.6 and primarily consisted of accelerated depreciation. The obligation related to severance costs and retention bonuses was $0.3 and $1.6 at January 31, 2020, and April 30, 2019, respectively.

Restructuring Costs: We completed the restructuring activities associated with our organization optimization program as of April 30, 2019, and as a result, we did not incur any related costs during the three and nine months ended January 31, 2020. We incurred restructuring costs of $11.1 and $28.0 during the three and nine months ended January 31, 2019, respectively, primarily consisting of employee-related costs. Total restructuring costs of $74.6 were incurred related to the program, which included $48.7 and $25.9 of employee-related costs and other transition and termination costs, respectively. Noncash charges included in the total restructuring costs were $15.2, of which $1.2 and $2.2 were incurred during the three and nine months ended January 31, 2019, respectively. Noncash charges primarily consisted of accelerated depreciation. The obligation related to severance costs and retention bonuses was fully satisfied as of January 31, 2020, and was $0.8 at April 30, 2019.

XML

Other Financial Instruments and Fair Value Measurements

9 Months Ended

Jan. 31, 2020

Fair Value Disclosures [Abstract]

Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]

Note 12: Other Financial Instruments and Fair Value Measurements

Financial instruments, other than derivatives, that potentially subject us to significant concentrations of credit risk consist principally of cash investments, short-term borrowings, and trade receivables. The carrying value of these financial instruments approximates fair value. Our remaining financial instruments, with the exception of long-term debt, are recognized at estimated fair value in the Condensed Consolidated Balance Sheets.

The following table provides information on the carrying amounts and fair values of our financial instruments.

	January 31, 2020				April 30, 2019
	Carrying Amount		Fair Value		Carrying Amount		Fair Value
Marketable securities and other investments	$	40.7	$	40.7	$	40.9	$	40.9
Derivative financial instruments – net	(176.4)		(176.4)		(68.9)		(68.9)
Total long-term debt	(5,083.1)		(5,386.8)		(5,484.8)		(5,504.0)

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Valuation techniques are based on observable and unobservable inputs. Observable inputs reflect readily obtainable data from independent sources, while unobservable inputs reflect our market assumptions.

The following tables summarize the fair values and the levels within the fair value hierarchy in which the fair value measurements fall for our financial instruments.

	Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Fair Value at January 31, 2020
Marketable securities and other investments: (A)
Equity mutual funds	$	9.6	$	—	$	—	$	9.6
Municipal obligations	—		31.1		—		31.1
Money market funds	—		—		—		—
Derivative financial instruments: (B)
Commodity contracts – net	(7.5)		(0.3)		—		(7.8)
Foreign currency exchange contracts – net	—		0.3		—		0.3
Interest rate contracts	—		(168.9)		—		(168.9)
Total long-term debt (C)	(4,662.4)		(724.4)		—		(5,386.8)
Total financial instruments measured at fair value	$	(4,660.3)	$	(862.2)	$	—	$	(5,522.5)

	Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Fair Value at April 30, 2019
Marketable securities and other investments: (A)
Equity mutual funds	$	8.7	$	—	$	—	$	8.7
Municipal obligations	—		31.7		—		31.7
Money market funds	0.5		—		—		0.5
Derivative financial instruments: (B)
Commodity contracts – net	(20.7)		(0.3)		—		(21.0)
Foreign currency exchange contracts – net	(0.1)		1.3		—		1.2
Interest rate contracts	—		(49.1)		—		(49.1)
Total long-term debt (C)	(4,646.6)		(857.4)		—		(5,504.0)
Total financial instruments measured at fair value	$	(4,658.2)	$	(873.8)	$	—	$	(5,532.0)

(A)Marketable securities and other investments consist of funds maintained for the payment of benefits associated with nonqualified retirement plans. The funds include equity securities listed in active markets, municipal obligations valued by a third party using valuation techniques that utilize inputs that are derived principally from or corroborated by observable market data, and money market funds with maturities of three months or less. Based on the short-term nature of these money market funds, carrying value approximates fair value. As of January 31, 2020, our municipal obligations are scheduled to mature as follows: $0.3 in 2020, $1.0 in 2021, $1.5 in 2022, $1.0 in 2023, and the remaining $27.3 in 2024 and beyond.

(B)Level 1 commodity and foreign currency exchange derivatives are valued using quoted market prices for identical instruments in active markets. Level 2 commodity and foreign currency exchange derivatives are valued using quoted prices for similar assets or liabilities in active markets. The Level 2 interest rate contracts are valued using standard valuation techniques, the income approach, and observable Level 2 market expectations at the measurement date to convert future amounts to a single discounted present value. Level 2 inputs for the valuation of the interest rate contracts are limited to prices that are observable for the asset or liability. For additional information, see Note 11: Derivative Financial Instruments.

(C)Long-term debt is composed of public Senior Notes classified as Level 1 and the Term Loan classified as Level 2. The public Senior Notes are traded in an active secondary market and valued using quoted prices. The fair value of the Term Loan is based on the net present value of each interest and principal payment calculated utilizing an interest rate derived from an estimated yield curve obtained from independent pricing sources for similar types of term loan borrowing arrangements. For additional information, see Note 9: Debt and Financing Arrangements.

During the third quarter of 2020 and 2019, we recognized impairment charges of $52.4 and $107.2, respectively, related to certain indefinite-lived trademarks in the U.S. Retail Pet Foods segment, which were included as a noncash charge in our Condensed Statements of Consolidated Income. We utilized Level 3 inputs based on management's best estimates and assumptions to estimate the fair value of the indefinite-lived trademarks. For additional information, see Note 8: Goodwill and Other Intangible Assets.

XML

Derivative Financial Instruments (Tables)

9 Months Ended

Jan. 31, 2020

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Fair value of derivative instruments

The following tables set forth the gross fair value amounts of derivative instruments recognized in the Condensed Consolidated Balance Sheets.

	January 31, 2020
	Other Current Assets		Other Current Liabilities		Other Noncurrent Assets		Other Noncurrent Liabilities
Derivatives designated as hedging instruments:
Interest rate contracts	$	—	$	168.9	$	—	$	—
Total derivatives designated as hedging instruments	$	—	$	168.9	$	—	$	—
Derivatives not designated as hedging instruments:
Commodity contracts	$	8.6	$	16.4	$	—	$	—
Foreign currency exchange contracts	0.4		0.1		—		—
Total derivatives not designated as hedging instruments	$	9.0	$	16.5	$	—	$	—
Total derivative instruments	$	9.0	$	185.4	$	—	$	—

	April 30, 2019
	Other Current Assets		Other Current Liabilities		Other Noncurrent Assets		Other Noncurrent Liabilities
Derivatives designated as hedging instruments:
Interest rate contracts	$	—	$	49.1	$	—	$	—
Total derivatives designated as hedging instruments	$	—	$	49.1	$	—	$	—
Derivatives not designated as hedging instruments:
Commodity contracts	$	4.8	$	25.8	$	—	$	—
Foreign currency exchange contracts	1.4		0.2		—		—
Total derivatives not designated as hedging instruments	$	6.2	$	26.0	$	—	$	—
Total derivative instruments	$	6.2	$	75.1	$	—	$	—

Pre-tax gains and losses recognized on interest rate contracts designated as cash flow hedges

The following table presents information on the pre-tax gains and losses recognized on interest rate contracts designated as cash flow hedges.

	Three Months Ended January 31,				Nine Months Ended January 31,
	2020		2019		2020		2019
Gains (losses) recognized in other comprehensive income (loss)	$	(22.7)	$	(48.1)	$	(119.8)	$	(37.6)
Less: Gains (losses) reclassified from accumulated other comprehensive income (loss) to interest expense	(0.1)		(0.1)		(0.3)		(0.3)
Change in accumulated other comprehensive income (loss)	$	(22.6)	$	(48.0)	$	(119.5)	$	(37.3)

Net realized and unrealized gains and losses recognized in cost of products sold on derivatives not designated as qualified hedging instruments

The following table presents the net gains and losses recognized in cost of products sold on derivatives not designated as hedging instruments.

	Three Months Ended January 31,				Nine Months Ended January 31,
	2020		2019		2020		2019
Gains (losses) on commodity contracts	$	(7.3)	$	(25.8)	$	(4.8)	$	(55.9)
Gains (losses) on foreign currency exchange contracts	0.3		0.2		(0.8)		1.7
Total gains (losses) recognized in cost of products sold	$	(7.0)	$	(25.6)	$	(5.6)	$	(54.2)

Schedule of unallocated derivative gains (losses)

The following table presents the activity in unallocated derivative gains and losses.

	Three Months Ended January 31,				Nine Months Ended January 31,
	2020		2019		2020		2019
Net gains (losses) on mark-to-market valuation of unallocated derivative positions	$	(7.0)	$	(25.6)	$	(5.6)	$	(54.2)
Less: Net gains (losses) on derivative positions reclassified to segment operating profit	(14.7)		(22.7)		(43.2)		(29.2)
Unallocated derivative gains (losses)	$	7.7	$	(2.9)	$	37.6	$	(25.0)

Outstanding derivative contracts

The following table presents the gross notional value of outstanding derivative contracts.

	January 31, 2020		April 30, 2019
Commodity contracts	$	808.9	$	544.8
Foreign currency exchange contracts	88.1		144.9
Interest rate contracts	800.0		800.0

XML

Common Shares (Tables)

9 Months Ended

Jan. 31, 2020

Stockholders' Equity Note [Abstract]

Common Shares Information

The following table sets forth common share information.

	January 31, 2020	April 30, 2019
Common shares authorized	300.0	300.0
Common shares outstanding	114.0	113.7
Treasury shares	32.5	32.8

XML

Derivative Financial Instruments (Details Textual) - USD ($) $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Jan. 31, 2020	Jan. 31, 2019	Jan. 31, 2020	Jan. 31, 2019	Apr. 30, 2019	Apr. 30, 2015	Nov. 30, 2018	Jun. 30, 2018
Derivative Financial Instruments (Textual) [Abstract]
Interest expense – net	$ (45.1)	$ (51.6)	$ (143.6)	$ (158.8)
Amortization of deferred gain on early termination agreement	2.1		6.2
Derivative Financial Instruments (Additional Textual) [Abstract]
Cash margin accounts related to derivative instruments recognized	25.7		25.7		$ 40.7
Cumulative net mark-to-market valuation of certain derivative positions recognized in unallocated derivative gains (losses)			$ (14.9)		(52.5)
Commodity contracts
Derivative Financial Instruments (Textual) [Abstract]
Derivative instrument maturity			1 year
Gross notional amount	808.9		$ 808.9		544.8
Foreign currency exchange contracts
Derivative Financial Instruments (Textual) [Abstract]
Derivative instrument maturity			1 year
Gross notional amount	88.1		$ 88.1		144.9
Interest rate contracts
Derivative Financial Instruments (Textual) [Abstract]
Gross notional amount	800.0		800.0		800.0		$ 300.0	$ 500.0
Deferred pre-tax gain (loss) included in accumulated other comprehensive loss	(172.0)		(172.0)		(52.5)
Tax impact related to deferred losses and gains on cash flow hedges included in accumulated other comprehensive loss	$ 39.6		39.6		$ 12.1
Effective portion of the hedge loss reclassified to interest expense over the next twelve months			(8.9)
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax			(168.9)
Total Through Q3 2020 [Member]
Derivative Financial Instruments (Textual) [Abstract]
Amortization of deferred gain on early termination agreement			39.2
2020 [Member]
Derivative Financial Instruments (Textual) [Abstract]
Amortization of deferred gain on early termination agreement			1.9
2021 [Member]
Derivative Financial Instruments (Textual) [Abstract]
Amortization of deferred gain on early termination agreement			8.4
2022 [Member]
Derivative Financial Instruments (Textual) [Abstract]
Amortization of deferred gain on early termination agreement			$ 4.0
Cash [Member] | Interest rate swap | Fair Value Hedging [Member]
Derivative Financial Instruments (Textual) [Abstract]
Gain (loss) on early termination agreement						$ 58.1
Accrued and Prepaid Interest, Net [Member] | Interest rate swap | Fair Value Hedging [Member]
Derivative Financial Instruments (Textual) [Abstract]
Gain (loss) on early termination agreement						$ (4.6)

XML

Derivative Financial Instruments (Details 1) - Cash Flow Hedging [Member] - Interest rate contracts - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jan. 31, 2020	Jan. 31, 2019	Jan. 31, 2020	Jan. 31, 2019
Derivative Instruments, Gain (Loss) [Line Items]
Gains (losses) recognized in other comprehensive income (loss)	$ (22.7)	$ (48.1)	$ (119.8)	$ (37.6)
Change in accumulated other comprehensive income (loss)	(22.6)	(48.0)	(119.5)	(37.3)
Interest Expense [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gains (losses) reclassified from accumulated other comprehensive income (loss) to interest expense	$ (0.1)	$ (0.1)	$ (0.3)	$ (0.3)

XML

Derivative Financial Instruments

9 Months Ended

Jan. 31, 2020

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Financial Instruments

We are exposed to market risks, such as changes in commodity prices, foreign currency exchange rates, and interest rates. To manage the volatility related to these exposures, we enter into various derivative transactions. We have policies in place that define acceptable instrument types we may enter into and establish controls to limit our market risk exposure.

Commodity Price Management: We enter into commodity derivatives to manage price volatility and reduce the variability of future cash flows related to anticipated inventory purchases of key raw materials, notably green coffee, corn, edible oils, soybean meal, and wheat. We also enter into commodity derivatives to manage price risk for energy input costs, including diesel fuel and natural gas. Our derivative instruments generally have maturities of less than one year.

We do not qualify commodity derivatives for hedge accounting treatment, and as a result, the derivative gains and losses are immediately recognized in earnings. Although we do not perform the assessments required to achieve hedge accounting for derivative positions, we believe all of our commodity derivatives are economic hedges of our risk exposure.

The commodities hedged have a high inverse correlation to price changes of the derivative instrument. Thus, we would expect that over time any gain or loss in the estimated fair value of the derivatives would generally be offset by an increase or decrease in the estimated fair value of the underlying exposures.

Foreign Currency Exchange Rate Hedging: We utilize foreign currency derivatives to manage the effect of foreign currency exchange fluctuations on future cash payments primarily related to purchases of certain raw materials and finished goods. The contracts generally have maturities of less than one year. We do not qualify instruments used to manage foreign currency exchange exposures for hedge accounting treatment.

Interest Rate Hedging: We utilize derivative instruments to manage interest rate risk associated with anticipated debt transactions, as well as to manage changes in the fair value of our long-term debt. At the inception of an interest rate contract, the instrument is evaluated and documented for qualifying hedge accounting treatment. If the contract is designated as a cash flow hedge, the mark-to-market gains or losses on the contract are deferred and included as a component of accumulated other comprehensive income (loss) and reclassified to interest expense in the period during which the hedged transaction affects earnings. If the contract is designated as a fair value hedge, the contract is recognized at fair value on the balance sheet, and changes in the fair value are recognized in interest expense. Generally, changes in the fair value of the contract are equal to changes in the fair value of the underlying debt and have no net impact on earnings.

We entered into interest rate contracts in November 2018 and June 2018, with notional values of $300.0 and $500.0, respectively, to manage our exposure to interest rate volatility associated with anticipated debt financing in 2020. These interest rate contracts are designated as cash flow hedges, and as a result, unrealized losses of $168.9 were deferred in accumulated other comprehensive income (loss) at January 31, 2020.

In 2015, we terminated the interest rate swap on the Senior Notes due October 15, 2021, which was designated as a fair value hedge and used to hedge against the changes in the fair value of the debt. As a result of the early termination, we received $58.1 in cash, which included $4.6 of accrued and prepaid interest. The gain on termination was recorded as an increase in the long-term debt balance and is being recognized over the remaining life of the underlying debt as a reduction to interest expense. To date, we have recognized $39.2 of the gain, of which $2.1 and $6.2 was recognized during the three and nine months ended January 31, 2020, respectively. The remaining gain will be recognized as follows: $1.9 through the remainder of 2020, $8.4 in 2021, and $4.0 in 2022.

The following tables set forth the gross fair value amounts of derivative instruments recognized in the Condensed Consolidated Balance Sheets.

	January 31, 2020
	Other Current Assets		Other Current Liabilities		Other Noncurrent Assets		Other Noncurrent Liabilities
Derivatives designated as hedging instruments:
Interest rate contracts	$	—	$	168.9	$	—	$	—
Total derivatives designated as hedging instruments	$	—	$	168.9	$	—	$	—
Derivatives not designated as hedging instruments:
Commodity contracts	$	8.6	$	16.4	$	—	$	—
Foreign currency exchange contracts	0.4		0.1		—		—
Total derivatives not designated as hedging instruments	$	9.0	$	16.5	$	—	$	—
Total derivative instruments	$	9.0	$	185.4	$	—	$	—

	April 30, 2019
	Other Current Assets		Other Current Liabilities		Other Noncurrent Assets		Other Noncurrent Liabilities
Derivatives designated as hedging instruments:
Interest rate contracts	$	—	$	49.1	$	—	$	—
Total derivatives designated as hedging instruments	$	—	$	49.1	$	—	$	—
Derivatives not designated as hedging instruments:
Commodity contracts	$	4.8	$	25.8	$	—	$	—
Foreign currency exchange contracts	1.4		0.2		—		—
Total derivatives not designated as hedging instruments	$	6.2	$	26.0	$	—	$	—
Total derivative instruments	$	6.2	$	75.1	$	—	$	—

We have elected to not offset fair value amounts recognized for our exchange-traded derivative instruments and our cash margin accounts executed with the same counterparty that are generally subject to enforceable netting agreements. We are required to maintain cash margin accounts in connection with funding the settlement of our open positions. At January 31, 2020, and April 30, 2019, we maintained cash margin account balances of $25.7 and $40.7, respectively, included in other current assets in the Condensed Consolidated Balance Sheets. The change in the cash margin account balances is included in other – net, investing activities in the Condensed Statements of Consolidated Cash Flows. In the event of default and immediate net settlement of all of our open positions with individual counterparties, all of our exchange-traded derivative liabilities would be fully offset by either our derivative asset positions or margin accounts based on the net asset or liability position with our individual counterparties.

Interest expense – net, as presented in the Condensed Statements of Consolidated Income, was $45.1 and $51.6 for the three months ended January 31, 2020 and 2019, respectively, and was $143.6 and $158.8 for the nine months ended January 31, 2020 and 2019, respectively. The following table presents information on the pre-tax gains and losses recognized on interest rate contracts designated as cash flow hedges.

	Three Months Ended January 31,				Nine Months Ended January 31,
	2020		2019		2020		2019
Gains (losses) recognized in other comprehensive income (loss)	$	(22.7)	$	(48.1)	$	(119.8)	$	(37.6)
Less: Gains (losses) reclassified from accumulated other comprehensive income (loss) to interest expense	(0.1)		(0.1)		(0.3)		(0.3)
Change in accumulated other comprehensive income (loss)	$	(22.6)	$	(48.0)	$	(119.5)	$	(37.3)

Included as a component of accumulated other comprehensive income (loss) at January 31, 2020, and April 30, 2019, were deferred net pre-tax losses of $172.0 and $52.5, respectively, related to the active and terminated interest rate contracts. The related net tax benefit recognized in accumulated other comprehensive income (loss) at January 31, 2020, and April 30, 2019, was $39.6 and $12.1, respectively. Approximately $8.9 of the net pre-tax loss will be recognized over the next 12 months related to the active and terminated interest rate contracts.

The following table presents the net gains and losses recognized in cost of products sold on derivatives not designated as hedging instruments.

	Three Months Ended January 31,				Nine Months Ended January 31,
	2020		2019		2020		2019
Gains (losses) on commodity contracts	$	(7.3)	$	(25.8)	$	(4.8)	$	(55.9)
Gains (losses) on foreign currency exchange contracts	0.3		0.2		(0.8)		1.7
Total gains (losses) recognized in cost of products sold	$	(7.0)	$	(25.6)	$	(5.6)	$	(54.2)

Commodity and foreign currency exchange derivative gains and losses are reported in unallocated derivative gains and losses outside of segment operating results until the related inventory is sold. At that time, we reclassify the hedge gains and losses from unallocated derivative gains and losses to segment profit, allowing our segments to realize the economic effect of the hedge without experiencing any mark-to-market volatility. The following table presents the activity in unallocated derivative gains and losses.

	Three Months Ended January 31,				Nine Months Ended January 31,
	2020		2019		2020		2019
Net gains (losses) on mark-to-market valuation of unallocated derivative positions	$	(7.0)	$	(25.6)	$	(5.6)	$	(54.2)
Less: Net gains (losses) on derivative positions reclassified to segment operating profit	(14.7)		(22.7)		(43.2)		(29.2)
Unallocated derivative gains (losses)	$	7.7	$	(2.9)	$	37.6	$	(25.0)

The net cumulative unallocated derivative losses were $14.9 and $52.5 at January 31, 2020, and April 30, 2019, respectively.

The following table presents the gross notional value of outstanding derivative contracts.

	January 31, 2020		April 30, 2019
Commodity contracts	$	808.9	$	544.8
Foreign currency exchange contracts	88.1		144.9
Interest rate contracts	800.0		800.0

XML

Earnings per Share

9 Months Ended

Jan. 31, 2020

Earnings Per Share [Abstract]

Earnings per Share

The following table sets forth the computation of net income per common share and net income per common share – assuming dilution under the two-class method.

	Three Months Ended January 31,				Nine Months Ended January 31,
	2020		2019		2020		2019
Net income	$	187.4	$	121.4	$	553.2	$	442.9
Less: Net income allocated to participating securities	1.1		0.6		3.2		2.3
Net income allocated to common stockholders	$	186.3	$	120.8	$	550.0	$	440.6
Weighted-average common shares outstanding	113.4		113.2		113.3		113.1
Add: Dilutive effect of stock options	—		—		—		—
Weighted-average common shares outstanding – assuming dilution	113.4		113.2		113.3		113.1
Net income per common share	$	1.64	$	1.07	$	4.85	$	3.89
Net income per common share – assuming dilution	$	1.64	$	1.07	$	4.85	$	3.89

XML

Acquisition

9 Months Ended

Jan. 31, 2020

Business Combinations [Abstract]

Acquisition

On May 14, 2018, we acquired the equity of Ainsworth Pet Nutrition, LLC (“Ainsworth”), a leading producer, distributor, and marketer of premium pet food and pet snacks, predominantly within the U.S., in an all-cash transaction valued at $1.9 billion. The transaction was funded with a bank term loan and borrowings under our commercial paper program of approximately $1.5 billion and $400.0, respectively. For additional information on the financing associated with this transaction, refer to Note 9: Debt and Financing Arrangements.

During 2019, the final purchase price was allocated to the underlying assets acquired and liabilities assumed based upon their estimated fair values at the date of acquisition. We determined the estimated fair values based on independent appraisals, discounted cash flow analyses, quoted market prices, and other estimates made by management. The purchase price allocation included total intangible assets of $1.3 billion. The purchase price exceeded the estimated fair value of the net identifiable tangible and intangible assets acquired and, as a result, the excess was allocated to goodwill. As a result of the acquisition, we recognized total goodwill of $617.8 within the U.S. Retail Pet Foods segment, which represented the value we expected to achieve through the implementation of operational synergies and growth opportunities as a result of integrating Ainsworth into our U.S. Retail Pet Foods segment. Of the total goodwill, $446.0 was deductible for income tax purposes at the acquisition date, of which $392.9 remains deductible at January 31, 2020. The goodwill and indefinite-lived trademarks within the U.S. Retail Pet Foods segment, inclusive of the recently acquired Ainsworth business, remain susceptible to future impairment charges due to the narrow differences between fair value and carrying value. Any significant adverse change in our near or long-term projections or macroeconomic conditions could result in future impairment charges. For more information, see Note 8: Goodwill and Other Intangible Assets.

XML

Other Financial Instruments and Fair Value Measurements (Tables)

9 Months Ended

Jan. 31, 2020

Fair Value Disclosures [Abstract]

Carrying amount and fair value of financial instruments

The following table provides information on the carrying amounts and fair values of our financial instruments.

	January 31, 2020				April 30, 2019
	Carrying Amount		Fair Value		Carrying Amount		Fair Value
Marketable securities and other investments	$	40.7	$	40.7	$	40.9	$	40.9
Derivative financial instruments – net	(176.4)		(176.4)		(68.9)		(68.9)
Total long-term debt	(5,083.1)		(5,386.8)		(5,484.8)		(5,504.0)

Financial assets (liabilities) measured at fair value on a recurring basis

The following tables summarize the fair values and the levels within the fair value hierarchy in which the fair value measurements fall for our financial instruments.

	Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Fair Value at January 31, 2020
Marketable securities and other investments: (A)
Equity mutual funds	$	9.6	$	—	$	—	$	9.6
Municipal obligations	—		31.1		—		31.1
Money market funds	—		—		—		—
Derivative financial instruments: (B)
Commodity contracts – net	(7.5)		(0.3)		—		(7.8)
Foreign currency exchange contracts – net	—		0.3		—		0.3
Interest rate contracts	—		(168.9)		—		(168.9)
Total long-term debt (C)	(4,662.4)		(724.4)		—		(5,386.8)
Total financial instruments measured at fair value	$	(4,660.3)	$	(862.2)	$	—	$	(5,522.5)

	Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Fair Value at April 30, 2019
Marketable securities and other investments: (A)
Equity mutual funds	$	8.7	$	—	$	—	$	8.7
Municipal obligations	—		31.7		—		31.7
Money market funds	0.5		—		—		0.5
Derivative financial instruments: (B)
Commodity contracts – net	(20.7)		(0.3)		—		(21.0)
Foreign currency exchange contracts – net	(0.1)		1.3		—		1.2
Interest rate contracts	—		(49.1)		—		(49.1)
Total long-term debt (C)	(4,646.6)		(857.4)		—		(5,504.0)
Total financial instruments measured at fair value	$	(4,658.2)	$	(873.8)	$	—	$	(5,532.0)

(A)Marketable securities and other investments consist of funds maintained for the payment of benefits associated with nonqualified retirement plans. The funds include equity securities listed in active markets, municipal obligations valued by a third party using valuation techniques that utilize inputs that are derived principally from or corroborated by observable market data, and money market funds with maturities of three months or less. Based on the short-term nature of these money market funds, carrying value approximates fair value. As of January 31, 2020, our municipal obligations are scheduled to mature as follows: $0.3 in 2020, $1.0 in 2021, $1.5 in 2022, $1.0 in 2023, and the remaining $27.3 in 2024 and beyond.

(B)Level 1 commodity and foreign currency exchange derivatives are valued using quoted market prices for identical instruments in active markets. Level 2 commodity and foreign currency exchange derivatives are valued using quoted prices for similar assets or liabilities in active markets. The Level 2 interest rate contracts are valued using standard valuation techniques, the income approach, and observable Level 2 market expectations at the measurement date to convert future amounts to a single discounted present value. Level 2 inputs for the valuation of the interest rate contracts are limited to prices that are observable for the asset or liability. For additional information, see Note 11: Derivative Financial Instruments.

(C)Long-term debt is composed of public Senior Notes classified as Level 1 and the Term Loan classified as Level 2. The public Senior Notes are traded in an active secondary market and valued using quoted prices. The fair value of the Term Loan is based on the net present value of each interest and principal payment calculated utilizing an interest rate derived from an estimated yield curve obtained from independent pricing sources for similar types of term loan borrowing arrangements. For additional information, see Note 9: Debt and Financing Arrangements.

XML

Recently Issued Accounting Standards (Details) - USD ($) $ in Millions	Jan. 31, 2020	May 01, 2019	Apr. 30, 2019
Operating lease right-of-use assets	$ 168.0		$ 0.0
Total operating lease liabilities	175.2
Accounting Standards Update 2016-02 [Member]
Operating lease right-of-use assets		$ 159.2
Total operating lease liabilities		$ 166.6
New Accounting Pronouncement, Early Adoption, Effect [Member] | Accounting Standards Update 2018-15 [Member] | Other Noncurrent Assets [Member]
Capitalized third-party cloud computing implementation costs	$ 3.4

XML

Integration and Restructuring Costs (Tables)

9 Months Ended

Jan. 31, 2020

Restructuring and Related Activities [Abstract]

Integration costs

The following table summarizes our integration costs incurred related to the Ainsworth acquisition.

	Three Months Ended January 31,				Nine Months Ended January 31,				Total Costs Incurred to Date at January 31, 2020
	2020		2019		2020		2019
Employee-related costs	$	0.3	$	5.4	$	1.7	$	13.2	$	17.2
Other transition and termination costs	3.0		2.3		8.2		10.7		24.8
Total integration costs	$	3.3	$	7.7	$	9.9	$	23.9	$	42.0

XML

Accumulated Other Comprehensive Income (Loss)

9 Months Ended

Jan. 31, 2020

Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]

Accumulated Other Comprehensive Income (Loss)

The components of accumulated other comprehensive income (loss), including the reclassification adjustments for items that are reclassified from accumulated other comprehensive income (loss) to net income, are shown below.

	Foreign Currency Translation Adjustment		Net Gains (Losses) on Cash Flow Hedging Derivatives (A)		Pension and Other Postretirement Liabilities (B)		Unrealized  Gain (Loss) on Available- for-Sale Securities		Accumulated Other Comprehensive Income (Loss)
Balance at May 1, 2019	$	(35.5)	$	(40.4)	$	(110.0)	$	4.1	$	(181.8)
Reclassification adjustments	—		0.3		5.2		—		5.5
Current period credit (charge)	2.6		(119.8)		—		1.2		(116.0)
Income tax benefit (expense)	—		27.5		(1.2)		(0.3)		26.0
Balance at January 31, 2020	$	(32.9)	$	(132.4)	$	(106.0)	$	5.0	$	(266.3)

	Foreign Currency Translation Adjustment		Net Gains (Losses) on Cash Flow Hedging Derivatives (A)		Pension and Other Postretirement Liabilities (B)		Unrealized Gain (Loss) on Available- for-Sale Securities		Accumulated Other Comprehensive Income (Loss)
Balance at May 1, 2018	$	(16.4)	$	(2.9)	$	(101.0)	$	3.6	$	(116.7)
Reclassification adjustments	—		0.3		6.0		—		6.3
Current period credit (charge)	(10.1)		(37.6)		(2.4)		(0.5)		(50.6)
Income tax benefit (expense)	—		8.5		(0.9)		0.1		7.7
Balance at January 31, 2019	$	(26.5)	$	(31.7)	$	(98.3)	$	3.2	$	(153.3)

(A)The reclassification from accumulated other comprehensive income (loss) to interest expense was related to terminated interest rate contracts. The current period credit (charge) relates to the unrealized gains (losses) on the interest rate contracts entered into in November 2018 and June 2018. For additional information, see Note 11: Derivative Financial Instruments.

(B)Amortization of net losses and prior service costs was reclassified from accumulated other comprehensive income (loss) to other income (expense) – net.

XML

Basis of Presentation

9 Months Ended

Jan. 31, 2020

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of Presentation

The unaudited interim condensed consolidated financial statements of The J. M. Smucker Company (“Company,” “we,” “us,” or “our”) have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments of a normal recurring nature considered necessary for a fair presentation have been included.

Operating results for the nine months ended January 31, 2020, are not necessarily indicative of the results that may be expected for the year ending April 30, 2020. For further information, reference is made to the consolidated financial statements and notes included in our Annual Report on Form 10-K for the year ended April 30, 2019.

XML

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Millions		Jan. 31, 2020	Apr. 30, 2019
Current Assets
Cash and cash equivalents		$ 74.4	$ 101.3
Trade receivables, less allowance for doubtful accounts		477.3	503.8
Inventories:
Finished products		615.1	590.8
Raw materials		343.7	319.5
Total Inventory		958.8	910.3
Other current assets		92.2	109.8
Total Current Assets		1,602.7	1,625.2
Property, Plant, and Equipment
Land and land improvements		123.7	122.1
Buildings and fixtures		958.2	903.2
Machinery and equipment		2,369.0	2,185.0
Construction in progress		194.9	321.8
Gross Property, Plant, and Equipment		3,645.8	3,532.1
Accumulated depreciation		(1,734.1)	(1,619.7)
Total Property, Plant, and Equipment		1,911.7	1,912.4
Other Noncurrent Assets
Operating lease right-of-use assets		168.0	0.0
Goodwill		6,312.8	6,310.9
Other intangible assets – net		6,491.4	6,718.8
Other noncurrent assets		149.6	144.0
Total Other Noncurrent Assets		13,121.8	13,173.7
Total Assets		16,636.2	16,711.3
Current Liabilities
Accounts payable		575.0	591.0
Accrued trade marketing and merchandising		198.7	142.7
Current portion of long-term debt	[1]	499.8	798.5
Short-term borrowings		310.0	426.0
Current operating lease liabilities		41.7	0.0
Other current liabilities		452.2	383.3
Total Current Liabilities		2,077.4	2,341.5
Noncurrent Liabilities
Long-term debt, less current portion	[1]	4,583.3	4,686.3
Deferred income taxes		1,364.2	1,398.6
Noncurrent operating lease liabilities		133.5	0.0
Other noncurrent liabilities		307.4	314.4
Total Noncurrent Liabilities		6,388.4	6,399.3
Total Liabilities		8,465.8	8,740.8
Shareholders’ Equity
Common shares		29.0	28.9
Additional capital		5,787.2	5,755.8
Retained income		2,620.5	2,367.6
Accumulated other comprehensive income (loss)		(266.3)	(181.8)
Total Shareholders’ Equity		8,170.4	7,970.5
Total Liabilities and Shareholders’ Equity		$ 16,636.2	$ 16,711.3

[1] Represents the carrying amount included in the Condensed Consolidated Balance Sheets, which includes the impact of capitalized debt issuance costs, terminated interest rate contracts, and offering discounts.

XML

Reportable Segments (Details 2) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Jan. 31, 2020	Jan. 31, 2019	Jan. 31, 2020	Jan. 31, 2019
Product category information [Line Items]
Net sales		$ 1,972.3	$ 2,011.9	$ 5,709.0	$ 5,935.9
Percent of product sales attributable to primary reportable segment				75.00%
U.S. Retail Pet Foods [Member]
Product category information [Line Items]
Net sales		721.9	759.0	$ 2,101.7	2,158.3
U.S. Retail Pet Foods [Member] | Dog food [Member]
Product category information [Line Items]
Net sales	[1]	300.8	337.5	899.0	980.9
U.S. Retail Pet Foods [Member] | Cat food [Member]
Product category information [Line Items]
Net sales	[1]	223.9	218.9	633.6	615.2
U.S. Retail Pet Foods [Member] | Pet snacks [Member]
Product category information [Line Items]
Net sales	[1]	214.6	217.9	617.8	607.6
U.S. Retail Coffee [Member]
Product category information [Line Items]
Net sales		558.8	561.6	1,567.9	1,596.0
U.S. Retail Coffee [Member] | Coffee [Member]
Product category information [Line Items]
Net sales	[1]	650.7	653.5	1,824.5	1,867.3
U.S. Retail Consumer Foods [Member]
Product category information [Line Items]
Net sales		422.9	422.7	1,251.2	1,367.9
U.S. Retail Consumer Foods [Member] | Peanut butter [Member]
Product category information [Line Items]
Net sales	[1]	180.0	188.5	533.3	574.6
U.S. Retail Consumer Foods [Member] | Fruit spreads [Member]
Product category information [Line Items]
Net sales	[1]	88.3	86.0	264.0	254.6
U.S. Retail Consumer Foods [Member] | Frozen handheld [Member]
Product category information [Line Items]
Net sales	[1]	82.6	67.3	247.5	210.5
U.S. Retail Consumer Foods [Member] | Shortening and oils [Member]
Product category information [Line Items]
Net sales	[1]	68.9	74.8	192.2	207.0
U.S. Retail Consumer Foods [Member] | Juices and beverages [Member]
Product category information [Line Items]
Net sales	[1]	30.4	30.6	94.0	96.7
International and Away From Home [Member]
Product category information [Line Items]
Net sales		268.7	268.6	788.2	813.7
International and Away From Home [Member] | Portion control [Member]
Product category information [Line Items]
Net sales	[1]	42.0	40.1	123.9	122.6
International and Away From Home [Member] | Baking mixes and ingredients [Member]
Product category information [Line Items]
Net sales	[1],[2]	19.6	21.9	59.3	164.6
International and Away From Home [Member] | Other [Member]
Product category information [Line Items]
Net sales	[1]	$ 70.5	$ 74.9	$ 219.9	$ 234.3

[1] The primary reportable segment generally represents at least 75 percent of total net sales for each respective product category.

[2] During the three and nine months ended January 31, 2019, the primary reportable segment was U.S. Retail Consumer Foods, as the majority of the net sales within this category were related to the divested U.S. baking business. For more information, see Note 5: Divestiture.

XML

Goodwill and Other Intangible Assets - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jan. 31, 2020	Jan. 31, 2019	Jan. 31, 2020	Jan. 31, 2019	Apr. 30, 2019
Goodwill and Intangible Assets [Line Items]
Other intangible assets impairment charges	$ 52.4	$ 107.2	$ 52.4	$ 107.2
Goodwill	6,312.8		6,312.8		$ 6,310.9
U.S. Retail Pet Foods [Member]
Goodwill and Intangible Assets [Line Items]
Other intangible assets impairment charges	52.4	$ 107.2
Goodwill	2,400.0		2,400.0
Indefinite-lived intangible assets not subject to amortization, Net	1,400.0		1,400.0
U.S. Retail Pet Foods [Member] | Trademarks
Goodwill and Intangible Assets [Line Items]
Annual amortization expense	$ 4.5		$ 4.5

XML

Common Shares (Details) - shares	9 Months Ended
	Jan. 31, 2020	Jan. 31, 2019	Apr. 30, 2019
Common Shares Information
Common shares authorized	300,000,000.0		300,000,000.0
Common shares outstanding	114,000,000.0		113,700,000
Treasury shares	32,500,000		32,800,000
Common Shares (Additional Textual) [Abstract]
Stock Repurchased During Period, Shares	0	0
Shares remaining for repurchase	3,600,000

XML

Leases (Details 4)	Jan. 31, 2020
Leases [Abstract]
Operating Lease, Weighted Average Remaining Lease Term	4 years 9 months 18 days
Finance Lease, Weighted Average Remaining Lease Term	3 years 4 months 24 days
Operating Lease, Weighted Average Discount Rate, Percent	3.10%
Finance Lease, Weighted Average Discount Rate, Percent	3.00%

XML

Leases (Details) - USD ($) $ in Millions	Jan. 31, 2020	Apr. 30, 2019
Operating lease right-of-use assets	$ 168.0	$ 0.0
Current operating lease liabilities	41.7	0.0
Noncurrent operating lease liabilities	133.5	$ 0.0
Total operating lease liabilities	175.2
Total finance lease liabilities	5.9
Machinery and Equipment [Member]
Machinery and equipment	13.4
Accumulated Depreciation [Member]
Accumulated depreciation	(6.9)
Property, Plant and Equipment [Member]
Total property, plant, and equipment	6.5
Other Current Liabilities [Member]
Current finance lease liabilities	2.2
Other Noncurrent Liabilities [Member]
Noncurrent finance lease liabilities	$ 3.7